1,860 Matching Annotations
  1. Last 7 days
    1. Fig. 3

      NonPatientCell Sarcoplasmic reticulum of cardiac muscle cell, FMA:62390

      GeneAlteration The D307H mutant was generated using Quick Change (Life Sciences). Substitution of the CAC codon with GAC resulted in a BamH1 restriction site that was used along with complete sequencing of the DNA inserts to verify sequence.

      FunctionalEvidence (fig. 3) Diminished sensitivity to Ca2+ leading to more intercellular Ca2+

      FAVariant NM_001232.3(CASQ2):c.919G>C (p.Asp307His), 17610

      CaseAddInfo Fig 4&5 show evidence for the conformation change responsible for the sensitivity difference.

      gnomAD 0.00003249 link

    1. Patient II-3 of the family presented in figure 2belonged to a large MHS family in which an R1086H mutation responsible for the MHS trait was identified in the CACNA1S  gene.

      Case# Monnier 2:3, male, French

      CasePresentingHPOs HP:0002047

      CasePreviousTesting N/A

      CaseMethod1 sequenced all cDNA

      CaseGenotypingMethod single strand conformation analysis and sequencing

      Variant NM_000069.2(CACNA1S):c.3257G>A (p.Arg1086His)

      ClinVar 17626

      gnomAD 0.00002978 link<br /> gnomAD did not include the G>A mutation, only C>T but it was the same amino acid change

      VariantEvidence N/A, all of these case studies claim ICVT verifies the phenotype but that doesn't seem like enough to pass for variant evidence since it is tested in patient muscle tissue.

      CaseAddInfo Family not counted, too few segregations for the R1086H variant.

    1. FSIP2_2 

      CaseFSIP2_2 male, 52yo report, Tunisian

      CasePresentingHPOs HP:0003251, HP:0012207, HP:0012868

      (male infertility, asthenospermia, sperm tail anomaly)

      HPOsFreeText Sperm volume: 4.7mL, sperm concentration: 1.25 million/mL, total motility: 0h, vitality: 7%, normal spermatozoa: 0%, absent flagella: 16%, short flagella: 50%, coiled flagella: 18%, flagella of irregular caliber: 36%

      CaseNotHPOs n/a

      CasePreviousTesting Previous genetic analysis of DNAH1, CFAP43, and CFAP44 did not end in diagnosis. "Normal somatic karyotypes 46,XY and were negative for Y chromosome microdeletions."

      Variant NM_173651.3(FSIP2):c.2282dup (p.Asn761Lysfs)

      ClinVar 586973

      gnomAD not in gnomAD

      CaseAddInfo Consanguineous parents

      CasePMIDs 29449551

    2. FSIP2_1 

      CaseFSIP2_1 male, 44yo report, Tunisian

      CasePresentingHPOs HP:0003251, HP:0012207, HP:0012868

      (male infertility, asthenospermia, sperm tail anomaly)

      HPOsFreeText Sperm volume: 2.5mL, sperm concentration: 6.7 million/mL, total motility: 1h, vitality: 47%, normal spermatozoa: 0%, absent flagella: 2%, short flagella: 32%, coiled flagella: 26%, flagella of irregular caliber: 57%

      CaseNotHPOs n/a

      CasePreviousTesting Previous genetic analysis of DNAH1, CFAP43, and CFAP44 did not end in diagnosis. "Normal somatic karyotypes 46,XY and were negative for Y chromosome microdeletions."

      Variant NM_173651.3(FSIP2):c.910del (p.Gln304Lysfs)

      ClinVar 586972

      gnomAD not in gnomAD

      CaseAddInfo Consanguineous parents

      CasePMIDs 29449551

    1. Accelerated Ca2+ Current Activation Through α1ST1354S Leads to an Increase of SR Ca2+ Release in the Presence of Caffeine

      NonPatientCell Mouse cell line, EFO:0002887 "Myotubes of the homozygous CaVα1S-null (dysgenic) mouse cell line GLT were cultured on 35-mm culture dishes as described previously (32)."

      GeneAlteration Mouse GLT line myotubes were transfected with GFP-tagged α1S cDNA constructs at the onset of myoblast fusion using FuGENE 6 transfection reagent according to the manufacturer's protocols (Roche Diagnostics).

      FunctionalEvidence Fig 3: faster voltage-gated activation than WT. Fig 6: increased release of calcium ions in the presence of caffeine vs WT.

      FAVariants NM_000069.2(CACNA1S):c.4060A>T (p.Thr1354Ser), ClinVar ID: 161208

    1. third affected individual in this family (individual III-3) was very similar and consistent with a spastic-ataxia phenotype.

      Case#: Family 1, Individual III-3, Male, 8yo, dx at 6mo

      CasePresentingHPOs: HP:0000639, HP:0012389, HP:0001270, HP:0002078, HP:0002070, HP:0001260, HP:0007256

      CaseNotHPOs:

      CasePreviousTesting: MRI

      CaseGenotypingMethod: combination of homozygosity mapping and WES, haplotype analysis

      Variant: NM_177400.2(NKX6-2):c.121A>T (p.Lys41Ter)

      ClinVar: 430622, https://www.ncbi.nlm.nih.gov/clinvar/variation/430622/

      gnomAD: n/a

      VariantEvidence:

      CaseAddInfo: Wheelchair bound at 8 yo.

      CasePMIDs:

    2. Children (individuals 6 [IV-6] and 7 [IV-7]) of a third consanguineous Saudi Arabian family presented with nystagmus and developmental delay, most pronounced in the motor domain

      FamilyName: Family 3 (individuals 6 and 7)

      FamilyPresentingHPOS: HP:0000639, HP:0012736, HP:0001252, HP:0001257

      FamilyNotHPOs:

      CountryOrigin: Saudi Arabia

      Ethnicity: n/a

      Race: n/a

      FamilyPreviousTesting: MRI showed brain hypomyelination

      FamilyGenotypingMethod: combination of homozygosity mapping and WES, autozygosity mapping

      Affected: 3

      Unaffected:

      Segregations:

      PublishedLOD:

      eLOD:

      AddSegregationInfo: consanguineous family

      ProbandLabel: IV-6 (individual 6), Female, 6yo, dx at 1mo

      Variant: NM_177400.2(NKX6-2):c.487C>G (p.Leu163Val)

      ClinVar: 430623, https://www.ncbi.nlm.nih.gov/clinvar/variation/430623/

      gnomAD: n/a

      CasePresentingHPOs:

      CasePresentingHPOTerm:

      CaseNotHPOs:

      AddCaseInfo:

      VariantEvidence:

    1. Case#: Consequence 14 Table 1 in Data Supplement (1 cases)

      DiseaseAssertion: HCM

      FamilyInfo: N/A

      CasePresentingHPOs: N/A

      CaseHPOFreeText: Cardiac magnetic resonance imaging, BSA, NYHA functional class, obstructive HCM, atrial fibrillation, coronary artery disease, NSVT, Syncope, SCD family hitory, wall thickness

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: Additional oligonucleotide hybridization–based DNA sequencing and dideoxy-based DNA sequencing for MYBPC3, TMP1, TNNC1, TNNI2, TNNI3, TNNT2, ACTC1, MYL3

      CaseGenotypingMethod: oligonucleotide hybridization–based DNA sequencing and dideoxy-based DNA sequencing

      Variant: NM_000257.4(MYH7):c.1208G>A (p.Arg403Gln)

      ClinVar: 14087 https://www.ncbi.nlm.nih.gov/clinvar/variation/14087/

      CAID: n/a

      gnomAD: absent

    2. CaseMYH7-9: N/A

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)

      HPOsFreeText: N/A

      CaseNotHPOs: N/A

      NotHPOsFreeText: N/A

      CaseAddInfo: 1 other proband shares this genotype

      CaseGenotypingMethod: Testing for all 8 sarcomeric genes, plus GLA, LAMP2, and PRKAG2 was initiated in all probands. After the direct sequencing, the variants were filtered for pathogenicity and classified.

      Variant: NM_000257.3:c.1816G>A (p.Val606Met)

      ClinVar: 14091 https://www.ncbi.nlm.nih.gov/clinvar/variation/14091/

      gnomAD: European (Non-Finnish) 1.548e-5, Overall 7.070e-6 https://gnomad.broadinstitute.org/variant/14-23896866-C-T

    3. CaseMYH7-28: N/A

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)

      HPOsFreeText: N/A

      CaseNotHPOs: N/A

      NotHPOsFreeText: N/A

      CaseAddInfo: N/A

      CaseGenotypingMethod: Testing for all 8 sarcomeric genes, plus GLA, LAMP2, and PRKAG2 was initiated in all probands. After the direct sequencing, the variants were filtered for pathogenicity and classified.

      Variant: NM_000257.3:c.2782G>A (p.Asp928Asn)

      ClinVar: 164313 https://www.ncbi.nlm.nih.gov/clinvar/variation/164313/

      gnomAD: Not in gnomAD

    4. CaseMYH7-20: N/A

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)

      HPOsFreeText: N/A

      CaseNotHPOs: N/A

      NotHPOsFreeText: N/A

      CaseAddInfo: N/A

      CaseGenotypingMethod: Testing for all 8 sarcomeric genes, plus GLA, LAMP2, and PRKAG2 was initiated in all probands. After the direct sequencing, the variants were filtered for pathogenicity and classified.

      Variant: NM_000257.3:c.2945T>C (p.Met982Thr)

      ClinVar: 42941 https://www.ncbi.nlm.nih.gov/clinvar/variation/42941/

      gnomAD: European (Non-Finnish) 1.416e-3, Overall 8.484e-4 https://gnomad.broadinstitute.org/variant/14-23892910-A-G

    5. CaseMYH7-31: N/A

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)

      HPOsFreeText: N/A

      CaseNotHPOs: N/A

      NotHPOsFreeText: N/A

      CaseAddInfo: N/A

      CaseGenotypingMethod: Testing for all 8 sarcomeric genes, plus GLA, LAMP2, and PRKAG2 was initiated in all probands. After the direct sequencing, the variants were filtered for pathogenicity and classified.

      Variant: NM_000257.3:c.788T>C (p.Ile263Thr)

      ClinVar: 43106 https://www.ncbi.nlm.nih.gov/clinvar/variation/43106/

      gnomAD: European (Non-Finnish) 8.792e-6, Overall 3.977e-6 https://gnomad.broadinstitute.org/variant/14-23900635-A-G

    1. 6

      Case6: Male, 40 yrs report

      CasePresentingHPOs: N/A

      HPOsFreeText: N/A

      CaseNotHPOs: N/A

      NotHPOsFreeText: N/A

      CaseAddInfo: Son of Case 4, Sibling of Case 5

      CasePreviousTesting: N/A

      CaseGenotypingMethod: The TPM2 gene was sequenced and variants identified. No other information is provided.

      Variant: NM_003289.3:c.14_16delAGA (p.Lys7del)

      ClinVar: 140486 https://www.ncbi.nlm.nih.gov/clinvar/variation/140486/

      gnomAD: Not in gnomAD

    2. 3

      Case3: Male, 41 yrs report

      CasePresentingHPOs: HP:0012432, HP:0003738, HP:0003236, HP:0003273, HP:0003044, HP:0012785, HP:0006466, HP:0005997, HP:0003798, HP:0100295, HP:0031237, HP:0003201, HP:0012548 (Chronic fatigue, Exercise-induced myalgia, Elevated serum creatine phosphokinase, Hip contracture, Shoulder flexion contracture, Flexion contracture of finger, Ankle contracture, Neck flexion contracture, Nemaline bodies, Muscle fiber atrophy, Internally nucleated skeletal muscle fibers, Rhabdomyolysis, Skeletal muscle fatty infiltration)

      HPOsFreeText: Jaw contractures, Core-like regions

      CaseNotHPOs: HP:0001627 (Cardiac abnormality)

      NotHPOsFreeText: N/A

      CaseAddInfo: Variant is confirmed de novo via parental testing

      CasePreviousTesting: ACTA1 and TPM3 were sequenced and returned negative.

      CaseGenotypingMethod: The TPM2 gene was sequenced and variants identified. No other information is provided.

      Variant: NM_003289.3:c.14_16delAGA (p.Lys7del)

      ClinVar: 140486 https://www.ncbi.nlm.nih.gov/clinvar/variation/140486/

      gnomAD: Not in gnomAD

    3. 2

      Case2: Male, 14 yrs report

      CasePresentingHPOs: HP:0002355, HP:0002527, HP:0000023, HP:0001763, HP:0002942, HP:0001276, HP:0006466, HP:0003089 (Difficulty walking, Falls, Inguinal hernia, Pes planus, Thoracic kyphosis, Hypertonia, Ankle contracture, hamstring contracture)

      HPOsFreeText: In-toe gait, Tendo-Achilles release performed

      CaseNotHPOs: N/A

      NotHPOsFreeText: N/A

      CaseAddInfo: Son of Case 1, Variant is de novo in mother

      CasePreviousTesting: N/A

      CaseGenotypingMethod: The TPM2 gene was sequenced and variants identified. No other information is provided.

      Variant: NM_003289.3:c.14_16delAGA (p.Lys7del)

      ClinVar: 140486 https://www.ncbi.nlm.nih.gov/clinvar/variation/140486/

      gnomAD: Not in gnomAD

    1. From supplemental tables S2 and S3 (authors used hg19 alignment).

      MONDO: MONDO:0005144 for FALS

      Case#4: Smith 2014 FALS R320C, M, 64 y.o. onset, Italy

      CasePresentingHPOs: HP:0007354

      CaseHPOFreeText: spinal-onset ALS with upper and lower motor neuron signs

      CasePreviousTesting: All FALS were screened for known causative mutations/repeat expansions in SOD1, C9orf72, TARDBP, FUS, PFN1, UBQLN2, OPTN, VCP and ANG and removed from cohort if positive for variant.

      CaseMethod1: This case identified through case-control study

      CaseGenotypingMethod: Exome sequencing, confirmed with Sanger sequencing.

      Variant: NM_006000.3(TUBA4A):c.958C>T (p.Arg320Cys)

      ClinVar: 180182

      gnomAD: 2-220115463-G-A; Total overall AF (non-neuro) = 0.000009609; TUBA4A_p.Arg320Cys_gnomAD

      CaseAddInfo: This variant found in 0/13023 control samples.

    1. A(VI3)

      FamilyName: PLAA L752F Founder families

      FamilyPresentingHPOs: HP:0002061, HP:0002191, HP:0006986, HP:0002273, HP:0002493, HP:0001332, HP:0001332, HP:0011344, HP:0031826, HP:0002267

      FamilyHPOFreeText: Posture deformation, including dystonic posturing, rigidity and freezing.Motor delay was severely impaired and classified as Level V according to the Gross Motor Function Classification System.

      FamilyNotHPOs:

      CountryOrigin: Israel

      Ethnicity:

      Race:

      FamilyPreviousTesting:

      FamilyMethod1: Linkage and haplotype analysis

      FamilyMethod2: mIPs-Gene panels

      FamilyGenotypingMethod: Linkage and haplotype analysis revealed a common founder mutation between Families 1/A and 2/B (Figure 2). mIP technology was used for gene sequencing to confirm the genetic alteration of the PLAA gene, in homozygosity. Confirmation of the PLAA variant was done by Sanger Sequencing.

      Affected: 7

      Unaffected: 23

      Segregations:

      PublishedLOD: 3.24

      eLOD: n/a

      AddSegregationInfo: Families 1/A and 2/B were found to share a common ancestor, and thus revealed a founder mutation.

      ProbandLabel: Family A-VI3, female, AoO= 4 months, AaR= 15 years

      Variant: NM_001031689.2(PLAA):c.2254C>T (p.Leu752Phe)

      ClinVar: 427940

      Hoomzygous, Asserted Pathogenic on ClinVar, no star, updated June 21, 2017

      gnomAD: n/a

      FamilyAddInfo:

      FamilyPMIDs: n/a

      CasePresentingHPOs: HP:0001508, HP:0000253, HP:0003487, HP:0007103, HP:0012448, HP:0012444, HP:0002808, HP:0000768, HP:0000998, HP:0005692, HP:0001371, HP:0001838, HP:0007410, HP:0012713, HP:0007377, HP:0009051

      CasePresentingHPOsFreeText: The delayed myelination was noted along corticospinal tract and posterior genu of capsula interna at age 13 months of age. Brain atrophy noted at 3.5 years old. Central bilateral disturbance in central tract conduction above the brainstem noted by somatosensory evoked potentials (SSEP). Sedimentation of glycogen like material (PAS positive) in muscle biopsy.

      CaseNOTHPOs: HP:0001250

      CaseNOTHPOSFreeTExt: Normal respiratory chain.

      VariantEvidence: Molecular modeling revealed the the Leu752Phe variant is likely to disrupt the PUL domain and may result in an alteration of the protein structure that could affect function (Fig. 2E). Examination in patient derived cells shows that the Leu752Phe variant disrupts the ability of PLAA to induce prostoglandin biogenesis (Fig. 4). As this mechanism is not known to be disease related, it does show an alteration of the protein function by the variant, thus supporting pathogenicity.

    1. c.788G>C mutation

      Case# III-1, Female, Caucasian

      CasePresentingHPOs HP:0001643

      CaseMethod1 WES

      CaseMethod2 PCR

      Variant NM_001136239.3(PRDM6):c.788G>C (p.Cys263Ser)

      ClinVar 243050

      VariantEvidence Functional in vitro characterization of PRDM6 p.Cys263Ser in HEK293 cells and human aortic VSMCs showed that the variant protein significantly loses its capability for nuclear localization (Fig 3). DNA overexpression in adenovirus virus infected WT and mutant variants showed MYH11 is also not suppressed by mutant where it is suppressed in WT (Figure 4). Immunoblots of histones in WT human aortic smooth muscle transfected with the variant showed reduced histone modification and and suppression of contractile proteins. (Fig. 5)

    1. Case 12

      Case12 Male, Finland

      CasePresentingHPOs HP:0000202, HP:0000347, HP:0001841, HP:0010066, HP:0001627, HP:0000157, HP:0002101, HP:0002323, HP:0000316, HP:0000445, HP:0001162, HP:0030449

      (Oral Cleft, Micrognathia, Preaxial foot polydactyly, Duplicated hallux, Congenital heart defect, Tongue abnormality, Defective lung lobation, Anencephaly, Hypertelorism, Broad nose, Postaxial hand polydactyly, Therapeutic abortion)

      HPOsFreeText Crown-heel length 19.5cm, body weight 245g, abnormal larynx trachea, uterus duplex, absent developed and identifiable mamillary bodies, absent anterior commissure, difficult to identify nucleus dentatus, gliovascular tissue on the base of the cranium, hypertelorism, broad nose, postaxial polydactyly in hands, and preaxial polydactyly in feet

      CaseNotHPOs HP:0001161

      (Hand polydactyly)

      NotHPOsFreeText true alobar or semilobar holoprosencephaly

      CasePreviousTesting n/a

      Variant NM_145014.2(HYLS1):c.632A>G (p.Asp211Gly), homozygous

      ClinVar 1143

      gnomAD MAF= 0.009594(European(Finnish)), no homozygotes

      CaseAddInfo induced abortion at 24+0wk gestational age

      CasePMIDs n/a

    1. Western Blots Demonstrate Decreased mTOR Signaling in Fibroblasts of Affected Individuals

      PatientCell CL:0000057 (Fibroblast)

      GeneFunction GO:0032006, (regulation of TOR signaling)

      GeneAlteration n/a

      FunctionalEvidence Western blot of PS6 isoforms, a product of mTOR signalling, were 74% reduced in patient 2-1 fibroblasts compared to control (Fig 3).

      Western blot of PS6 in subject 1-1&1-2 fibroblasts also demonstrated 78% reduced PS6 compared to controls (Fig 2b).

      As S6 is phosphorylated during normal mTOR activation, reduced PS6 suggests reduced mTOR signalling.

      29283439 (fig 3) suggests that the p.Arg126Ter variant in patient fibroblasts causes increased autophagy compared to controls due to the increase in autophagiosomes. (fig 5) the same variant also leads to excess oligosaccharides as a downstream effect of increased autophagy as show using mass spec.

      FAVariants (Fig 3) NM_001163435.2(TBCK):c.831_832insTA (p.Pro278Tyrfs), ClinVar: 225238, (Fig 2) NM_033115.4(TBCK):c.1708+1G>A, ClinVar: 183338

    1. the Lys82Arg (exon 3) mutation was identified in the CALR3 gene. The proband (II:1) was aged 41 years at presentation and had severe exertional symptoms associated with left ventricular outflow tract obstruction. He has improved symptomatically following transseptal alcohol ablation. His 3 children are currently clinically normal but have decline genetic testing

      Proband 2: male, Dx at 41 years, LV septal wall thickness = 22mm, improved following transseptal alcohol ablation, 3 unaffected children

      HP:0001639, HP:0011103

      Hypertrophic cardiomyopathy, Abnormality of the left ventricular outflow tract

      Variant: NM_145046.4(CALR3):c.245A>G (p.Lys82Arg)

      ClinVar ID: 30907

      https://www.ncbi.nlm.nih.gov/clinvar/variation/30907/

      ExAC Score: Overall 0.0005987

      http://gnomad.broadinstitute.org/variant/19-16601330-T-C

    1. Figure 5.

      NonHumanModel Mus musculus

      GeneAlteration oligonucleotide-directed mutagenesis of lambda phage to make a p.T494M vector to inject mice.

      ModelPhenotype HP:0031531

      HumanPhenotype HP:0000572

      ModelEvidence Electron microscopy of retina showed degeneration of RPE indicated by abnormal basal morphology (fig. 5)

      ModelVariant NM_004698.3(PRPF3):c.1481C>T (p.Thr494Met), 3352

    1. ndividuals F4-II1 (male, born in 2002, died in 2011) and F4-II2 (female, born in 2003)

      Family#PresentingHPOs HP:0001999, HP:0003155, HP:0003124, HP:0003141, HP:0012347, HP:0012358, HP:0001399 (Dysmorphic facies, Elevated alkaline phosphatase, High cholesterol, Increased LDL cholesterol, Abnormal protein N-linked glycosylation, Abnormal protein O-linked glycosylation, Liver failure)

      HPOsFreeText elevated AT

      FamilyNotHPOs n/a

      CountryOrigin n/a

      Ethnicity Turkish

      Race n/a

      Family#PreviousTesting Metabolic work up: Elevated AT, ALP, total cholesterol and LDL cholesterol, abnormal N- and O- glycosylation

      Family#Method1 Sanger

      Family#Method2 n/a

      Family#GenotypingMethod Sanger on proband targeting CCDC115

      Affected 2

      Unaffected 0

      Segregations n/a

      PublishedLOD n/a

      eLOD n/a

      AddSegregationInfo consanguinity

      ProbandLabel F4-II1, male,9yo death

      Case1PreviousTesting Metabolic results: AST 192–669 U/l[normal range, 0–50 U/l], ALT 83–308 U/l [normal range, 0–50 U/l], ALP 702 U/l[normal range, < 360 U/l]

      Case2 F4-II2, female, 8yo diagnosis

      Case2PreviousTesting Metabolic results: AST 98–422 U/l [normal range, 0–50 U/l], ALT 98–178 U/l [normal range, 0–50 U/l], ALP 710–985 U/l [normal range, < 360 U/l]. AT and CDG profile normalized after liver transplant.

      Variant NM_032357.3(CCDC115):c.31G>T (p.Asp11Tyr), homozygous

      ClinVar 218963

      gnomAD n/a

      VariantEvidence n/a

      FamilyAddInfo n/a

      FamilyPMIDs n/a

    1. Subject 2

      Case# Subject 2, F, 5mo died, Kurdish

      CasePresentingHPOs HP:0001319, HP:0008872, HP:0002033, HP:0003128, HP:0002490, HP:0001531, HP:0040288, HP:0001712, HP:0001410, HP:0002098, HP:0002910, HP:0002126, HP:0000365, HP:0002151 (Neonatal hypotonia, Feeding difficulties in infancy, Poor suck, Hyperlactatemia, Increased CSF lactate level, Failure to thrive in infancy, Nasogastric tube feeding, Left ventricular hypertrophy, Decreased liver function, Respiratory distress, Elevated transaminases, Polymicrogyria, Deafness, Elevated serum lactate)

      HPOFreeText: After caesarean delivery, neonatal hypotonia, poor feeding, and sucking. (3 months) failure to thrive, nasogastric feeding, left ventricular hypertrophy and impaired liver function. Brain MRI: bifrontal polymicrogyria and acoustic oto-emissions suggested deafness (4 months). Died of respiratory distress at 5 months.

      CaseNotHPOs n/a

      CasePreviousTesting Serum lactate (7.4 mmol/L; normal range 0.90–1.70 mmol/L), lactate to pyruvate ratio (170; normal range 30–50), CSF lactate (3.1 mmol/L; control < 2.2 mmol/L), liver function (AST: 84 UI/L, normal range 15–60; ALT: 52 UI/L, normal range 7–40; gGT: 262 UI/L, normal range 6–25 UI/L). Screened panel of known mitochondrial disease genes. Analysis of mtDNA and mtDNA copy number from patient muscle DNA were normal, thus excluding mtDNA rearrangements and point mutations.

      CaseMethod1 WES

      CaseMethod2 Sanger

      CaseGenotypingMethod WES confirmed with Sanger in patient and parents to confirm in trans

      Variant NM_017819.3(TRMT10C):c.542G>T (p.Arg181Leu) -homozygous

      ClinVar 224316

      gnomAD 0.0003508(Latino), 0.0001121(Total) -no homozygotes on record

      VariantEvidence n/a

      CaseAddInfo non-consanguineous, healthy older brother, c.542G>T variant in ExAC (10/120,324 alleles) and ESP6500 (1/11,824 alleles)

      CaseAddPMIDs n/a

    1. P7

      CaseP7 male, 59yo, Tunisia

      CasePresentingHPOs HP:0012207, HP:0012865, HP:0012868, HP:0003251

      (reduced sperm motility, sperm head anomaly, sperm tail anomaly, male infertility)

      HPOsFreeText Patient's sperm volume: 5mL(lower reference limit: 1.5), sperm concentration: 15.5million/mL(reference: 15), total motility after 1hr: 4%(reference: 40), vitality: 47%(reference:53%), normal spermatozoa: 0%(reference: 4), abnormal acrosome: 95%, abnormal head morphology: 7%, abnormal base: 3%, absent flagella: 30.5%, short flagella: 25%, coiled flagella: 27%, flagella of irregular caliber: 33%, multiple anomalies index: 2.56%.

      CaseNotHPOs n/a

      CasePreviousTesting Previously screened all patients for DNAH1, CFAP43, and CFAP44 variants. Somatic karyotypes were normal.

      Variant NM_144668.5:c.3007_3337del

      ClinVar 586974

      gnomAD not in gnomAD

      CaseAddInfo consanguinity

      CasePMIDs 29449551

    2. P6

      CaseP6 male, 28yo report, Tunisia

      CasePresentingHPOs HP:0012207, HP:0003251

      (reduced sperm motility, male infertility)

      HPOsFreeText Patient's sperm volume: 3mL(lower reference limit: 1.5), sperm concentration: 7.8million/mL(reference: 15), total motility after 1hr: 5%(reference: 40), normal spermatozoa: 0%(reference: 4).

      CaseNotHPOs n/a

      CasePreviousTesting Previously screened all patients for DNAH1, CFAP43, and CFAP44 variants. Somatic karyotypes were normal.

      Variant NM_144668.5:c.3007_3337del

      ClinVar 586974

      gnomAD not in gnomAD

      CaseAddInfo consanguinity

      CasePMIDs 29449551

    3. P5

      CaseP5 male, 31yo report, Tunisia

      CasePresentingHPOs HP:0012207, HP:0012865, HP:0012868, HP:0003251

      (reduced sperm motility, sperm head anomaly, sperm tail anomaly, male infertility)

      HPOsFreeText Patient's sperm volume: 3.4mL(lower reference limit: 1.5), sperm concentration: 60million/mL(reference: 15), total motility after 1hr: 5%(reference: 40), vitality: 62%(reference:53%), normal spermatozoa: 0%(reference: 4), abnormal acrosome: 80%, abnormal head morphology: 8%, abnormal base: 2%, absent flagella: 24%, short flagella: 50%, coiled flagella: 8%, flagella of irregular caliber: 68%, multiple anomalies index: 2.5%.

      CaseNotHPOs n/a

      CasePreviousTesting Previously screened all patients for DNAH1, CFAP43, and CFAP44 variants. Somatic karyotypes were normal.

      Variant NM_144668.5:c.3007_3337del

      ClinVar 586974

      gnomAD not in gnomAD

      CaseAddInfo nonconsanguineous

      CasePMIDs 29449551

    1. KMP 11

      Case#: KMP 11, female, 57 yrs, East Slovakia

      DiseaseAssertion: HCM

      FamilyInfo: yes

      CasePresentingHPOs: n/a

      CaseHPOFreeText: symptomatic; LVEF 60%; NYHA I.; ECG; echocardiography;

      CaseNotHPOs: n/a

      CaseNotHPOFreeText: no LVOTO; no ICD

      CasePreviousTesting: Additional Sanger sequencing of exons 12, 24, 25 of MYBPC3, exon 12 NEBL, exons 12, 20, 21 of SCN5A, exon 7 of TNNI3, and exon 9 of TNNT2 gene

      CaseGenotypingMethod: Sanger sequencing;

      Variant: NM_000257.4(MYH7):c.2845G>A (p.Glu949Lys)

      ClinVar: 14093 https://www.ncbi.nlm.nih.gov/clinvar/variation/14093/

      CAID: n/a

      gnomAD: absent

    1. One of these subjects, a female, was shown to be heterozygous for the previously described apoB-100 R3500Q mutation [[2], [19]].

      Case# Patient 5, Caucasian, Female, age 61

      CasePreviousTesting Screened for prevalent European mutations in apoB with DGGE.

      CasePresenting HPOs HP:0005145 Narrowing of Coronary Artery and HP:0003124 Hypercholesterolemia

      CaseNotHPOs n/a

      CaseGenotypingMethod PCR fraction of exom 26, denaturing gradiant gel electrophoresis

      Variant NM_000384.2(APOB):c.10580G>A (p.Arg3527Gln)

      ClinVar 17890

      gnomAD 0.0005791 gnomaD

      VariantEvidence high LDL-cholesterol levels(mg/dl) P5=240, PMID: 3477815- reduced LDLR affinity

      CaseAddInfo significantly lower fractional catabolic rate/production rate according to pending model

    1. two participants who underwent sequencing (Participants II.4 and II.5)

      Case#: II.4 - male, 23, European descent II.5 - male, 28, European descent CasePresentingHPOs: Both patients II.4 and II.5 - HP:0003233 (low HDL cholesterol), HP:0012153 (hypotriglyceridemia), HP:0003563(decreased LDL cholesterol)

      CaseMethod1: Exome CaseMethod2: Sanger

      Variant: NM_014495.3(ANGPTL3):c.385G>T (p.Glu129Ter) and NM_014495.3(ANGPTL3):c.50_51delCCinsGA (p.Ser17Ter)

      ClinVar: 18439 (p.Ser17Ter), 18440 (p.Glu129Ter), for both variants - 1 assertion for pathogenic based on OMIM but no assertion criteria provided

      gnomAD: not in gnomAD

      VariantEvidence: 12 other individuals from the Dallas Heart Study with ANGPTL3 frameshift mutations with phenotypes in Supplementary doc (PMID 19075393), additive dosage model with 2 mutations, 1 mutation and 0 (in supplementary table 5), “key enzymes in the metabolism of circulating triglycerides and HDL cholesterol, respectively, are elevated in Angptl3-knockout mice, suggesting that increased activity of these enzymes may explain the low levels of triglycerides and HDL cholesterol in humans with ANGPTL3 nonsense mutations” (PMIDs 17110602, 12097324, and 17681148)

    1. Figure 1

      MiltingF1

      FamilyNotHPOs HP:0100660, HP:0004756, HP:0001645, HP:0031317

      CountryOrigin Germany

      Ethnicity Danish

      Family#PreviousTesting: whole genome Family#Method1 PCR

      Family#GenotypingMethod Liquid Chromatography screening

      Affected 8

      Unaffected 6

      Segregations 7

      eLOD 2.1

      ProbandLabel Milting3:1 female

      Variant NM_024334.2(TMEM43):c.1073C>T (p.Ser358Leu)

      ClinVar 734

    1. Patient TTD218UT is of Moroccan origin and was born to consanguineous parents. She was referred to the clinical geneticist at 1.5 years of age with brittle hair (low cysteine content and tiger-tail banding pattern), ichthyosis, microcephaly (−2.5 SD), psychomotor retardation, short stature (−2.5 SD) and microcytic anemia. She showed recurrent aggravation of hair-loss by tufted breakage at the scalp boundary immediately following episodes of infection-induced fever. Also upon long-term exposure to the heat of the sun, she appears to have increased hair-loss. At the age of 8 years, she shows no signs of progressive deterioration. She has a happy and friendly personality with an IQ of 54 (at 7 years of age). She has a limited physical endurance. Laboratory investigation revealed microcytic hypochromic anemia (Hb 6.5) without sequence anomalies nor deletions or duplications of the genes encoding for the alpha or beta globin chains (not shown). We performed whole genome sequencing on patient’s DNA, using the sequencing-by-ligation method from Complete Genomics (16,17). Surprisingly, we identified a homozygous variant in the GTF2E2/TFIIEβ gene, creating a missense mutation (c.C559T [p.Asp187Tyr]). This mutation is identical to one of the mutations in GTF2E2/TFIIEβ previously described by Kuschal et al. (14). Its homozygous presence was confirmed by Sanger sequencing of cDNA generated from patient’s cells and found to co-segregate with the phenotype within the family (Fig. 1A and B).

      Case: TTD218UT

      Demographics: Female, 1.5 years at diagnosis. Moroccan origin.

      CasePresentingHPOs: HP:0004779, HP:0045055, HP:0008064, HP:0000252, HP:0001263, HP:0004322, HP:0001935, HP:0004840, HP:0040082, HP:0100025

      Individual showed recurrent aggravation of hair-loss by tufted breakage at the scalp boundary immediately following episodes of infection-induced fever, and upon long-term exposure to the heat of the sun, she appears to have increased hair-loss. She had an IQ of 54 (at 7 years) and limited physical endurance.

      CaseNOTHPOs: Progressive deterioration at 8 years

      CasePreviousTesting: None

      CaseGenotypingMethod: Whole genome sequencing, confirmed by Sanger sequencing.

      Variant: NM_002095.5(GTF2E2):c.C559T [p.Asp187Tyr]

      ClinVar ID: 225841

      Pathogenic, non-LOF variant gnomAD: hypomorphic, homozygous missense. Not in gnomAD.

      AddCaseInfo: The parents of this individual were consanguineous and were heterozygous for the mutation. Of 3 siblings, two (a brother and a sister) were found to be heterozygous carriers, while one was found to have the homozygous wild type alleles (a sister).

      VariantEvidence: The variant has been previously reported by Kauschal et al (26996949) in a 16-yr old Moroccan girl. The identification of this variant in four individuals of Moroccan origin suggests the possibility of a founder mutation. Since the variant has been already scored, this proband is not being scored.

    1. c.934C>T (p.R312W)

      Case# Baskin RW, Female, 31

      CasePresentingHPOs HP:0004756, HP:0011841, HP:0002013

      CasePreviousTesting patients referred to our high-risk hereditary heart disorders clinic for assessment of possible ARVC, as well as DNA-bearing blood or tissue samples sent for clinical ARVC gene-testing from other physicians, clinics or institutions to our CLIA-approved molecular genetics laboratory at the Hospital for Sick Children (listed on www.genetests.org).

      CaseMethod1 PCR

      CaseGenotypingMethod direct sequence analysis of all exons and flanking intron sequences of DSP (MIM 125647), PKP2 (MIM 602861), DSC2 (MIM 125645), DSG2 (MIM 125671) and TMEM43.

      Variant NM_024334.2(TMEM43):c.934C>T (p.Arg312Trp)

      ClinVar 36873

      gnomAD 0.03553 link

    1. PCR amplification of tumor DNA was performed with 10 to 100 ng DNA in a final volume of 15 μL containing 1.5 mM MgCl2, 10 mM Tris-HCl, 50 mM KCl, 0.02 mM dATP, 0.2 mM dGTP, dTTP, and dCTP, 0.8 μCi α32P-dATP (Amersham, Buckinghamshire, United Kingdom), 15 pmol of each forward and reverse primer (Table 2), and 3U Taq polymerase (Ampli Taq Gold, Perkin Elmer Europe). PCR was performed for 35 cycles of 95°C for 30 sec, 55°C for 45 sec, and 1 min at 72°C, followed by 1 cycle at 72°C for 10 min. PCR products were electrophoresed overnight at 8W on a nondenaturing gel, containing 8% polyacrylamide ([49:1] Fluka, Neu-Ulm, Germany) and 10% glycerol (v/v). After electrophoresis, the gel was dried and exposed to an X-ray film.

      ArticleReferenceSequence: Not specified- Assumption: Nucleotide change is not specified in the paper, only protein coding change is. cDNA variant was inferred based on protein coding change, and reported based on VHL reference sequence NM_000551.3

      GenotypingMethod: PCR amplification using genomic DNA as template was carried out followed by single-strand polymorphism analysis. After PCR, the BigDye® Terminator V3.1 cycle sequencing kit (Applied Biosystems, Foster City, CA) was used to sequence samples.

      SamplingMethod: tissue resection

    1. 510, 17MbPCCLPNEYes (17 years/lung)NoVHLc.499C>T (de novo)bp.(Arg167Gln)No

      PatientID: 5

      KindredID: 7

      Case: M, 17Y0M, Spanish

      DiseaseAssertion: VHL

      FamilyInfo: No family history, assumed de-novo, but unclear if parents were tested to confirm de-novo assertion.

      CohortInfo: 36 pediatric patients with pheochromocytomas and/or parangangliomas.

      CasePresentingHPOs: HP:0002666 (pheochromocytoma)

      CaseHPOFreeText: The patient had a benign bilateral pheochromocytoma that was secreting norepinephrine at age 10. At age 17, the pheochromocytoma reoccured but this time was malignant and metastasized to the lungs.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: RET, SDHA, SDHB, SDHC, SDHD, SDHAF2, TMEM127, MAX

      PreviouslyPublished: Yes source unknown.

      SupplementalData: N/A

      Variant: p.R167W (c.499C>T) *The authors of this paper have seemingly called the wrong protein change for this variant.

      CaseProblemVariantFreeText: N/A

      LegacyVariant: N/A

      ClinVarID: 2218 https://www.ncbi.nlm.nih.gov/clinvar/variation/2218/

      CAID: N/A

      gnomAD: 0.000007954 https://gnomad.broadinstitute.org/variant/3-10191506-C-T

      VariantEvidence: N/A

      MutationType: missense_variant; transition

      CivicName: R167W (c.499C>T)

      MultipleGeneVariants: N/A

    1. 14 c.497T>C p.Val166Ala p.V166A Bilateral Pheo

      PatientID: None

      KindredID: 14

      Case: 15Y0M, F, Ethnicity Unknown

      DiseaseAssertion: pheochromocytoma

      FamilyInfo: The patient has no family history of VHL disease. Genetic testing reveals no mutation in patient's parents indicating that the mutation in patient is sporadic. This was further said to have occurred de novo.

      CasePresentingHPOs: HP:0002666 (pheochromocytoma)

      CaseHPOFreeText: bilateral pheochromocytoma diagnosed at age 11 years. She was said to have single-organ involvement and did not fulfill diagnostic criteria of VHL. 

      CaseNotHPOs: HP:0009711; HP:0005584; HP:0010797; HP:0000107; HP:0001737 (retinal capillary hemangioma, renal cell carcinoma, hemangioblastoma, renal cyst, pancreatic cysts)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: Previously reported, HGMD (Human Gene Mutation Database: http://uwcmml1s.uwcm.ac.uk/uwcm/mg/search/120488.html)

      SupplementalData: N/A

      Variant: p.V166A (c.497T>C)

      CaseProblemVariantFreeText: N/A

      LegacyVariant: N/A

      ClinVarID: 43605 https://www.ncbi.nlm.nih.gov/clinvar/variation/43605/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant;transition

      CivicName: V166A (c.497T>C)

      MultipleGeneVariants: N/A

    1. PatientID: 21

      KindredID: 21

      Case: M, 32Y0M, Korean

      DiseaseAssertion: VHL

      FamilyInfo: Family history positive for VHL. No details provided.

      CohortInfo: 26 Korean patients with more than one HAB in the CNS or eye, a single HAB in the CNS or retina plus a visceral manifestation (multiple renal, pancreatic or hepatic cysts, pheochromocytoma and RCC) and positive family history plus any one of the above manifestations.

      CasePresentingHPOs: HP:0010797; HP:0002666 (Hemangioblastoma, Pheochromocytoma)

      CaseHPOFreeText: CNS hemangioblastoma. Multiple or bilateral pheochromocytoma. Pheochromocytoma. Diagnosed with VHL Type 2A.

      CaseNotHPOs: HP:0009711; HP:0005584 (Retinal capillary hemangioma, Renal cell carcinoma)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: 16142346

      SupplementalData: N/A

      Variant: p.G93D (c.278G>A)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 496054, https://www.ncbi.nlm.nih.gov/clinvar/variation/496054/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant;transition

      CivicName: G93D (c.278G>A)

      MultipleGeneVariants: N/A

    2. Genomic DNA was purified from peripheral blood leukocytes using a QIAamp DNA Blood Mini Kit (Qiagen GmbH, Hilden, Germany) according to the manufacturer’s instructions. The three exons of the VHL gene as well as their flanking introns were amplified using the following primers: 1F 5′-IndexTermCGCGAAGACTACGGAGGT-3′ and 1R 5′-IndexTermCTTCAGACCGTGCTATCGTC-3′; 2F 5′-IndexTermCTCCCAAAGTGCTGGGATTA-3′ and 2R 5′-IndexTermTGGGCTTAATTTTTCAAGTGG-3′; 3F 5′-IndexTermAGTTGTTGGCAAAGCCTCTT-3′ and 3R 5′-IndexTermAAGGAAGGAACCAGTCCTGT-3′. We confirmed mutations in both strands by direct sequencing with the primers that were also used in the PCR. PCR was carried out using a thermal cycler (Model 9700; Applied Biosystems, Foster City, CA, USA) as follows: 35 cycles of denaturation at 94 °C for 30 s, annealing at 60 °C for 30 s, and extension at 72 °C for 1 min. The amplicon was purified using Agencourt AMPure XP (Beckman Coulter Genomics, Danvers, MA, USA) and direct sequencing was performed using the BigDye Terminator Cycle Sequencing Ready Reaction kit on an ABI Prism 3130 genetic analyzer (Applied Biosystems). All variants were confirmed based on the National Center for Biotechnology Information single-nucleotide polymorphism database and the Human Gene Mutation Database. The method for detection of VHL germline mutations, including that for multiple ligation-dependent probe amplification, used in Samsung Hospital was previously reported.11

      ArticleReferenceSequence: Not specified – Assumption: variants assumed to have been documented by the author under reference sequence NM_000551.3

      GenotypingMethod: Direct sequencing was performed using the BigDye Terminator Cycle Sequencing Ready Reaction kit on an ABI Prism 3130 genetic analyzer (Applied Biosystems).

      SamplingMethod: peripheral blood leukocytes

    1. AD 13 50 M ? ? - - ? - - c.340 ? 1 G[A p.G114D b

      PatientID: 13

      KindredID: AD

      Case: M, 50Y0M, Indian

      DiseaseAssertion: VHL

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0005584; HP:0001737 (Renal cell carcinoma, Pancreatic cysts)

      CaseHPOFreeText: Multi-cystic pancreatic lesions, RCC.

      CaseNotHPOs: HP:0002666; HP:0030393; HP:0009711; HP:0010797 (Pheochromocytoma, Endolymphatic sac tumor, Retinal capillary hemangioma, Hemangioblastoma)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.G114D (c.340+1G>A)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 223190, https://www.ncbi.nlm.nih.gov/clinvar/variation/223190/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: splice_site_variant; missense_variant;transition

      CivicName: G114D (c.340+1G>A) and c.340+5G>C

      MultipleGeneVariants: N/A

    1. PatientID: 224

      KindredID: 83

      Case: M, 53Y0M, Chinese

      DiseaseAssertion: VHL

      FamilyInfo: The patient had the same germline mutation as his sister (the proband). His sister presented with a pheochromocytoma at age 38. His mother had a CNS hemangioblastoma at 52, but no genotyping information is available for her.

      CasePresentingHPOs: HP:0005584 (Renal cell carcinoma)

      CaseHPOFreeText: The patient presented with renal cell carcinoma at age 53.

      CaseNotHPOs: HP:0009711; HP:0001737; HP:0001732; HP:0010797; HP:0002666 (Retinal capillary hemangioma, Pancreatic cysts, Abnormality of the pancreas, Hemangioblastoma, Pheochromocytoma)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: This cohort was also published in a later paper by Wang et al., 2018 (PMID: 29330336).

      SupplementalData: Patient and family genotype-phenotype information is listed in Supplementary Table 1.

      Variant: p.R167Q (c.500G>A)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 2216, https://www.ncbi.nlm.nih.gov/clinvar/variation/2216/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant;transition

      CivicName: R167Q (c.500G>A)

      MultipleGeneVariants: N/A

    2. PatientID: 276

      KindredID: 107

      Case: M, 50Y0M, Chinese

      DiseaseAssertion: VHL

      FamilyInfo: The proband, patient 276, presented with a retinal angioma at age 31, and a CNS hemangioblastoma and multiple pancreatic cysts/tumors at age 37. The proband has a father who presented with a CNS hemangioblastoma at age 50.

      CasePresentingHPOs: HP:0001737; HP:0001732; HP:0010797 HP:0009711 (Pancreatic cysts, Abnormality of the pancreas, Hemangioblastoma, Retinal capillary hemangioma)

      CaseHPOFreeText: The proband's father presented with a CNS hemangioblastoma at age 50.

      CaseNotHPOs: HP:0002666; HP:0005584 (Pheochromocytoma, Renal cell carcinoma)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: This cohort was also published in a later paper by Wang et al., 2018 (PMID: 29330336).

      SupplementalData: Patient and family genotype-phenotype information is listed in Supplementary Table 1.

      Variant: Exon 2-3 Deletion (c.341-?_642+?del)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: N/A

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: exon_loss_variant

      CivicName: Exon 2-3 Deletion

      MultipleGeneVariants: N/A

    3. PatientID: 208

      KindredID: 79

      Case: M, 49Y0M, Chinese

      DiseaseAssertion: VHL

      FamilyInfo: The proband's mother and sister had a CNS hemangioblastoma at ages 40 and 50, respectively. His nephew presented with a CNS hemangioblastoma (age 15), a retinal angioma (age 27), and renal cell carcinoma (age 25). His daughter had a retinal angioma at age 14, and a CNS hemangioblastoma at age 24. No genetic testing information was available for family members.

      CasePresentingHPOs: HP:0010797; HP:0001737; HP:0001732; HP:0002666; HP:0005584 (Hemangioblastoma, Pancreatic cysts, Abnormality of the pancreas, Pheochromocytoma, Renal cell carcinoma)

      CaseHPOFreeText: The proband presented with a CNS hemangioblastoma at age 29. At age 46, they presented with renal cell carcinoma and a pheochromocytoma. At age 49 they presented with multiple pancreatic cysts/tumors.

      CaseNotHPOs: HP:0009711; (Retinal Capillary Hemangioma)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: Kindred #79 was published in Wang et al., 2014 (PMID: 24581539). This cohort was also published in a later paper by Wang et al., 2018 (PMID: 29330336).

      SupplementalData: Patient and family genotype-phenotype information is listed in Supplementary Table 1.

      Variant: p.R167Q (c.500G>A)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 2216, https://www.ncbi.nlm.nih.gov/clinvar/variation/2216/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant;transition

      CivicName: R167Q (c.500G>A)

      MultipleGeneVariants: N/A

    4. PatientID: 186

      KindredID: 72

      Case: F, 39Y0M, Chinese

      DiseaseAssertion: VHL

      FamilyInfo: The proband, patient 72, has multiple family members with the same mutation. Her father (patient 73) had a CNS hemangioblastoma at 65, renal cell carcinioma at 54, and multiple pancreatic cysts/tumors at 67. Her sister 2 (second sister) had multiple pancreatic cysts/tumors at 36, and a CNS hemangioblastoma at 39. Her sister 3 had multiple pancreatic cysts/tumors at 32, and a retinal angioma at 34. The proband's sister 1 had a CNS hemangioblastoma at 22, but passed away before they could be diagnosed/ confirmed with the mutation.

      CasePresentingHPOs: HP:0010797; HP:0005584; HP:0001732; HP:0001737; HP:0002666 (Hemangioblastoma, Renal cell carcinoma, Abnormality of the pancreas, Pancreatic cysts, Pheochromocytoma)

      CaseHPOFreeText: The patient presented with a CNS hemangioblastoma, renal cell carcinoma, and multiple pancreatic cysts/tumors at 37, and a pheochromocytoma at 39.

      CaseNotHPOs: HP:0009711 (Retinal capillary hemangioma)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: This patient was also published in a later paper by Wang et al., 2018 (PMID: 29330336).

      SupplementalData: Patient and family genotype-phenotype information is listed in Supplementary Table 1.

      Variant: p.R167W (c.499C>T)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 2218; https://www.ncbi.nlm.nih.gov/clinvar/variation/2218/

      CAID: N/A

      gnomAD: 0.000007954; https://gnomad.broadinstitute.org/variant/3-10191506-C-T?dataset=gnomad_r2_1

      VariantEvidence: N/A

      MutationType: missense_variant;transition

      CivicName: R167W (c.499C>T)

      MultipleGeneVariants: N/A

    1. M199016NoHb, pheochromocytoma, pancreatic endocrine tumor, left adrenal nodule3Yesc.500G>A p.(Arg167Gln)5.75.534.6 (pheochromocytoma)

      PatientID: None

      KindredID: 2

      Case: M, 16Y0M, Ethnicity Unknown

      DiseaseAssertion: VHL

      FamilyInfo: None

      CasePresentingHPOs: HP:0002666, HP:0030405, HP:0011732 (pheochromocytoma, pancreatic endocrine tumour, Abnormality of adrenal morphology)

      CaseHPOFreeText: The patient had three tumours.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: Previously published in 24301059.

      SupplementalData: N/A

      Variant: p.R167Q (c.500G>A)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVar: 2216 https://www.ncbi.nlm.nih.gov/clinvar/variation/2216/

      CAID: N/A

      gnomAD: 0.000003977 https://gnomad.broadinstitute.org/variant/3-10191507-G-A

      VariantEvidence: The patient had a mosaic mutation with a mutated allele frequency of 5.7%. Copy number events of the mutated and wild type allele are available in table S4 of the supplemental.

      MutationType: missense_variant;transition

      CivicName: R167Q (c.500 G >A)

      MultipleGeneVariants: N/A

    1. WM06 VHL VHL 0.84 

      PatientID: WM06

      KindredID: 12

      Case: Sex Unknown, 10Y0M, Ethnicity Unknown

      DiseaseAssertion: pheochromocytoma

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0002666 (pheochromocytoma)

      CaseHPOFreeText: N/A

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: MAX, RET, SDHA, SDHB, SDHC, SDHD, TMEM127

      PreviouslyPublished: N/A

      SupplementalData: Yes

      Variant: N/A - Unspecified

      LegacyVariant: Given as an unspecified germline mutation

      CaseProblemVariantFreeText: N/A

      ClinVarID: N/A

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: N/A

      CivicName: N/A

      MultipleGeneVariants: N/A

    2. VCB.14T VHL VHL 0.63 

      PatientID: VCB.14T

      KindredID: 6

      Case: Sex Unknown, 34Y0M, Ethnicity Unknown

      DiseaseAssertion: pheochromocytoma

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0002668; HP:0002666 (paraganglioma, pheochromocytoma)

      CaseHPOFreeText: Presented with bilateral pheochromocytoma

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: MAX, RET, SDHA, SDHB, SDHC, SDHD, TMEM127

      PreviouslyPublished: 25545346 (see table S1 and S10)

      SupplementalData: Yes

      Variant: p.R167W (c.499C>T)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 2218, https://www.ncbi.nlm.nih.gov/clinvar/variation/2218/

      CAID: N/A

      gnomAD: 0.000007954, https://gnomad.broadinstitute.org/variant/3-10191506-C-T?dataset=gnomad_r2_1

      VariantEvidence: N/A

      MutationType: missense_variant;transition

      CivicName: R167W (c.499C>T)

      MultipleGeneVariants: SDHA, Germline, c.619A>C (p.Arg207=); SDHA, Germline, c.1969G>A (p.Val657Ile); KIF1B, Germline, c.2192A>G (p.Asn777Ser); MDH2, Somatic, c.26C>T (p.Ala9Val)

    1. 12 missenses

      27 index patients suspected of having VHL disease from unrelated Chinese families and their relatives were studied. The nucleotide were numbered according to the sequence numbering by Latif et al, 1993 and this was converted to NM_000551.3. The paper did not differentiate between a pancreatic cysts and tumor and presented these together as a 'pancreatic lesion'. The paper summariezed the phenotypes of the families together. Family 7 was found with p.Asn78Thr mutation in the VHL gene: 1/2 members had CNS hemangioblastoma and 2/2 has renal cell carcinoma. ACMG PP4

    2. Intron1 IVS1-38 C>T

      27 index patients suspected of having VHL disease from unrelated Chinese families and their relatives were studied. The nucleotide were numbered according to the sequence numbering by Latif et al, 1993 and this was converted to NM_000551.3. The paper did not differentiate between a pancreatic cysts and tumor and presented these together as a 'pancreatic lesion'. The paper summarized the phenotypes of the families together. Family 20 was found with an intron mutation in the VHL gene (paper reported as IVS1-38C>T which was converted to recommended HGVS notation): both members had CNS hemangioblastomas and retinal capillary hemangioblastomas.

      This intron variant (IVS1-38 C>T) is unknown. The entered coordinates do not agree with the intron/exon boundaries for the selected transcript; The base at c.340 not "C". Authors were contacted and could not confirm.

    3. 4 partial deletions

      27 index patients suspected of having VHL disease from unrelated Chinese families and their relatives were studied. The nucleotide were numbered according to the sequence numbering by Latif et al, 1993 and this was converted to NM_000551.3. The paper did not differentiate between a pancreatic cysts and tumor and presented these together as a 'pancreatic lesion'. The paper summarized the phenotypes of the families together. Family 23 was found with an exon 3 deletion of the VHL gene: 4/4 members had CNS hemangioblastoma and 1/4 had retinal capillary hemangioma. ACMG PVS1 PP4

    1. PatientID: 8

      KindredID: 8

      Case: M, 66Y0M, Korean

      DiseaseAssertion: VHL

      FamilyInfo: N/A

      CohortInfo: 55 patients treated at Asan Medical Center in Korea treated between January 1995 and February 2013 clinically diagnosed with VHL disease and presenting with pancreatic lesions.

      CasePresentingHPOs: HP:0001737, HP:0030405 (Pancreatic cysts, Pancreatic endocrine tumor)

      CaseHPOFreeText: At age 56, the patient had a serous cystadenoma of the pancreas and a pancreatic endocrine tumour. A Pylorus-preserving pancreaticoduodenectomy was performed and the largest tumour resected was 40 mm. On follow up 170 months later the patient had no evidence of disease.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.R167Q (c.500G>A)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVar: 2216 https://www.ncbi.nlm.nih.gov/clinvar/variation/2216/

      CAID: N/A

      gnomAD: 0.000003977 https://gnomad.broadinstitute.org/variant/3-10191507-G-A

      VariantEvidence:N/A

      MutationType: missense_variant;transition

      CivicName: R167Q (c.500 G >A)

      MultipleGeneVariants: N/A

    1. One year later, a 10-year-old sister of the proband (II-2) was referred to our service because of palpitations, weight loss, diaphoresis, and shooting pain attacks that had started about two weeks earlier. Based on this clinical picture and because of her family history, a pheochromocytoma was suspected immediately. Her urinary metanephrines were elevated to 12.2 mg/g creatinine (< 1 mg/g). A CT of the abdomen revealed a mass in the left adrenal; there were no lesions in the pancreas or the kidney. This mass was also positive on MIBG scintigraphy. As in her brother, there was no suggestion that the paraganglia would also be involved. Her MRI of the brain, and her echocardiogram were both normal. She was then treated with an alpha-blocker (prazosin) in preparation for an open adrenalectomy. Histology and immunohistochemistry confirmed diagnosis of a pheochromocytoma in the left adrenal gland.

      PatientID: II-2

      KindredID: 1

      Case: F, 10Y0M, Ethnicity Unknown

      DiseaseAssertion: Adrenal pheochromoyctoma

      FamilyInfo: The patient’s brother (II-1) was found to harbor the same germline mutation the patient harbored and had bilateral adrenal pheochromocytoma at 14Y. The same germline missense mutation was detected in another sister (II-4) with right adrenal pheochromocytoma and her asymptomatic daughter (III-1). The father was not available for genetic testing because he had died, apparently secondary to a hypertensive crisis. The five other family members which underwent genetic testing did not have the mutation.

      CasePresentingHPOs: HP:0006748 (Adrenal pheochromocytoma)

      CaseHPOFreeText: At 10Y, the patient reported palpitations, weight loss, diaphoresis, and shooting pain attacks. Her urinary metanephrines were elevated to 12.2 mg/g creatinine. A CT of the abdomen revealed a mass in the left adrenal gland. Histology and immunohistochemistry confirmed diagnosis of left adrenal pheochromocytoma. Additional screening revealed no other tumours, so this fit the criteria of VHL type 2C.

      CaseNotHPOs: HP:0002668; HP:0012090; HP:0012210 (Paraganglioma, abnormal pancreas morphology, abnormal renal morphology)

      CaseNotHPOFreeText: There were no lesions in the pancreas or the kidney, there was also no suggestion that the paraganglia would also be involved. Her MRI of the brain, and her echocardiogram were both normal.

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.V166F (c.496G>T)

      LegacyVariant: N/A

      ClinVarID: 2224, https://www.ncbi.nlm.nih.gov/clinvar/variation/2224/

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant;transversion

      CivicName: V166F(c.496G>T)

      MultipleGeneVariants: N/A

    1. KindredID: 1112

      Case: Sex Unknown, Age Unknown, Ethnicity Unknown

      DiseaseAssertion: VHL

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0002666; HP:0010797; HP:0009711 (Pheochromocytoma, Hemangioblastoma, Retinal capillary hemangioma)

      CaseHPOFreeText: N/A

      CaseNotHPOs: HP:0030405; HP:0005584 (Pancreatic endocrine tumor, Renal cell carcinoma)

      CaseNotHPOFreeText: The patient had no cysts (type or location was not specified).

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.R161* (c.481C>T)

      CaseProblemVariantFreeText: N/A

      LegacyVariant: p.R161* (c.694C>T)

      ClinVarID: 2217, https://www.ncbi.nlm.nih.gov/clinvar/variation/2217/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: Variant reported as 694, C to T (Arg to stop), assumed to be reported in legacy nomenclature (AF010238.1) and mapped to c.481C>T, p.Arg161* (NM_000551.3).

      MutationType: stop_gained; missense_variant;transition

      CivicName: R161* (c.481C>T)

      MultipleGeneVariants: N/A

    1. Peripheral blood samples were collected for mutation analysis of the RET proto-oncogene and VHL tumor suppressor gene. Genomic DNA was extracted from whole-blood samples using the QIAamp blood kit (Qiagen, Hilden, Germany) according to the manufacturer's instructions. Polymerase chain reaction (PCR) amplification of all exons and the flanking splice junctions of RET and VHL was performed, followed by direct bidirectional DNA sequencing. One hundred unrelated controls with a similar ethnic background were also included in this study

      ArticleReferenceSequence: Not specified – Assumption: variants assumed to have been documented by the author under reference sequence NM_000551.3

      GenotypingMethod: Analysis of the RET and VHL genes in patients was done using direct bidirectional DNA sequencing

      SamplingMethod: peripheral blood

    1. A 20-year-old Caucasian woman presented to our institution with decreased vision in the right eye (RE) with a 4-month evolution. The patient’s vital signs were within normal limits, and no abnormalities were noticed upon physical and neurological examination. Similarly, her past medical history was unremarkable. Her best corrected visual acuity (BCVA) was 50 ETDRS (Early Treatment Diabetic Retinopathy Study) letters in the RE and 84 ETDRS letters in the left eye. Her intraocular pressure (IOP) was normal in both eyes, and the result of her anterior segment examination was unremarkable. Upon ophthalmoscopic examination, a red-colored globular lesion of 3 disk diameters (DDs) with prominent feeder vessels was noticed in the superior temporal region of the retina in the RE (Fig. 1). The fellow eye was normal on fundus examination, and no other lesions were found in the posterior pole or periphery. Optical coherence tomography (OCT) was carried out using the DRI OCT Triton™ SS-OCT device (Topcon Medical, Tokyo, Japan).

      PatientID: None

      KindredID: 1

      Case: F, 20Y0M, Caucasian

      DiseaseAssertion: VHL

      FamilyInfo: The patient’s mother had died of pulmonary edema during pregnancy at the age of 40.

      CasePresentingHPOs: HP:0009711 (Retinal capillary hemangioma)

      CaseHPOFreeText: The patient presented with decreased vision in the right eye with a 4-month evolution. The patient’s vital signs were within normal limits, and no abnormalities were noticed upon physical and neurological examination. Similarly, her past medical history was unremarkable. Upon ophthalmoscopic examination, a red-colored globular lesion of 3 disk diameters with prominent feeder vessels was noticed in the superior temporal region of the retina. A structural OCT B-scan showed a diffuse cystoid macular edema, which involved the posterior pole and expanded outside the vascular arcades. The other eye was normal.

      CaseNotHPOs: HP:0012443; HP:0011732 (Abnormality of brain morphology, abnormality of renal morphology)

      CaseNotHPOFreeText: Results of renal ultrasonography and magnetic resonance imaging of the brain were both negative for visceral lesions.

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.Y112C (c.335A>G)

      LegacyVariant: N/A

      ClinVarID: 223189, https://www.ncbi.nlm.nih.gov/clinvar/variation/223189/

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant;transition

      CivicName: Y112C(c.335A>G)

      MultipleGeneVariants: N/A

    1. GroupID: 85

      Case: 27Y0M, Sex Unknown, Ethnicity Unknown

      DiseaseAssertion: assumed VHL

      FamilyInfo: 1 of the 573 patients discussed in this paper were found to have this variant. This mutation (c.538A>G) was found in 1 VHL family with a single patient.

      CasePresentingHPOs: HP:0005584 (renal cell carcinoma)

      CaseHPOFreeText: patient had RCCs diagnosed at 27Y

      CaseNotHPOs: HP:0009711; HP:0006880; HP:0002666 (retinal capillary hemangioma; cerebellar hemangioblastoma; pheochromocytoma)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: Supplementary Table S1.

      Variant: p.I180V (c.538A>G)

      CaseProblemVariantFreeText: N/A

      LegacyVariant: N/A

      ClinVarID: 161401 https://www.ncbi.nlm.nih.gov/clinvar/variation/161401/

      CAID: N/A

      gnomAD: 0.00001061 https://gnomad.broadinstitute.org/variant/3-10191545-A-G

      VariantEvidence: N/A

      MutationType: missense_variant;transition

      CivicName: I180V (c.538A>G)

      MultipleGeneVariants: N/A

    1. PMID: 29813026

      PatientID: 2

      KindredID: 2

      Case: Sex Unknown, Age Unknown, Ethnicity Unknown

      DiseaseAssertion: hemangioblastoma

      FamilyInfo: N/A - Not specified

      CasePresentingHPOs: HP:0010797 (hemangioblastoma)

      CaseHPOFreeText: VHL syndromic HB

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: Null (Complete deletion)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: N/A

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: A VHL subject in our patient population had a full length deletion (FLD) in the germline VHL gene, but a VHL gene tumor second hit mutation (c.360-362 del AGA) causing an amino acid change of p.RD120-121S detected in the HB tumor

      MutationType: deletion

      CivicName: Deletion AND R120_121S (c.360_362delAGA)

      MultipleGeneVariants: Somatic, VHL, c.360_362delAGA, p.Arg120_121Ser

    1. VHL-gene mutation analysis (40/110)

      ArticleReferenceSequence: Not specified - Assumption: variants assumed to have been documented by the author under reference sequence NM_000551.3.

      GenotypingMethod: The three exons of the VHL gene (coding region of 852 nucleotides) were sequenced. PCR products were purified with the QiA quick PCR purification kit (Qiagen, Hilden, Germany), and the sequencing reactions were done using the ABI PRISM DYE Terminator sequencing kit (Perkin-Elmer Applied Biosystems Division, Foster City, CA), and were analysed on the ABI 373 A sequencer.

      SamplingMethod: Peripheral blood

    1. GroupID: 91

      DiseaseAssertion: VHL

      GroupSize: 4

      GroupNumberMales: N/A

      GroupNumberFemales: N/A

      GroupEthnicity: French

      GroupAgeRange: N/A

      GroupInfo: 4 members of this family were found to harbor the c.388G>C germline variant of the VHL gene. Member 6200 had no renal involvement. Member 6410 presented with mild renal disease. Members 5838 and 5839 presented with moderate renal disease (RCC). Families were recruited from the French VHL Registry. Enrolment in the study required identification of the germline VHL mutation (currently 85% of the families included in the French VHL Registry) and available data regarding renal phenotype. A total of 126 families fulfilled these criteria.

      GroupPresentingHPOs: HP:0009726; HP:0005584 (Renal neoplasm, Renal cell carcinoma)

      GroupHPOFreeText: Mild renal disease (simple renal cyst, multicystic kidney[s], small lesion [less than 10 mm in size] of unknown significance, or small solid tumor without indication for surgical removal [less than 30 mm in size]). Moderate renal disease (less than five solid lesions requiring surgical treatment, either unilateral or bilateral).

      GroupNotHPOs: N/A

      GroupNotHPOFreeText: N/A

      GroupPreviousTesting: N/A

      PreviouslyPublished: Paper states that this family is previously reported in PMID 12202531 and/or 9829912, where 3 and 1 individuals respectively with this mutation are reported. It is unclear if one or both of these previously reported groups are the same as the current family.

      SupplementalData: Phenotype and genotype information can be found in Supplementary Table S1.

      Variant: p.V130L (c.388G>C)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 2229, https://www.ncbi.nlm.nih.gov/clinvar/variation/2229/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant;transversion

      CivicName: V130L (c.388G>C)

      MultipleGeneVariants: N/A

    2. GroupID: 394

      DiseaseAssertion: VHL

      GroupSize: 3

      GroupNumberMales: N/A

      GroupNumberFemales: N/A

      GroupEthnicity: French

      GroupAgeRange: N/A

      GroupInfo: 3 members of this family were found to harbor a germline large rearrangement of the VHL gene. Member 9248 presented with moderate renal disease (RCC). Member 9313 and 2222 presented with severe renal disease (RCC). Families were recruited from the French VHL Registry. Enrolment in the study required identification of the germline VHL mutation (currently 85% of the families included in the French VHL Registry) and available data regarding renal phenotype. A total of 126 families fulfilled these criteria.

      GroupPresentingHPOs: HP:0005584 (Renal cell carcinoma)

      GroupHPOFreeText: Moderate renal disease (less than five solid lesions requiring surgical treatment, either unilateral or bilateral). Severe renal disease (any solid lesion before 25 years of age, five or more solid lesions within one or two kidneys, or metastasis of renal cell carcinoma).

      GroupNotHPOs: N/A

      GroupNotHPOFreeText: N/A

      GroupPreviousTesting: N/A

      PreviouslyPublished: Paper states that this family is previously reported in PMID 12202531, where 12 individuals with this mutation are reported. It is unclear which of the previously reported individuals correspond to which of the currently reported families/individuals (i.e. families 40, 90, 174, 237, 264, 284, 307 or 394).

      SupplementalData: Phenotype and genotype information can be found in Supplementary Table S1.

      Variant: Rearrangement

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: N/A

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: rearrangement_region

      CivicName: Rearrangement

      MultipleGeneVariants: N/A

    1. 1 inframe insertion

      PatientID: 26

      KindredID: 31

      Case: Sex unknown, Age unknown, French

      DiseaseAssertion: VHL

      FamilyInfo: None

      CasePresentingHPOs: HP:0005584; HP:0030405 (renal cell carcinoma, pancreatic endocrine tumour)

      CaseHPOFreeText: N/A

      CaseNotHPOs: HP:0002666 (pheochromocytoma)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.R177_L178ins6 (c.531_532ins18)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: Stated in the paper as: p.R177_L178ins6 (c.531_532ins18) - NM_000551.3:c.531_532ins18: char 24: Syntax error - due to it's non specific nomenclature. (Can't verify coordinates of specific insertion).

      ClinVarID: N/A

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: inframe_insertion

      CivicName: R177_L178ins6 (c.531_532ins18) 

      MultipleGeneVariants: N/A

    2. 5 nonsense mutations

      PatientID: 30

      KindredID: 64

      Case: Sex unknown, Age unknown, French

      DiseaseAssertion: VHL

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0005584; HP:0030405 (renal cell carcinoma, pancreatic endocrine tumour)

      CaseHPOFreeText: N/A

      CaseNotHPOs: HP:0002666 (pheochromocytoma)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.Q73* (c.217C>T)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 223164 https://www.ncbi.nlm.nih.gov/clinvar/variation/223164/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence:N/A

      MutationType: stop_gained

      CivicName: Q73* (c.217C>T)

      MultipleGeneVariants: N/A

    1. c.548 C>Aap.S183X

      GroupID: 27B

      DiseaseAssertion: Unknown. Patients were pulled from either the VHL-Registry or NET-Registry and recorded with the given mutation. Symptoms or manifestations are not clear.

      GroupSize: 4

      GroupNumberMales: N/A

      GroupNumberFemales: N/A

      GroupEthnicity: N/A

      GroupAgeRange: N/A

      GroupInfo: 4 patients with the given mutation were grouped as group 27(B) in this study. These patients were asymptomatic or unclear of symptoms.

      GroupPresentingHPOs: N/A

      GroupHPOFreeText: N/A

      GroupNotHPOs: HP:0030405 (pancreatic endocrine tumor)

      GroupNotHPOFreeText: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.S183* (c.548C>A)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 2215 https://www.ncbi.nlm.nih.gov/clinvar/variation/2215/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: stop_gained

      CivicName: S183* (c.548C>A)

      MultipleGeneVariants: N/A

    1. BIP–27–19Renal cysts, pancreatic cysts, and polyglobulia1

      PatientID: None

      KindredID: B

      Case: M, 27Y0M, Hungarian

      DiseaseAssertion: VHL

      FamilyInfo: The parents of the patient rejected clinical and genetic screening, whereas clinical screening in a younger brother of the index patient revealed no abnormality.

      CasePresentingHPOs: HP:0009711, HP:0000107, HP:0001737, HP:0001901, HP:0006880 (retinal capillary hemangioma, renal cyst, pancreatic cysts, polycythemia, cerebellar hemangioblastoma)

      CaseHPOFreeText: Retina involvement presented at age 19. The patient had cerebellar hemangioma as well as renal and pancreatic cysts at the age of 27 years.

      CaseNotHPOs: HP:0005584, HP:0002666 (renal cell carcinoma, pheochromocytoma)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.R161* (c.481C>T)

      CaseProblemVariantFreeText: N/A

      LegacyVariant: N/A

      ClinVarID: 2217 https://www.ncbi.nlm.nih.gov/clinvar/variation/2217/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: stop_gained

      CivicName: R161* (c.481C>T)

      MultipleGeneVariants: N/A

    1. 15 I 6 23 No manifestations M c.496G > T (p.Val166Phe)

      PatientID: I

      KindredID: 15

      Case: Sex Unknown, 23Y0M, Danish

      DiseaseAssertion: Asymptomatic

      FamilyInfo: 2 other family members presented with the same VHL variant. Patient 15-II presented with 2 pheochromocytoma (8Y) 2 CNS hb (12Y and 13Y) and 2 retinal hemangioblastomas (8Y, 12Y). Patient 15-III presented with 2 pheochromocytoma (15Y).

      CasePresentingHPOs: N/A

      CaseHPOFreeText: Diagnosed with VHL at age 6Y. Age at the end of study: 23Y.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.V166F (c.496G>T)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 2224, https://www.ncbi.nlm.nih.gov/clinvar/variation/2224/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant;transversion

      CivicName: V166F (c.496G>T)

      MultipleGeneVariants: N/A

    1. PatientID: V-20

      KindredID: 2

      Case: M, Age Unknown, German

      DiseaseAssertion: VHL

      FamilyInfo: Family 2 is comprised of 131 individuals over six generations including 65 members (50% of those at risk) with VHL type 2A (72% clinically affected, 12% obligate carriers, and 15% positive genetic analysis alone) and nearly equal gender distribution for affected status (54% male). An additional six members (II-3, II-4, II -5, III-1, III-2, and III-3) are suspected to have VHL without confirmation. Of note, the nuclear family (branch IV-13) contains 13 siblings, of whom 12 have been diagnosed with pheo. The presenting tumor types in Family 2 were pheo (70%), HB (17%), and RA (13%). No Family 2 member had RCC as the initial manifestation. Distribution of HB and RA are not described except for patient IV-8.

      CasePresentingHPOs: HP:0002666 (Pheochromocytoma)

      CaseHPOFreeText: N/A

      CaseNotHPOs: HP:0005584 (Renal cell carcinoma)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: 7759077

      SupplementalData: N/A

      Variant: p.Y98H (c.292T>C)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 2223, https://www.ncbi.nlm.nih.gov/clinvar/variation/2223/

      CAID: N/A

      gnomAD: 0.00001343, https://gnomad.broadinstitute.org/variant/3-10183823-T-C

      VariantEvidence: N/A

      MutationType: missense_variant;transition

      CivicName: Y98H (c.292T>C)

      MultipleGeneVariants: N/A

    1. M22redMale22Pro86Arg1st R (2 subs R, no L)Former- <10 pack years33.46 (5*)No

      PatientID: None

      KindredID: 3

      Case: M, 22Y0M, Ethnicity Unknown

      DiseaseAssertion: Clear Cell Renal Cell Carcinoma

      FamilyInfo: N/A

      CohortInfo: The National Cancer Institute has a frozen tumour bank of ccRCC tumours that have been removed from VHL patients. We selected six patients, three males and three females, with at least five tumours from a single surgery from one kidney.

      CasePresentingHPOs: HP:0006770 (clear cell renal cell carcinoma)

      CaseHPOFreeText: One of the samples from this patient had few variants and clustered with the normal samples. Further inspection showed these samples were cyst-like rather than tumours, so they were excluded from further analysis. This suggests that the patient had renal cysts alongside ccRCC at age 22.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.P86R(c.257C>G)

      LegacyVariant:N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 223170 https://www.ncbi.nlm.nih.gov/clinvar/variation/223170/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant;transversion

      CivicName: P86R(c.257C>G)

      MultipleGeneVariants: N/A

    1. P5PCC VHL c.292T>C

      PatientID: P5

      KindredID: 2

      Case: Sex Unknown, Age Unknown, Ethnicity Unknown

      DiseaseAssertion: pheochromocytoma

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0002666 (pheochromocytoma)

      CaseHPOFreeText: N/A

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.Y98H (c.292T>C)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVar: 2223 https://www.ncbi.nlm.nih.gov/clinvar/variation/2223/

      CAID: N/A

      gnomAD: 0.00001343 https://gnomad.broadinstitute.org/variant/3-10183823-T-C

      VariantEvidence: N/A

      MutationType: missense_variant;transition

      CivicName: Y98H (c.292T>C)

      MultipleGeneVariants: N/A

    1. variants of VHL in 18 probands

      PatientID: 2

      KindredID: 2

      Case: Sex Unknown, Age Unknown, Ethnicity Unknown

      DiseaseAssertion: VHL

      FamilyInfo: No family information provided.

      CasePresentingHPOs: HP:0002666; HP:0002668 (Pheochromocytoma; paraganglioma)

      CaseHPOFreeText: Patient had pheochromocytoma and/or paraganglioma (table 2).

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.R79G (c.235C>G)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 411988, https://www.ncbi.nlm.nih.gov/clinvar/variation/411988/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant, transversion

      CivicName: R79G (c.235C>G)

      MultipleGeneVariants: N/A

    1. Patient 2c.163_164insGframeshift + STOP codon1

      PatientID: 2

      KindredID: 2

      Case: Sex Unknown, Age Unknown, Ethnicity Unknown

      DiseaseAssertion: VHL

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0030405 (pancreatic endocrine tumor)

      CaseHPOFreeText: Hereditary PNET with a confirmed germline mutation.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.E55Gfs*77 (c.163_164insG)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: c.163_164insG automapped to NM_000551.3:c.163dupG

      ClinVarID: 223159 https://www.ncbi.nlm.nih.gov/clinvar/variation/223159/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: plus_1_frameshift_variant; duplication

      CivicName: E55fs (c.163dupG)

      MultipleGeneVariants: N/A

    1. PatientID: N/A

      KindredID: 442

      Case: Age unknown, Sex unknown, Ethnicity unknown

      DiseaseAssertion: assumed VHL

      FamilyInfo: Paper states: Germline, de novo (no clear confirmation)

      CasePresentingHPOs: HP:0005584; HP:0010797 (renal cell carcinoma, hemangioblastoma)

      CaseHPOFreeText: Bilateral RCC and a hemangioblastoma

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: Yes (Specifically Supp. Table S2)

      Variant: p.G144* (c.430G>T)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 223208 https://www.ncbi.nlm.nih.gov/clinvar/variation/223208/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: stop_gained

      CivicName: G144* (c.430G>T)

      MultipleGeneVariants: N/A

    1. Genetic analysis of VHL gene in this patient revealed a heterogeneous 5' splice site variation of intron 1 of the VHL gene that affects splice site of exon 1 (c. 340 + 1G > A). This mutation was pathogenic for VHL syndrome and previously reported in a few cases.

      ArticleReferenceSequence: Not specified – Assumption: variants assumed to have been documented by the author under reference sequence NM_000551.3

      GenotypingMethod: N/A

      SamplingMethod: N/A

    1. In four families, partial deletions of one or more exons were detected by Southern blot analysis

      PatientID: 2

      KindredID: A

      Case: M, Age unknown, Turkish

      DiseaseAssertion: assumed VHL

      FamilyInfo: 5 family members are grouped with this deletion (ages 16-37Y; mean 31Y). VHL was clinically diagnosed in, at minimum, the proband. See Fig. 2 for family pedigree. This patient’s last two brothers were not tested for the DNA deletion however it is assumed by the authors due to the segregation observed.

      CasePresentingHPOs: HP:0009711; HP:0010797 (retinal capillary hemangioma; hemangioblastoma)

      CaseHPOFreeText: N/A

      CaseNotHPOs: HP:0002666; HP:0005584 (pheochromocytoma; renal cell carcinoma)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: Deletion of exons 1 and 2

      CaseProblemVariantFreeText: N/A

      LegacyVariant: N/A

      ClinVarID:N/A

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: HindIII and revealed an aberrant banding pattern in three affected family members (1, 2, and 9)

      MutationType: exon_loss_variant

      CivicName: exon 1-2 deletion

      MultipleGeneVariants: N/A

    1. Figure 1.

      PatientID: II:5

      KindredID: 1

      Case: M, Age Unknown, Ethnicity Unknown

      DiseaseAssertion: Asymptomatic

      FamilyInfo: Look to proband (III:3) for extensive family info.

      CohortInfo: Patients with the diagnosis of familial or sporadic PHEO and their relatives.

      CasePresentingHPOs: N/A

      CaseHPOFreeText: N/A

      CaseNotHPOs: HP:0005584 (Renal cell carcinoma)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: Figure 1

      Variant: p.P138= (c.414A>G)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 223206, https://www.ncbi.nlm.nih.gov/clinvar/variation/223206/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant;transition

      CivicName: P138= (c.414A>G)

      MultipleGeneVariants: N/A

    1. c.496_506del11 (p.Val166Serfs*4) in seven individuals, belonging to two pedigrees.

      PatientID: 44

      KindredID: 44

      Case: Sex Unknown, Age Unknown, Ethnicity Unknown

      DiseaseAssertion: VHL

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0010797; HP:0006770 (hemangioblastoma; clear cell renal cell carcinoma)

      CaseHPOFreeText: N/A

      CaseNotHPOs: HP:0100634; HP:0030405; HP:0009711; HP:0030421 (Neuroendocrine neoplasm, pancreatic neuroendocrine neoplasm, retinal capillary hemangioma, Epididymal neoplasm)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: 29437867 (likely family 17 - see here for more info)

      SupplementalData: Yes; see table S1 for VHL subject genetic and manifestation information.

      Variant: p.V166Sfs*4 (c.496_506del11)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 223229 https://www.ncbi.nlm.nih.gov/clinvar/variation/223229/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: minus_2_frameshift_variant

      CivicName: V166Sfs*4 (c.496_506del)

      MultipleGeneVariants: N/A

    1. PatientID: 11 (Father)

      KindredID: 7

      Case: M, 39Y0M, Ethnicity Unknown

      DiseaseAssertion: VHL

      FamilyInfo: 6 members of this family were found to harbor the c.319C>G germline variant of the VHL gene. ID 24 presented with renal abnormalities, and pheochromocytoma, and died at age 62. ID 1 presented with pheochromocytoma. ID 2 presented with pancreatic abnormalities. ID 10 presented with CNS hemangioblastoma, pancreatic abnormalities and pheochromocytoma. ID 4 presented with pheochromocytoma.

      CasePresentingHPOs: HP:0002666; HP:0000077; HP:0001732 (Pheochromocytoma, Abnormality of the kidney, Abnormality of the pancreas)

      CaseHPOFreeText: The patient presented with renal and pancreatic cyst or tumor (unspecified) (33Y), pheochromocytoma (21Y) and other undefined phenotypes (33Y).

      CaseNotHPOs: HP:0009711; HP:0005584; HP:0010797 (Retinal capillary hemangioma, Renal cell carcinoma, Hemangioblastoma)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: Supplementary Table 1.

      Variant: p.R107G (c.319C>G)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 43599, https://www.ncbi.nlm.nih.gov/clinvar/variation/43599/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant;transversion

      CivicName: R107G (c.319C>G)

      MultipleGeneVariants: N/A

    2. PatientID: 6 (Sister)

      KindredID: 1

      Case: F, 24Y0M, Ethnicity Unknown

      DiseaseAssertion: VHL

      FamilyInfo: 9 members of this family were found to harbor the c.193T>G germline variant of the VHL gene. ID 35 was asymptomatic. IDs 1 (proband), 28, 2, 17 and 19 all presented with pheochromocytoma. ID 5 presented with CNS hemangioblastoma, retinal angioma and renal cyst OR tumor (not specified). ID 21 presented with retinal angioma and pheochromocytoma.

      CasePresentingHPOs: HP:0002666 (Pheochromocytoma)

      CaseHPOFreeText: The patient presented with a Pheochromocytoma at age 9.

      CaseNotHPOs: HP:0009711; HP:0005584; HP:0001732; HP:0000077; HP:0010797 (Retinal capillary hemangioma, Renal cell carcinoma, Abnormality of the pancreas, Abnormality of the kidney, Hemangioblastoma)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: Supplementary Table 1.

      Variant: p.S65A (c.193T>G)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 223160, https://www.ncbi.nlm.nih.gov/clinvar/variation/223160/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant;transversion

      CivicName: S65A (c.193T>G)

      MultipleGeneVariants: N/A

    1. her 17-year-old sister

      PatientID: None

      KindredID: 1

      Case: F, 17Y0M, Ethnicity Unknown

      DiseaseAssertion: Retinal hemangioblastoma

      FamilyInfo: The heterozygous missense variant NM_000551.3:c.311G>T was identified on her 21-year-old sister and her mother, but not her father. The sister had hypertension and a paraganglioma. The patient’s mother had refused a complete staging.

      CasePresentingHPOs:HP:0009711 (Retinal hemangioblastoma)

      CaseHPOFreeText: The patient’s evaluation was normal with the exception of a small retinal hemangioblastoma.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.G104V(c.311G>T)

      LegacyVariant: N/A

      ClinVarID: 223183, http://www.ncbi.nlm.nih.gov/clinvar/variation/223183

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant;transversion

      CivicName: G104V(c.311G>T)

      MultipleGeneVariants: N/A

    1. Whole blood was collected for genomic DNA analysis and VHL gene sequencing, which confirmed VHLs (Fig. 2). The VHL gene nucleotide sequence was obtained by EMBL Nucleotide Sequence Database [BBC+00] (http://www.ebi.ac.uk/embl/index.html; ENST00000256196, sequence: {"type":"entrez-nucleotide","attrs":{"text":"JQ821733","term_id":"392055954","term_text":"JQ821733"}}JQ821733). Sequencing was performed by polymerase chain reaction using the following primers: F: TACTACAGAGGCATGAACACC and R: CCCCTAAACATCACAATGC. In silico analyses by the mutation analyzer 2.0.28 (https://mutalyzer.nl) suggested the pathogenic potential of this variant. Pheochromocytoma was excluded by 24-h metanephrine and serum catecholamine measurement.

      ArticleReferenceSequence: Not specified – Assumption: variants assumed to have been documented by the author under reference sequence NM_000551.3

      GenotypingMethod: Sanger sequencing was performed by PCR using specific primers, on all 3 exons of the VHL gene. In silico analyses by the mutation analyzer 2.0.28 (https://mutalyzer.nl) suggested the pathogenic potential of this variant.

      SamplingMethod: whole blood

    1. three familial cases

      PatientID: 8

      KindredID: C

      Case: M, Age Unknown, Japanese

      DiseaseAssertion: Asymptomatic

      FamilyInfo: This mutation was found in a family of 10 individuals; six were found to carry the mutation NM_000551.3:c.464-1G>T the patient carried, and three presented with symptoms. They were identified with hemangioblastomas of the central nervous system and retinal angiomas. The eldest patient also had renal cell carcinoma (patient C-1).

      CasePresentingHPOs: N/A

      CaseHPOFreeText: N/A

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: (c.464-1G>T)

      LegacyVariant: (c.677-1G>T)

      ClinVarID: 223221, http://www.ncbi.nlm.nih.gov/clinvar/variation/223221

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: splice_site_variant

      CivicName: SpliceSite(c.464-1G>T)

      MultipleGeneVariants: N/A

    1. Case presentationFirst onsetA 19-years-old female was first found with occupation about 6.2 cm × 5.7 cm in the right adrenal five years ago based on CT scan at a regular physical examination, accompanied with fever and headache with high blood pressure. Tumor resection was performed, and pathological diagnosis was right pheochromocytoma. The patient was regularly subjected to follow-up.Secondary onsetDuring this hospitalization, CT scan found multiple tumor occupation in left adrenal and paraganglion region zones with round nodular shadows. Meanwhile, she had fever and headache with high blood pressure. Based on medical history and examination, she was diagnosed as left pheochromocytoma. Meanwhile, the occupying lesions in right lung and pancreas were found, located in extrabasal segment of inferior lobar and head respectively.Case characteristicsThe case characteristics were summarized: 1. A 12y female; 2. Tumor occupation was first found in right adrenal; 3. Tumor resection was performed and the pathological diagnosis was pheochromocytoma; 4. Multiple round nodular shadows were found in left adrenal and paraganglion region zones after five years; 6. The symptoms were fever and headache with high blood pressure; 7. The diagnosis was pheochromocytoma (PCC) and paraganglioma (PGL) (Combined PPGLs); 8. The occupying lesions located in right lung and pancreas were scanned and diagnosed with masses.Diagnostic methodThe patient was followed up regularly. Based on personal medical history, symptoms and imaging examinations, the patient was diagnosed as PPGLs combined with right lung and pancreas occupation.Multidisciplinary team discussion based on professional board indicated the following views: (1) The diagnosis was possibly considered as atypical VHL type II. Further qualitative diagnosis relied on genetic examination; (2) Other lesions like retina tumor should be examined. (3) PPGLs was surgically resected for pursuing pathological diagnosis. (4) The occupying lesions in right lung and pancreas were performed with puncture biopsy for further diagnosis. The diagnosis and treatment workflow were shown in Fig. 1.

      PatientID: 1 (case)

      KindredID: 1

      Case: F, 19Y0M, Ethnicity Unknown

      DiseaseAssertion: assumed VHL

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0006748; HP:0002666; HP:0030445; HP:0030405 (adrenal pheochromocytoma; pheochromocytoma; Pulmonary carcinoid tumor; Pancreatic endocrine tumor)

      CaseHPOFreeText: At 12 years old, a female patient presented with fever and headache with high blood pressure. Upon a CT scan, a right adrenal tumor was detected and tumor resection was performed, revealing a pathological diagnosis of pheochromocytoma. Upon further review, a CT scan found multiple tumors in left adrenal and paraganglion region zones with round nodular shadows. She was diagnosed with pheochromocytoma (PCC) and paraganglioma (PGL). A lung puncture revealed a carcinoid and a pancreatic puncture indicates a neuroendocrine tumor. Left adrenalectomy and PPGL resection was performed and diagnosis was pathologically confirmed

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting:

      PreviouslyPublished: N/A

      SupplementalData: Yes (somatic info)

      Variant: p.R167Q (c.500G>A)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 2216, https://www.ncbi.nlm.nih.gov/clinvar/variation/2216/

      CAID: N/A

      gnomAD: 0.000003977, https://gnomad.broadinstitute.org/variant/3-10191507-G-A

      VariantEvidence: N/A

      MutationType: missense_variant; transition

      CivicName: R167Q (c.500G>A)

      MultipleGeneVariants: N/A

    1. Materials and MethodsPatients and Sample CollectionOur study included 314 PPGL patients from the Peking Union Medical College Hospital, Beijing, China. Most patients had undergone surgery and were histopathologically diagnosed with PPGL. For the patients with unresectable or metastatic tumor, PPGL diagnosis was established on the basis of clinical features (headache, palpitations and sweating), increased 24-h urinary catecholamine excretion or plasma metanephrines and imaging tests. 99mTc-hydrazinonicotinyl-Tyr3-0ctreotide (99mTc-HYNIC-TOC) scintigraphy, Iodine-131 metaiodobenzylguanidine scintigraphy and contrast-enhanced thoracoabdominal-pelvic computed tomography (CT) were performed for almost all PPGLs. Some patients underwent head and neck enhanced CT or head and neck enhanced MRI examination. 18F-FDG-PET/CT or 68Ga-DOATATATE-PET/CT were performed to patients suspected of metastasis or PPGLs with multiple lesions. Blood samples of the patients were collected, with informed consents obtained from the patients and approval from the medical ethics committee of the hospital.Genomic DNA Preparation and Sanger SequencingGenomic DNA was extracted from the peripheral blood of PPGL patients by using blood DNA Midi Kit (Omega Bio-Tek, Norcross, Georgia, USA). For patients with metastatic PPGL, all the coding sequences and the intro-exon junctions of SDHB ({"type":"entrez-nucleotide","attrs":{"text":"NM_003000.3","term_id":"1732746310","term_text":"NM_003000.3"}}NM_003000.3) were amplified and sequenced on an ABI3730 DNA analyzer (Applied Biosystems, CA, USA). For patients with head or neck PPGL, all the coding sequences and the intron-exon junctions of SDHB and SDHD ({"type":"entrez-nucleotide","attrs":{"text":"NM_003002.4","term_id":"1519245278","term_text":"NM_003002.4"}}NM_003002.4) were amplified and sequenced. As for patients with clinically-diagnosed hereditary syndromes, such as multiple endocrine neoplasia Type 2 (MEN2) and Von Hippel-Lindau (VHL) disease, hot spots (10, 11, 16 exons) of RET ({"type":"entrez-nucleotide","attrs":{"text":"NM_020630.4","term_id":"126273513","term_text":"NM_020630.4"}}NM_020630.4) and all exons, including intro-exon junctions of VHL ({"type":"entrez-nucleotide","attrs":{"text":"NM_000551.3","term_id":"319655736","term_text":"NM_000551.3"}}NM_000551.3), were amplified and sequenced, respectively. The primers used for the PCR amplification were listed in Supplementary Table 1.Next-Generation SequencingFor all the patients except those whose variants were detected by the aforementioned Sanger sequencing, next-generation sequencing covering SDHA ({"type":"entrez-nucleotide","attrs":{"text":"NM_004168.4","term_id":"1519245104","term_text":"NM_004168.4"}}NM_004168.4), SDHB ({"type":"entrez-nucleotide","attrs":{"text":"NM_003000.3","term_id":"1732746310","term_text":"NM_003000.3"}}NM_003000.3), SDHC ({"type":"entrez-nucleotide","attrs":{"text":"NM_003001.5","term_id":"1779948875","term_text":"NM_003001.5"}}NM_003001.5), SDHD ({"type":"entrez-nucleotide","attrs":{"text":"NM_003002.4","term_id":"1519245278","term_text":"NM_003002.4"}}NM_003002.4), SDHAF2 ({"type":"entrez-nucleotide","attrs":{"text":"NM_017841.4","term_id":"1779948864","term_text":"NM_017841.4"}}NM_017841.4), VHL ({"type":"entrez-nucleotide","attrs":{"text":"NM_000551.3","term_id":"319655736","term_text":"NM_000551.3"}}NM_000551.3), RET ({"type":"entrez-nucleotide","attrs":{"text":"NM_020630.4","term_id":"126273513","term_text":"NM_020630.4"}}NM_020630.4), MAX ({"type":"entrez-nucleotide","attrs":{"text":"NM_002382.5","term_id":"1653960896","term_text":"NM_002382.5"}}NM_002382.5), TEMEM127 ({"type":"entrez-nucleotide","attrs":{"text":"NM_017849.4","term_id":"1777425445","term_text":"NM_017849.4"}}NM_017849.4), FH ({"type":"entrez-nucleotide","attrs":{"text":"NM_000143.4","term_id":"1779521770","term_text":"NM_000143.4"}}NM_000143.4), NF1 ({"type":"entrez-nucleotide","attrs":{"text":"NM_001042492.3","term_id":"1732746177","term_text":"NM_001042492.3"}}NM_001042492.3), and KIF1B ({"type":"entrez-nucleotide","attrs":{"text":"NM_015074.3","term_id":"189339259","term_text":"NM_015074.3"}}NM_015074.3) was performed to examine the potential pathogenic germline variations.The probes of target regions for relevant genes were designed against Agilent available online (http://www.agilent.com). Agilent SureSelectXT custom kit (Agilent Technologies, Palo Alto, CA) was used to generate sequence library according to instructions. Briefly, fragments of 180-280bp were produced by using a hydrodynamic shearing system (Covaris, Massachusetts, USA). The DNA fragments were end-repaired, A-tailed and adapter-ligated for Illumina sequencing. Then, size selection, PCR amplification and library hybridization were performed. Each captured library with an index was loaded onto the Illumina HiSeq X platform (Illumina Inc., San Diego, CA), and 150-bp paired-end reads were generated.The fastq files were subjected to quality control to exclude unwanted sequences, including adapter-contaminated or low quality or unrecognizable nucleotides. The fastq files were aligned against the Human Reference Genome (UCSC hg19) by using the Burrows-Wheeler Aligner (BWA). Then, the SAM tools (11) were used to generate the final BAM file (12) to calculate the sequence coverage and depth by sorting the BAM files and performing repeated marking, partial realignment and base quality recalibration. At last, the Variant Call Format files obtained in the previous step were annotated by ANNOVAR (13).Annotated variants with coverage over 10×, mutant allele frequency (MAF) < 0.01 in the 1,000 Genomes databases and in the exonic or splicing region (10 bp upstream and downstream of splicing sites) were retained (14). The synonymous variants were excluded. Non-synonymous SNVs were retained if at least two of the functional predictions by PolyPhen-2, SIFT, MutationTaster and CADD showed the SNV was damaging. “Benign” or “likely benign” variants in ClinVar were eliminated (15–18). American College of Genomic Medicine (ACMG) guidelines were used for the classification of variant pathogenicity (19). All the variants were confirmed by Sanger sequencing.

      ArticleReferenceSequence: NM_000551.3

      GenotypingMethod: Sanger sequencing and next-generation sequencing covering SDHA, SDHB, SDHC, SDHD, SDHAF2, VHL, RET, MAX, TMEM127, FH, NF1, and KIF1B was performed to examine potential pathogenic germline variations

      SamplingMethod: peripheral blood

    1. PatientID: IV-11

      KindredID: 1

      Case: M, 36Y0M, Ethnicity Unknown

      DiseaseAssertion: VHL

      FamilyInfo: Family’s roots were traced to the German town of Leipzig in Saxony, from whence the original 11 siblings had immigrated to America around 1670. The following report is a 2011 updated pedigree on the previously reported Tisherman kindred. At the time of this study, 43/49 patients have undergone mutational analysis revealing the VHL familial mutation (Y112H) and 35/49 patients have clinical VHL manifestations. Phenotypic cumulative lifetime risk was 71% for Pheo/PGL, 15% for hemangioblastoma, 33% for retinal angioma, 3% for renal cell carcinoma, and 3% for pancreatic cysts. 6 members of the family (all deceased; 4 males, 2 females) had suspected VHL and 2 (males) of these were suspected to have had Pheo/PGL.

      CasePresentingHPOs: HP:0002666 (Pheochromocytoma)

      CaseHPOFreeText: R Pheo + preaortic metastases age 21. L Pheo + periadrenal mets age 27. Distant metastases age 34. Deceased (36Y). Cause of death: “Metastatic PH, MI”.

      CaseNotHPOs: HP:0005584; HP:0009711; HP:0002668 (Renal cell carcinoma, Retinal capillary hemangioma, Paraganglioma)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: 9201016; 8239848 (no genetic information; only phenotypes)

      SupplementalData: N/A

      Variant: p.Y112H (c.334T>C)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 2222, https://www.ncbi.nlm.nih.gov/clinvar/variation/2222/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant;transition

      CivicName: Y112H (c.334T>C)

      MultipleGeneVariants: N/A

    1. Case 12In 1993, a 39-yr-old female with recent onset of hypertension was diagnosed with a right pheochromocytoma. At age 36, a suspected left pheochromocytoma was noted by CT and increased urinary metanephrines was confirmed at age 39 by [123I]MIBG scintigraphy. This imaging showed in addition an uptake located in the neck. MRI confirmed a left adrenal tumor and a left 2-cm vagal paraganglioma that was removed and confirmed histopathologically. Genetic testing identified the VHL p.Tyr156Cys mutation. No other tumor of the VHL spectrum was discovered. Three of her four sons were found to carry the mutation. Clinical screening of all 3 disclosed a 2.4-cm abdominal paraganglioma in one of them but no lesion in the other brothers.

      PatientID: 12

      KindredID: 12

      Case: F, 36Y0M, Ethnicity Unknown

      DiseaseAssertion: assumed VHL

      FamilyInfo: 3/4 of her sons also carried the mutation, one of which presented with a paraganglioma.

      CohortInfo: An international consortium registered patients with head and neck paragangliomas with VHL or RET gene mutations.

      CasePresentingHPOs: HP:0002668; HP:0006748; HP:0002886 (paraganglioma, adrenal pheochromocytoma, vagal paraganglioma)

      CaseHPOFreeText: At 39Y (in 1993), she presented with recent onset of hypertension and was diagnosed with a right pheochromocytoma. (At age 36, a suspected left pheochromocytoma was noted by CT and confirmed at age 39 by [123I]MIBG scintigraphy). This imaging showed in addition an uptake located in the neck. MRI confirmed a left adrenal tumor and a left 2-cm vagal paraganglioma that was removed and confirmed histopathologically.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: No other tumor of the VHL spectrum was discovered. 

      CasePreviousTesting: RET

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.Y156C (c.467A>G)

      LegacyVariant: p.Y156C

      CaseProblemVariantFreeText: The publication only provides the p., the mutation was able to be deduced to p.Y156C (c.467A>G)

      ClinVarID: 43600 https://www.ncbi.nlm.nih.gov/clinvar/variation/43600/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant; transition

      CivicName: Y156C (c.467A>G)

      MultipleGeneVariants: N/A

    1. PatientID: 78

      KindredID: 78

      Case: Sex Unknown, 29Y0M, Ethnicity Unknown

      DiseaseAssertion: VHL

      FamilyInfo: Family history noted but details not specified.

      CasePresentingHPOs: HP:0001732 (Abnormality of the pancreas)

      CaseHPOFreeText: Pancreatic cysts or tumors.

      CaseNotHPOs: HP:0006770; HP:0002666; HP:0010797; HP:0009711; HP:0000107 (Clear cell renal cell carcinoma, Pheochromocytoma, Hemangioblastoma, Retinal capillary hemangioma, Renal cyst)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: Table S1, S2 and S3

      Variant: p.C162W (c.486C>G)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 223227, https://www.ncbi.nlm.nih.gov/clinvar/variation/223227/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant;transversion

      CivicName: C162W (c.486C>G)

      MultipleGeneVariants: N/A

    1. PatientID: None

      KindredID: 1

      Case: M, Age Unknown, Ethnicity Unknown

      DiseaseAssertion: Assumed VHL

      FamilyInfo: His brother and grandfather had the same VHL mutation. His mother also had this mutation and presented with pancreatic cysts, pheochromocytoma, endolymphatic sac tumor, and spinal hemangioblastoma.

      CohortInfo:Three patients with endolymphatic sac tumors were studied.

      CasePresentingHPOs: N/A

      CaseHPOFreeText: N/A

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: c.464-1G>A

      LegacyVariant: N/A

      CaseProblemVariantFreeText: The paper describes the mutation as "C-to-A transversion at position −1 on the exon 3 splice acceptor sequence in the VHL gene"

      ClinVar: 43603 https://www.ncbi.nlm.nih.gov/clinvar/variation/43603/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: splice_site_variant

      CivicName: Splice Site (c.464-1G>A)

      MultipleGeneVariants: N/A

    1. We identified deletions ranging from 0.5 kb to 250 kb affecting part of or the entire VHL and flanking genes in 54 families.

      GroupID: 43

      DiseaseAssertion: VHL

      GroupSize: N/A GroupNumberMales: N/A GroupNumberFemales: N/A GroupEthnicity: N/A GroupAgeRange: N/A

      GroupInfo: 54 VHL deletion families from the Freiburg registry were selected in order to assist in the correlation of VHL deletions to clinical phenotypes.

      GroupPresentingHPOs: HP:0005584; HP:0000107; HP:0009711; HP:0010797; HP:0030393; HP:0001737; HP:0030405 (Renal cell carcinoma, Renal cyst, Retinal capillary hemangioma, Hemangioblastoma, Endolymphatic sac tumor, Pancreatic cysts, Pancreatic endocrine tumor)

      GroupHPOFreeText: # of affected individuals: Renal cell carcinoma (1), Renal cyst (2), Retinal capillary hemangioma (4), Hemangioblastoma/brain/cerebellum (3), Endolymphatic sac tumor (2), Pancreatic cysts (3), Pancreatic endocrine tumor (1)

      GroupNotHPOs: N/A

      GroupNotHPOFreeText: N/A

      GroupPreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: Supplemental Table 2, Table 1, Table 3

      Variant: Exon 1-3 Deletion (c.1-?_642+?del)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: N/A

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: exon_loss_variant

      CivicName: Exon 1-3 Deletion

      MultipleGeneVariants: Germline, IRAK2, partial deletion

      MultipleGeneVariants: Germline, ENST197804, partial deletion

    1. 2.3.1 DNA extraction Tumoral DNA was extracted from formalin-fixed, paraffin-embedded tissues as previously described [38]. Briefly, paraffin sections of tumor tissue were selected by a pathologist (MB) and tissue cores removed from the respective blocks to ensure that the tumor cells comprised more than 90% of the samples. Uninvolved normal tissue or peripheral blood (PB) was used as the source of normal DNA control for each patient for LOH analysis. Tumour tissue was digested with SDS/proteinase K for 24 h at 48 °C, and DNA was extracted with phenol/chloroform [38]. DNA concentration was quantified by absorbance measurement at 260 and 280 nm using the Nanodrop spectrophotometer. 2.3.2 Mutation analysis PCR amplification was performed searching for point mutation in the entire VHL coding sequence and promoter region, including exon-intron boundaries. Amplification was performed in a Gene Amp PCR System 9700 (Perkin Elmer, Foster City, CA) in a final reaction volume of 25 μl containing 100 ng of genomic DNA template, 0.25 nM dNTPs, 20 pmol of each primer, 1 U HotMaster Taq polymerase (Eppendorf s.r.l., Milan, Italy), in 1X PCR Reaction Buffer. PCR cycling conditions consisted of an initial denaturation step at 94 °C for 2 min, followed by 35 cycles at 94 °C for 30 s, the specific annealing temperature for 30 s, and ending with a final elongation step at 72 °C for 7 min. PCR products were purified using GFX™ PCR DNA and Gel Band Purification Kit (GE Healthcare, Buckinghamshire, UK) and sequenced. Sequencing reactions were performed in 10 μl of the final volume composed of 3 pmol of primer, 4–6 ng of DNA template and 1 μl of Big Dye Terminator Read Reaction mix v.1.1 (Applied Biosystems by Thermo Fisher Scientific, Waltham, MA USA). Sequencing reactions were loaded on an ABI 3100 capillary sequencer (Applied Biosystems) and analyzed using the Sequencing Analysis software v.3.7 (PE Applied Biosystems). When mutations were detected in DNA from tumor samples, we searched for the same mutation in the corresponding PB DNA in order to identify germline mutations. 2.3.3 Loss of heterozygosity analysis Loss of heterozygosity (LOH) analysis using fluorescent-labeled DNA primers from matched PB and tumor tissues was performed using three microsatellite markers flanking the VHL gene: D3S1335, D3S1038, and D3S1317. PCR was performed in a 50 μl reaction volume containing 2,5 μl of 10X PCR Buffer (Eppendorf), 0.25 nM dNTPs, 20 pmol of each primer, 1 U HotMaster Taq (Eppendorf) and 100 ng of DNA. Cycling conditions consisted of 40 cycles of LMS2 (ABI Prism™ Linkage Mapping Set, version 2) method performed on a GeneAmp PCR System 9700 (Applied Biosystems) for all markers. After capillary array electrophoresis (ABI 3100, Applied Biosystems), and data analysis by the ABI Genescan and Genotyper Software 3.7 (Applied Biosystems), LOH or allelic imbalance (AI) value was quantified using the formula <<(peak 1 height/peak2 height in tumor DNA)/(peak 1 height/peak 2 height in normal DNA)>>, and following stricter criteria than previously suggested [39]. In fact, the cut-off for defining an AI was lowered to 0.5 whereas an AI > 0.5 and <0.65 defined a borderline case. LOH status was confirmed at least twice for each marker. 2.3.4 Methylation analysis The methylation status of the promoter region of the VHL gene was determined by methylation specific PCR (MSP) as previously described [28]. Briefly, 1 μg of the genomic DNA was modified with EpiTect®Bisulfite Kit (Qiagen, Hilden, Germany). Modified DNA was amplified by specific primers for both unmethylated and methylated sequences. PCR was performed in 20 μl reaction volumes containing 1X PCR Buffer [16.6 mM ammonium sulfate, 67 mM Tris (pH 8.8), 6.7 mM magnesium chloride, 10 mM b-mercaptoethanol, 1% DMSO, and 1.25 mM deoxynucleotide triphosphates), 0.2 mM each deoxynucleoside triphosphate, 100 pmol of each primer, 2 units of PlatinumTaq polymerase (Invitrogen), and 50 ng of bisulfite-modified DNA. PCR cycling conditions were as follows: 2 min at 94 °C, 5 cycles of 30 s denaturation at 94 °C, 30 s at 64 °C and 30 s extension at 72 °C, 5 cycles at 94 °C, 30 s at 62 °C and 30 s extension at 72 °C, 25 cycles at 94 °C, 30 s at 60 °C and 30 s extension at 72 °C, and a final extension step of 7 min at 72 °C. CpGenome Universal Methylated DNA (Millipore, Merck Millipore Inc., Billerica, Massachusetts) was used as a positive control. PCR products were loaded on 3% agarose gels with ethidium bromide and visualized under UV illumination.

      ArticleReferenceSequence: Not specified – only protein change was documented by the author, nucleotide variant was found under reference sequence NM_000551.3

      GenotypingMethod: PCR amplification of entire VHL coding sequence and promoter region, including exon-intron boundaries. Amplification was performed in a Gene Amp PCR System 9700. When mutations were detected in DNA from tumor samples, we searched for the same mutation in the corresponding PB DNA in order to identify germline mutations. LOH analysis and methylation specific PCR were also performed.

      SamplingMethod: formalin-fixed paraffin-embedded tissue, uninvolved normal tissue, peripheral blood

    1. In our study, group 5 represented the c.262T > C p.Trp88Arg mutation that included 21 patients from 2 families (Figure 4 and Table 3). Variability was observed in the mean age at onset for CHB and RCC, which were 41.1 ± 9.1 (range = 29–62) and 37.4 ± 12.9 (range = 23–65), respectively.

      PatientID: 12

      KindredID: 1 (group ID 5)

      Case: M, 40Y0M (deceased), Chinese

      DiseaseAssertion: assumed VHL

      CohortInfo: Clinical characteristics of 258 patients from 80 unrelated Chinese families were reported in this study. Grouped by the 21 mutations found, 2 families with 21 members total were described, and phenotypic information was given for this group.

      FamilyInfo: In family 1, 17 members were described. The first generation describes 5 members with the VHL mutation, each passing on the gene to further generations. Patient 12’s mother and brother had this familial mutation. His two daughters had not been yet tested at the time of the study. See Fig 4 for family pedigree; Table 3 for details.

      CasePresentingHPOs: HP:0005584 (renal cell carcinoma)

      CaseHPOFreeText: He had RCC at 40Y

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.W88R (c.262T>C)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 496053 https://www.ncbi.nlm.nih.gov/clinvar/variation/496053/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant;transition

      CivicName: W88R (c.262T>C)

      MultipleGeneVariants: N/A

    1. GroupID: None

      KindredID: 17

      DiseaseAssertion: VHL

      GroupSize: 10

      GroupNumberMales: N/A

      GroupNumberFemales: N/A

      GroupEthnicity: American Admixed /Latino

      GroupAgeRange: N/A

      GroupInfo: 10 members of a South American family expressed this mutation.

      GroupPresentingHPOs: HP:0010797, HP:0009711, HP:0005584 (hemangioblastoma, retinal capillary hemangioma, renal cell carcinoma)

      GroupHPOFreeText: All 10 family members had a central nervous system hemangioblastoma. One also had a retinal angioma. Five had renal carcinoma. One patient per family with renal tumour <3 cm under follow up detected by imaging.

      GroupNotHPOs: HP:0002894, HP:0002666 (neoplasm of the pancreas, pheochromocytoma )

      GroupNotHPOFreeText: N/A

      GroupPreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: Partial Deletion

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: N/A

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: Deletion

      CivicName: Partial Deletion and P61=( c.183C>G)

      MultipleGeneVariants: Germline, VHL, c.183C>G (Pro61Pro)

    1. We studied six patients with VHL disease and their relatives. Loss of heterozygosity (LOH) was determined by five flanking microsatellite polymorphic markers in the VHL locus

      PatientID: 4

      KindredID: F02

      Case: F, Age Unknown, Taiwanese

      DiseaseAssertion: Asymptomatic

      FamilyInfo: A total of 2 members of this family (F02) had a complete deletion of the VHL gene. One of these patients (3) presented with clinical features of VHL.

      CasePresentingHPOs: N/A

      CaseHPOFreeText: N/A

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: Figure 1

      Variant: Exon 1 Deletion (c.1-?_340+?del)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: N/A

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: Deletion of 53.3kb resulted in deletion of Exon 1 in the VHL gene.

      MutationType: exon_loss_variant

      CivicName: Exon 1 Deletion

      MultipleGeneVariants: Germline, FANCD2, deletion

    1. VHL mutational analysis Genomic DNA was extracted from peripheral blood leukocytes using the semi-automated Quickgene system (Fujifilm, Tokyo, Japan). The entire VHL coding sequence (three coding exons) as well as the intron/exon junctions were amplified by PCR using pairs of primers derived from the VHL published sequence. Primer sequences and annealing temperatures are available on request. Each 25 µl PCR amplification reaction contained 1X buffer, 200 ng of genomic DNA, 0.2 mM of each dNTP, 2 U Taq polymerase, 1 mM of forward and reverse primers, and 1.5 mM MgCl2. PCR products were analysed in 1.5% agarose gels from which the bands with the amplified templates were excised, and the DNA subsequently purified with the help of the Qiaex II kit (Qiagen, Hilden, Germany). Direct automated sequencing of VHL was performed with the BigDye Terminador Cycle Sequencing kit (Applied Biosystems, Foster City, CA, USA), adding about 15 ng of template DNA in each reaction and using a temperature program that included 25 cycles of denaturation at 95°C for 30 s, annealing at 50°C for 15 s, and extension at 60°C for 4 min. All samples were analized in an ABI Prism 310 Genetic Analyzer (Applied Biosystems). Wild-type (Ensembl Transcript ID: ENST00000256474) and mutated VHL sequences were compared manually.

      ArticleReferenceSequence: Not specified – Assumption: variants assumed to have been documented by the author under reference sequence NM_000551.3

      GenotypingMethod: PCR, direct automated sequencing wild-type and mutated VHL sequences were compared manually.

      SamplingMethod: peripheral blood leukocytes

    1. p.Pro81Ser has been inherited from his healthy father (I.1)

      PatientID: I.1

      KindredID: 3

      Case: M, Age Unknown, Ethnicity Unknown

      DiseaseAssertion:Asymptomatic

      FamilyInfo: The patient had a son who he passed this mutation to. The son (II.1) presented with hemangioblastoma and pancreatic cysts and had an additional de novo exon 1-3 deletion. Refer to figure 1, pedigree C for family information.

      CohortInfo: Patients were registrants from the European-American Pheochromocytoma-Paraganglioma and German von Hippel-Lindau Disease Registries.

      CasePresentingHPOs: N/A

      CaseHPOFreeText: N/A

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: RET/SDHB/SDHD/SDHC

      PreviouslyPublished: May have been previously published in 11106358 and/or 7563486.

      SupplementalData: Yes, File 1 for methods.

      Variant: p.P81S(c.241C>T)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 2233 https://www.ncbi.nlm.nih.gov/clinvar/variation/2233/

      CAID: N/A

      gnomAD: 0.0002179 https://gnomad.broadinstitute.org/variant/3-10183772-C-T

      VariantEvidence: N/A

      MutationType: missense_variant;transition

      CivicName: P81S(c.241C>T)

      MultipleGeneVariants: N/A

    1. 125

      Case#: Ahmad_2014_125

      DiseaseAssertion: VWD type 2A

      FamilyInfo: heterozygous (probably affected according to multimer analysis) mother

      ParentalGenotype: heterozygous mother, homozygous wt father and sibling

      CasePresentingHPOs: none described

      CaseHPOFreeText: none described

      CaseNotHPOs:

      CaseNotHPOFreeText:

      CasePreviousTesting: not reported

      GenotypingMethod: PCR, restriction digest

      Gene: VWF

      Variant: NM_000552.5(VWF):c.4883T>C (p.Ile1628Thr)

      HGVS:

      ClinVarID: 284

      CAID:

      gnomAD: not reported

      MultipleGeneVariants:

    1. Case 7

      Case: Case 7, ages 2-17, Croatian

      DiseaseAssertion: VWD2B

      FamilyInfo:

      ParentalGenotypes(s):

      CasePresentingHPOs:

      CaseHPOFreeText:

      CaseNOTHPOs:

      CaseNOTHPOFreeText: bleeding score= 0, VWF:GPIbM (%)= 47.0, VWF:Ag (%)= 59.1, vWF:GPIbM/vWF:Ag ratio= 0.80, FVIII:C (%): 78, VWF: CBA (%)= 36.8

      CasePreviousTesting:

      Gene: VWF

      Variant: c.3923G>A p.Arg1308His

      HGVS: NM_000552.5:c.3923G>A

      ClinVar: 100303

      gnomAD: https://gnomad.broadinstitute.org/variant/12-6128661-C-T?dataset=gnomad_r2_1, frequency: 0.00004603

    2. Case 8

      Case: Case 8, ages 2-17, Croatian

      DiseaseAssertion: VWD2B

      FamilyInfo:

      ParentalGenotypes(s):

      CasePresentingHPOs:

      CaseHPOFreeText:

      CaseNOTHPOs:

      CaseNOTHPOFreeText: bleeding score= 3, VWF:GPIbM (%)= 16.1, VWF:Ag (%)= 57.8, vWF:GPIbM/vWF:Ag ratio= 0.28, FVIII:C (%): 61, VWF: CBA (%)= 36.4

      CasePreviousTesting:

      Gene: VWF

      Variant: c.3946G>A, p.Val1316Met

      HGVS: NM_000552.5:c.3946G>A

      ClinVar: 290

      gnomAD: not in gnomad

    1. rs617505986127570c.5014G > A28p.G1672R30.000712A

      Case:n.a.

      DiseaseAssertion:VWD 2A

      FamilyInfo:n.a.

      ParentalGenotype(s):n.a.

      CasePresentingHPOs:n.a.

      CaseHPOFreeRext:n.a.

      CaseNOTHPOs:n.a.

      CaseNOTHPOFreeText:n.a.

      CasePreviousTesting:n.a.

      GenotypingMethod:n.a.

      PreviouslyPublished: If applicable.n.a.

      Gene: VWF

      Variant:c.5014G > A

      HGVS:NM_000552.5(VWF):c.5014G>A (p.Gly1672Arg)

      ClinVarID:100414

      CAID:n.a.

      gnomAD:n.a.

    1. 6

      Case#: 6, male, 20yo

      DiseaseAssertion: VWD1

      FamilyInfo: N/A

      ParentalGenotype: N/A

      CasePresentingHPOs: HP:0000421, HP:0004846, HP:0012147, HP:0030129, HP:0030130 (Epistaxis, Reduced quantity of VWF, Impaired ristocetin cofactor assay activity, Impaired von Willebrand factor collagen binding activity)

      CaseHPOFreeText: posttraumatic muscle and joint bleeds, Type O blood, VWF:Ag (0·55–2 iu/ml) pre = 0·34, VWF:RCo (0·55–2 iu/ml) pre = 0·24, FVIII:C (0·55–2 iu/ml) pre = 0·24, FVIII:C/VWF:Ag ratio = 0·71, VWF:FVIII binding (>20%) = 16%, VWF:FVIII binding/VWF:Ag (>0·7) = 0·47

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      ProteinExpression: N/A

      CasePreviousTesting: RFLP; confirmatory sequencing

      Gene: VWF

      Variant 1: NM_000552.4(VWF):c.2561G>A (p.Arg854Gln)

      ClinVar: 296; https://www.ncbi.nlm.nih.gov/clinvar/variation/296/

      gnomAD: MAF = 0.005692 (European Non-Finnish); https://gnomad.broadinstitute.org/variant/12-6143978-C-T

      Variant 2: N/A - stated to be a compound heterozygote for a 2N VWD and a presumed null mutation

    1. Supplementary Data Table S3

      Case: 155

      DiseaseEntity: HCM

      HPOsFreeText: left ventricular hypertrophy (LVH) ≥15 mm

      InheritancePattern: n/a

      CasePreviousTesting: MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1 (59 genes total tested)

      CaseGenotypingMethod: NGS of 59 genes (Supplemental Table S1), pathogenic and likely pathogenic variants confirmed via Sanger Sequencing

      Variant: NM_000257.4(MYH7):c.3158G>A (p.Arg1053Gln)

      ClinVar: 155814 https://www.ncbi.nlm.nih.gov/clinvar/variation/155814/

      gnomAD: 0.0006368, https://gnomad.broadinstitute.org/variant/14-23891476-C-T

      MultipleGeneVariants:

      (1) SDHA Variant

      Variant: NM_004168.4(SDHA):c.1886A>T (p.Tyr629Phe)

      ClinVar: 224949 https://www.ncbi.nlm.nih.gov/clinvar/variation/224949/

      gnomAD: 0.5249, https://gnomad.broadinstitute.org/variant/5-254599-A-T

    2. Supplementary Data Table S3

      Case: 48

      DiseaseEntity: HCM

      HPOsFreeText: left ventricular hypertrophy (LVH) ≥15 mm

      InheritancePattern: n/a

      CasePreviousTesting: MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1 (59 genes total tested)

      CaseGenotypingMethod: NGS of 59 genes (Supplemental Table S1), pathogenic and likely pathogenic variants confirmed via Sanger Sequencing

      Variant: NM_000257.4(MYH7):c.3158G>A (p.Arg1053Gln)

      ClinVar: 155814, https://www.ncbi.nlm.nih.gov/clinvar/variation/155814/

      gnomAD: 0.00006010, https://gnomad.broadinstitute.org/variant/14-23891476-C-T

    3. Supplementary Data Table S3

      Case: 17

      DiseaseEntity: HCM

      HPOsFreeText: left ventricular hypertrophy (LVH) ≥15 mm

      InheritancePattern: n/a

      CasePreviousTesting: MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1 (59 genes total tested)

      CaseGenotypingMethod: NGS of 59 genes (Supplemental Table S1), pathogenic and likely pathogenic variants confirmed via Sanger Sequencing

      Variant: NM_000257.4(MYH7):c.3158G>A (p.Arg1053Gln)

      ClinVar: 155814, https://www.ncbi.nlm.nih.gov/clinvar/variation/155814/

      gnomAD: 0.00006010, https://gnomad.broadinstitute.org/variant/14-23891476-C-T

      MultipleGeneVariants:

      (1) NEBL Variant

      Variant: NM_006393.2(NEBL):c.2054C>T (p.Ala685Val)

      ClinVar: 227732, https://www.ncbi.nlm.nih.gov/clinvar/variation/227732/

      gnomAD: 0.0003290, https://gnomad.broadinstitute.org/variant/10-21108354-G-A

      (2) RBM20 Variant

      Variant: NM_001134363.3(RBM20):c.2662G>A (p.Asp888Asn)

      ClinVar: 43995, https://www.ncbi.nlm.nih.gov/clinvar/variation/43995/

      gnomAD: 0.004046, https://gnomad.broadinstitute.org/variant/10-112581039-G-A

    4. Supplementary Data Table S3

      Case: 23

      DiseaseEntity: HCM

      HPOsFreeText: left ventricular hypertrophy (LVH) ≥15 mm

      InheritancePattern: n/a

      CasePreviousTesting: MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1 (59 genes total tested)

      CaseGenotypingMethod: NGS of 59 genes (Supplemental Table S1), pathogenic and likely pathogenic variants confirmed via Sanger Sequencing

      Variant: NM_000257.4(MYH7):c.3158G>A (p.Arg1053Gln)

      ClinVar: 155814, https://www.ncbi.nlm.nih.gov/clinvar/variation/155814/

      gnomAD: 0.00006010, https://gnomad.broadinstitute.org/variant/14-23891476-C-T

    5. Supplementary Data Table S3

      Case: 67

      DiseaseEntity: HCM

      HPOsFreeText: left ventricular hypertrophy (LVH) ≥15 mm

      InheritancePattern: n/a

      CasePreviousTesting: MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1 (59 genes total tested)

      CaseGenotypingMethod: NGS of 59 genes (Supplemental Table S1), pathogenic and likely pathogenic variants confirmed via Sanger Sequencing

      Variant: NM_000257.4(MYH7):c.3158G>A (p.Arg1053Gln)

      ClinVar: 155814 https://www.ncbi.nlm.nih.gov/clinvar/variation/155814/

      gnomAD: 0.0006368, https://gnomad.broadinstitute.org/variant/14-23891476-C-T

    6. Supplementary Data Table S3

      Case: 20

      DiseaseEntity: HCM

      HPOsFreeText: left ventricular hypertrophy (LVH) ≥15 mm

      InheritancePattern: n/a

      CasePreviousTesting: MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1 (59 genes total tested)

      CaseGenotypingMethod: NGS of 59 genes (Supplemental Table S1), pathogenic and likely pathogenic variants confirmed via Sanger Sequencing

      Variant: NM_000257.4(MYH7):c.2155C>T (p.Arg719Trp)

      ClinVar: 14104, https://www.ncbi.nlm.nih.gov/clinvar/variation/14104/

      gnomAD: 0.00003185, https://gnomad.broadinstitute.org/variant/14-23895180-G-A

      MultipleGeneVariants:

      (1) LDB3 Variant

      Variant: NM_007078.3(LDB3):c.295C>T (p.Pro99Ser)

      ClinVar: 178059, https://www.ncbi.nlm.nih.gov/clinvar/variation/178059/

      gnomAD: 0.0009830, https://gnomad.broadinstitute.org/variant/10-88439888-C-T

      (2) RBM20 Variant

      Variant: NM_001134363.3(RBM20):c.2662G>A (p.Asp888Asn)

      ClinVar: 43995, https://www.ncbi.nlm.nih.gov/clinvar/variation/43995/

      gnomAD: 0.004046, https://gnomad.broadinstitute.org/variant/10-112581039-G-A

    7. Supplementary Data Table S3

      Case: 333

      DiseaseEntity: HCM

      HPOsFreeText: left ventricular hypertrophy (LVH) ≥15 mm

      InheritancePattern: n/a

      CasePreviousTesting: MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1 (59 genes total tested)

      CaseGenotypingMethod: NGS of 59 genes (Supplemental Table S1), pathogenic and likely pathogenic variants confirmed via Sanger Sequencing

      Variant: NM_000257.4(MYH7):c.3158G>A (p.Arg1053Gln)

      ClinVar: 155814 https://www.ncbi.nlm.nih.gov/clinvar/variation/155814/

      gnomAD: 0.0006368, https://gnomad.broadinstitute.org/variant/14-23891476-C-T

      MultipleGeneVariants:

      (1) RBM20 Variant

      Variant: NM_001134363.3(RBM20):c.2662G>A (p.Asp888Asn)

      ClinVar: 43995 https://www.ncbi.nlm.nih.gov/clinvar/variation/43995/

      gnomAD: 0.02090, https://gnomad.broadinstitute.org/variant/10-112581039-G-A

      (2) SDHA Variant

      Variant: NM_004168.4(SDHA):c.1886A>T (p.Tyr629Phe)

      ClinVar: 224949 https://www.ncbi.nlm.nih.gov/clinvar/variation/224949/

      gnomAD: 0.5249, https://gnomad.broadinstitute.org/variant/5-254599-A-T

    8. Supplementary Data Table S3

      Case: 22

      DiseaseEntity: HCM

      HPOsFreeText: left ventricular hypertrophy (LVH) ≥15 mm

      InheritancePattern: n/a

      CasePreviousTesting: MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1 (59 genes total tested)

      CaseGenotypingMethod: NGS of 59 genes (Supplemental Table S1), pathogenic and likely pathogenic variants confirmed via Sanger Sequencing

      Variant 1: NM_000257.4(MYH7):c.1816G>A (p.Val606Met)

      ClinVar: 14091, https://www.ncbi.nlm.nih.gov/clinvar/variation/14091/

      gnomAD: 0.000007070, https://gnomad.broadinstitute.org/variant/14-23896866-C-T

      Variant 2: NM_000257.4(MYH7):c.3853+7C>T

      ClinVar: 42977, https://www.ncbi.nlm.nih.gov/clinvar/variation/42977/

      gnomAD: 0.002253, https://gnomad.broadinstitute.org/variant/14-23888685-G-A

    9. Supplementary Data Table S3

      Case: 276

      DiseaseEntity: HCM

      HPOsFreeText: left ventricular hypertrophy (LVH) ≥15 mm

      InheritancePattern: n/a

      CasePreviousTesting: MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1 (59 genes total tested)

      CaseGenotypingMethod: NGS of 59 genes (Supplemental Table S1), pathogenic and likely pathogenic variants confirmed via Sanger Sequencing

      Variant: NM_000257.4(MYH7):c.1816G>A (p.Val606Met)

      ClinVar: 14091 https://www.ncbi.nlm.nih.gov/clinvar/variation/14091/

      gnomAD: 0.00001548, https://gnomad.broadinstitute.org/variant/14-23896866-C-T

      MultipleGeneVariants:

      (1) LAMA4 Variant

      Variant: NM_001105206.3(LAMA4):c.3239G>A (p.Arg1080Gln)

      ClinVar: 44374 https://www.ncbi.nlm.nih.gov/clinvar/variation/44374/

      gnomAD: 0.02400, https://gnomad.broadinstitute.org/variant/6-112460365-C-T

      (2) NEBL Variant

      Variant: NM_006393.2(NEBL):c.109_110del (p.Leu37fs)

      ClinVar: 229042 https://www.ncbi.nlm.nih.gov/clinvar/variation/229042/

      gnomAD: 0.001673, https://gnomad.broadinstitute.org/variant/10-21185929-TAA-T

    10. Supplementary Data Table S3

      Case: 90

      DiseaseEntity: HCM

      HPOsFreeText: left ventricular hypertrophy (LVH) ≥15 mm

      InheritancePattern: n/a

      CasePreviousTesting: MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1 (59 genes total tested)

      CaseGenotypingMethod: NGS of 59 genes (Supplemental Table S1), pathogenic and likely pathogenic variants confirmed via Sanger Sequencing

      Variant: NM_000257.4(MYH7):c.3158G>A (p.Arg1053Gln)

      ClinVar: 155814 https://www.ncbi.nlm.nih.gov/clinvar/variation/155814/

      gnomAD: 0.0006368, https://gnomad.broadinstitute.org/variant/14-23891476-C-T

      MultipleGeneVariants:

      (1) MYBPC3 Variant

      Variant: NM_000256.3(MYBPC3):c.977G>A (p.Arg326Gln)

      ClinVar: 42813 https://www.ncbi.nlm.nih.gov/clinvar/variation/42813/

      gnomAD: 0.01364, https://gnomad.broadinstitute.org/variant/11-47367871-C-T

    11. Supplementary Data Table S3

      Case: 218

      DiseaseEntity: HCM

      HPOsFreeText: left ventricular hypertrophy (LVH) ≥15 mm

      InheritancePattern: n/a

      CasePreviousTesting: MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1 (59 genes total tested)

      CaseGenotypingMethod: NGS of 59 genes (Supplemental Table S1), pathogenic and likely pathogenic variants confirmed via Sanger Sequencing

      Variant: NM_000257.4(MYH7):c.2539_2541del (p.Lys847del)

      ClinVar: 42913 https://www.ncbi.nlm.nih.gov/clinvar/variation/42913/

      gnomAD: Not in gnomAD

      MultipleGeneVariants:

      (1) MYBPC3 Variant

      Variant: NM_000256.3(MYBPC3):c.2686G>A (p.Val896Met)

      ClinVar: 42652 https://www.ncbi.nlm.nih.gov/clinvar/variation/42652/

      gnomAD: 0.02794, https://gnomad.broadinstitute.org/variant/11-47357479-C-T

      (2) PSEN1 Variant

      Variant: NM_000021.4(PSEN1):c.953A>G (p.Glu318Gly)

      ClinVar: 98094 https://www.ncbi.nlm.nih.gov/clinvar/variation/98094/

      gnomAD: 0.03394, https://gnomad.broadinstitute.org/variant/14-73673178-A-G

      (3) TMPO Variant

      Variant: NM_001032283.2(TMPO):c.859G>C (p.Ala287Pro)

      ClinVar: 43693 https://www.ncbi.nlm.nih.gov/clinvar/variation/43693/

      gnomAD: 0.04732, https://gnomad.broadinstitute.org/variant/12-98938295-G-C

    12. Supplementary Data Table S3

      Case: 26

      DiseaseEntity: HCM

      HPOsFreeText: left ventricular hypertrophy (LVH) ≥15 mm

      InheritancePattern: n/a

      CasePreviousTesting: MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1 (59 genes total tested)

      CaseGenotypingMethod: NGS of 59 genes (Supplemental Table S1), pathogenic and likely pathogenic variants confirmed via Sanger Sequencing

      Variant: NM_000257.4(MYH7):c.3158G>A (p.Arg1053Gln)

      ClinVar: 155814, https://www.ncbi.nlm.nih.gov/clinvar/variation/155814/

      gnomAD: 0.00006010, https://gnomad.broadinstitute.org/variant/14-23891476-C-T

      MultipleGeneVariants:

      (1) FBN1 Variant

      Variant: NM_000138.4(FBN1):c.3077T>C (p.Phe1026Ser)

      ClinVar: 199948, https://www.ncbi.nlm.nih.gov/clinvar/variation/199948/

      gnomAD: 0.0006449, https://gnomad.broadinstitute.org/variant/15-48782053-A-G

      (2) SDHA Variant

      Variant: NM_004168.4(SDHA):c.1886A>T (p.Tyr629Phe)

      ClinVar: 224949, https://www.ncbi.nlm.nih.gov/clinvar/variation/224949/

      gnomAD: 0.1547, https://gnomad.broadinstitute.org/variant/5-254599-A-T

    13. Supplementary Data Table S3

      Case: 245

      DiseaseEntity: HCM

      HPOsFreeText: left ventricular hypertrophy (LVH) ≥15 mm

      InheritancePattern: n/a

      CasePreviousTesting: MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1 (59 genes total tested)

      CaseGenotypingMethod: NGS of 59 genes (Supplemental Table S1), pathogenic and likely pathogenic variants confirmed via Sanger Sequencing

      Variant: NM_000257.4(MYH7):c.3158G>A (p.Arg1053Gln)

      ClinVar: 155814 https://www.ncbi.nlm.nih.gov/clinvar/variation/155814/

      gnomAD: 0.0006368, https://gnomad.broadinstitute.org/variant/14-23891476-C-T

      MultipleGeneVariants:

      (1) DES Variant

      Variant: NM_001927.4(DES):c.638C>T (p.Ala213Val)

      ClinVar: 44265 https://www.ncbi.nlm.nih.gov/clinvar/variation/44265/

      gnomAD: 0.01512, https://gnomad.broadinstitute.org/variant/2-220284876-C-T

      (2) JUP Variant

      Variant: NM_002230.4(JUP):c.1942G>A (p.Val648Ile)

      ClinVar: 45842 https://www.ncbi.nlm.nih.gov/clinvar/variation/45842/

      gnomAD: 0.01341, https://gnomad.broadinstitute.org/variant/17-39913771-C-T

      (3) TTN Variant

      Variant: NM_001267550.2(TTN):c.33501_33503AGA[6] (p.Glu11172dup)

      ClinVar: 46889 https://www.ncbi.nlm.nih.gov/clinvar/variation/46889/

      gnomAD: 0.01788, https://gnomad.broadinstitute.org/variant/2-179544685-C-CTCT

    14. Supplementary Data Table S3

      Case: 25

      DiseaseEntity: HCM

      HPOsFreeText: left ventricular hypertrophy (LVH) ≥15 mm

      InheritancePattern: n/a

      CasePreviousTesting: MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1 (59 genes total tested)

      CaseGenotypingMethod: NGS of 59 genes (Supplemental Table S1), pathogenic and likely pathogenic variants confirmed via Sanger Sequencing

      Variant: NM_000257.4(MYH7):c.3158G>A (p.Arg1053Gln)

      ClinVar: 155814, https://www.ncbi.nlm.nih.gov/clinvar/variation/155814/

      gnomAD: 0.00006010, https://gnomad.broadinstitute.org/variant/14-23891476-C-T

      MultipleGeneVariants:

      (1) GAL Variant

      Variant: NM_015973.5(GAL):c.47C>T (p.Ala16Val)

      ClinVar: 475915, https://www.ncbi.nlm.nih.gov/clinvar/variation/475915/

      gnomAD: 0.006938, https://gnomad.broadinstitute.org/variant/11-68452438-C-T

    15. Supplementary Data Table S3

      Case: 47

      DiseaseEntity: HCM

      HPOsFreeText: left ventricular hypertrophy (LVH) ≥15 mm

      InheritancePattern: n/a

      CasePreviousTesting: MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1 (59 genes total tested)

      CaseGenotypingMethod: NGS of 59 genes (Supplemental Table S1), pathogenic and likely pathogenic variants confirmed via Sanger Sequencing

      Variant: NM_000257.4(MYH7):c.3158G>A (p.Arg1053Gln)

      ClinVar: 155814, https://www.ncbi.nlm.nih.gov/clinvar/variation/155814/

      gnomAD: 0.00006010, https://gnomad.broadinstitute.org/variant/14-23891476-C-T

      MultipleGeneVariants:

      (1) DOLK Variant

      Variant: NM_014908.3(DOLK):c.1dup (p.Met1fs)

      ClinVar: 167006, https://www.ncbi.nlm.nih.gov/clinvar/variation/167006/

      gnomAD: 0.006541, https://gnomad.broadinstitute.org/variant/9-131709581-A-AT

    16. Supplementary Data Table S3

      Case: 373

      DiseaseEntity: HCM

      HPOsFreeText: left ventricular hypertrophy (LVH) ≥15 mm

      InheritancePattern: n/a

      CasePreviousTesting: MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1 (59 genes total tested)

      CaseGenotypingMethod: NGS of 59 genes (Supplemental Table S1), pathogenic and likely pathogenic variants confirmed via Sanger Sequencing

      Variant: NM_000257.3:c.4903A>G (p.Met1635Val)

      CAID: CA044177 http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA044177

      gnomAD: 0.0005972, https://gnomad.broadinstitute.org/variant/14-23885263-T-C

      MultipleGeneVariants:

      (1) LMNA Variant

      Variant: NM_170707.4(LMNA):c.357C>T (p.Arg119=)

      ClinVar: 48062 https://www.ncbi.nlm.nih.gov/clinvar/variation/48062/

      gnomAD: 0.01294, https://gnomad.broadinstitute.org/variant/1-156100408-C-T

      (2) MYBPC3 Variant

      Variant: NM_000256.3(MYBPC3):c.3181C>T (p.Gln1061Ter)

      ClinVar: 42690 https://www.ncbi.nlm.nih.gov/clinvar/variation/42690/

      gnomAD: 0.0001913, https://gnomad.broadinstitute.org/variant/11-47355117-G-A

      (3) SCN5A Variant

      Variant: NM_000335.4(SCN5A):c.553G>A (p.Ala185Thr)

      ClinVar: 67996 https://www.ncbi.nlm.nih.gov/clinvar/variation/67996/

      gnomAD: 0.004251, https://gnomad.broadinstitute.org/variant/3-38662392-C-T

      (4) VCL Variant

      Variant: NM_014000.2(VCL):c.1535G>A (p.Arg512His)

      ClinVar: 450167 https://www.ncbi.nlm.nih.gov/clinvar/variation/450167/

      gnomAD: 0.0001973, https://gnomad.broadinstitute.org/variant/10-75854211-G-A

    17. Supplementary Data Table S3

      Case: 123

      DiseaseEntity: HCM

      HPOsFreeText: left ventricular hypertrophy (LVH) ≥15 mm

      InheritancePattern: n/a

      CasePreviousTesting: MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1 (59 genes total tested)

      CaseGenotypingMethod: NGS of 59 genes (Supplemental Table S1), pathogenic and likely pathogenic variants confirmed via Sanger Sequencing

      Variant: NM_000257.4(MYH7):c.3158G>A (p.Arg1053Gln)

      ClinVar: 155814 https://www.ncbi.nlm.nih.gov/clinvar/variation/155814/

      gnomAD: 0.0006368, https://gnomad.broadinstitute.org/variant/14-23891476-C-T

      MultipleGeneVariants:

      (1) DES Variant

      Variant: NM_001927.4(DES):c.638C>T (p.Ala213Val)

      ClinVar: 44265 https://www.ncbi.nlm.nih.gov/clinvar/variation/44265/

      gnomAD: 0.01512, https://gnomad.broadinstitute.org/variant/2-220284876-C-T

      (2) RBM20 Variant

      Variant: NM_001134363.3(RBM20):c.2662G>A (p.Asp888Asn)

      ClinVar: 44265 https://www.ncbi.nlm.nih.gov/clinvar/variation/44265/

      gnomAD: 0.02090, https://gnomad.broadinstitute.org/variant/10-112581039-G-A

    1. CasePT-45: United States

      CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)

      HPOsFreeText: N/A

      CaseNotHPOs: HP:0001650, HP:0001658 (Aortic valve stenosis, Myocardial infarction)

      NotHPOsFreeText: N/A

      CaseAddInfo: 2 others in the study have the same MYH7 variant, one sibling has the same multiple variants genotype


      CaseGenotypingMethod: DNA was collected from the participants using blood samples. 18 genes suspected on contributing to HCM were targeted and sequenced. The variants were then located and filtered for pathogenicity.


      Variant: NM_000257.3:c.1988G>A (p.Arg663His)

      ClinVar: 42875 https://www.ncbi.nlm.nih.gov/clinvar/variation/42875/

      gnomAD: European (non-Finnish) 3.097e-5, Overall 1.414e-5 https://gnomad.broadinstitute.org/variant/14-23896042-C-T


      Multiple Gene Variants:

      PRKAG2 Variant:

      Variant: NM_016203.3:c.1304A>G (p.Asn435Ser)

      ClinVar: 167533 https://www.ncbi.nlm.nih.gov/clinvar/variation/167533/

      gnomAD: Latino 3.104e-4, Overall 1.025e-4 https://gnomad.broadinstitute.org/variant/7-151262901-T-C

    2. CasePT-80: United States

      CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)

      HPOsFreeText: N/A

      CaseNotHPOs: HP:0001650, HP:0001658 (Aortic valve stenosis, Myocardial infarction)

      NotHPOsFreeText: N/A

      CaseAddInfo:


      CaseGenotypingMethod: DNA was collected from the participants using blood samples. 18 genes suspected on contributing to HCM were targeted and sequenced. The variants were then located and filtered for pathogenicity.


      Variant: NM_000257.3:c.2546T>C (p.Met849Thr)

      ClinVar: 42914 https://www.ncbi.nlm.nih.gov/clinvar/variation/42914/

      gnomAD: Not in gnomAD

    3. CasePT-35: United States

      CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)

      HPOsFreeText: N/A

      CaseNotHPOs: HP:0001650, HP:0001658 (Aortic valve stenosis, Myocardial infarction)

      NotHPOsFreeText: N/A

      CaseAddInfo: PT-36 and PT-37 are the proband's siblings in Family 18 with the same genotype


      CaseGenotypingMethod: DNA was collected from the participants using blood samples. 18 genes suspected on contributing to HCM were targeted and sequenced. The variants were then located and filtered for pathogenicity.


      Variant: NM_000257.3:c.1491G>T (p.Glu497Asp)

      ClinVar: 14124 https://www.ncbi.nlm.nih.gov/clinvar/variation/14124/

      gnomAD: Ashkenazi Jewish 1.984e-4, Overall 7.953e-6 https://gnomad.broadinstitute.org/variant/14-23897796-C-A

    1. Supplementary Data table 1

      Case:

      DiseaseAssertion: hypertrophic cardiomyopathy

      CaseHPOFreeText: maximal wall thickness (MWT) ≥15 mm

      CasePreviousTesting: Full testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1), Additional testing (TNNC1, CSRP3, TCAP, ABCC9, ACTN2, ANKRD1, BAG3, CALR3, CAV3, CRYAB, CTNNA3, DES, DSC2, DSG2, DSP, EMD, FHL1, GLA, JPH2, JUP, LAMA4, LAMP2, LDB3, LMNA, MIB1, MYH6, MYOZ2, MYPN, NEXN, PKP2, PLN, PRDM16, PRKAG2, RBM20, SCN5A, TAZ, TMEM43, TNNC1, TTN, TTR, VCL), electrocardiography

      CaseGenotypingMethod: direct sequencing of all coding intron-exon boundaries of 12 genes (prior to 2012), next-generation sequencing (post 2012)

      Variant: NM_000257.3(MYH7):c.2081G>A (p.Arg694His)

      ClinVar: 264068, https://www.ncbi.nlm.nih.gov/clinvar/variation/264068/

      gnomAD: 0.00001061, https://gnomad.broadinstitute.org/variant/14-23895254-C-T

    2. Supplementary Data table 1

      Case:

      DiseaseAssertion: hypertrophic cardiomyopathy

      CaseHPOFreeText: maximal wall thickness (MWT) ≥15 mm

      CasePreviousTesting: Full testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1), Additional testing (TNNC1, CSRP3, TCAP, ABCC9, ACTN2, ANKRD1, BAG3, CALR3, CAV3, CRYAB, CTNNA3, DES, DSC2, DSG2, DSP, EMD, FHL1, GLA, JPH2, JUP, LAMA4, LAMP2, LDB3, LMNA, MIB1, MYH6, MYOZ2, MYPN, NEXN, PKP2, PLN, PRDM16, PRKAG2, RBM20, SCN5A, TAZ, TMEM43, TNNC1, TTN, TTR, VCL), electrocardiography

      CaseGenotypingMethod: direct sequencing of all coding intron-exon boundaries of 12 genes (prior to 2012), next-generation sequencing (post 2012)

      Variant: NM_000257.3(MYH7):c.2104A>G (p.Ile702Val) listed in paper as p.Arg719Gln

      ClinVar: 217470, https://www.ncbi.nlm.nih.gov/clinvar/variation/217470/

      gnomAD: n/a

    1. Supplementary Data, Table 2

      Case: Australian

      DiseaseAssertion: HCM

      CaseHPOFreeText: maximum left ventricular wall thickness of ≥15 mm

      CasePreviousTesting: electrocardiography, echocardiography, Full testing (MYBPC3, MYH7, TNNT2, TNNI3, TPM1, MYL2, MYL3, ACTC1)

      CaseGenotypingMethod: DNA isolated from peripheral blood or buccal swabs, PCR, Sanger sequencing, segregation analysis, haplotype analysis of MYBPC3 and MYH7

      Variant: NM_000257.3(MYH7):c.4066G>A (p.Glu1356Lys)

      ClinVar: 164294, https://www.ncbi.nlm.nih.gov/clinvar/variation/164294/

      gnomAD: n/a

    2. Supplementary Data, Table 2

      Case: Australian

      DiseaseAssertion: HCM

      CaseHPOFreeText: maximum left ventricular wall thickness of ≥15 mm

      CasePreviousTesting: electrocardiography, echocardiography, Full testing (MYBPC3, MYH7, TNNT2, TNNI3, TPM1, MYL2, MYL3, ACTC1)

      CaseGenotypingMethod: DNA isolated from peripheral blood or buccal swabs, PCR, Sanger sequencing, segregation analysis, haplotype analysis of MYBPC3 and MYH7

      Variant: NM_000257.3(MYH7):c.1051A>G (p.Lys351Glu)

      ClinVar: 181335, https://www.ncbi.nlm.nih.gov/clinvar/variation/181335/

      gnomAD: n/a

    1. Patient AUS1 IV:1

      Case: Patient AUS1-IV:1, 21yo, female, Australia

      CasePresentingHPOs: HP:0030917, HP:0008947, HP:0004323, HP:0002091, HP:0002650, HP:0003306, HP:0003701, HP:0003691, HP:0005991, HP:0002058, HP:0000268, HP:0003458 (low APGAR score, early hypotonia, abnormality of habitus, restrictive lung disease, scoliosis, spinal rigidity, proximal muscle weakness, scapular winging, limited neck flexibility, myopathic face, dolichocephaly, Myopathic electromyogram)

      HPOsFreeText: born at term, mild meconium aspiration, crawled at 10mo, walked at 18mo, thin body habitus, required nocturnal non-invasive ventilation at 13yo, required posterior spinal fusion at 3rd thoracic vertebra and 5th lumbar vertebra at 15yo, normal cardiac function, normal creatine kinase (at 13yo = 188 IU/l)

      Muscle biopsy showed variation in myofiber size with increase in internal nuclei and split myofibers, scattered nuclear bags, scattered subsarcolemmal inclusions up to 4 µm, moth-eaten and lobulated appearance of myofibers, normal phosphorylase, inclusions reactive with slow myosin resembling hyaline bodies and were shown to be composed of fine filamentous material

      CaseNotHPOs: HP:0000602, HP:0100295 (ophthalmoplegia, muscle fiber degeneration)

      FamilyInfo: Pedigree in Fig. 2, consanguineous (first-cousin) parents, Middle Eastern ancestry, no family history of neurological or cardiac abnormalities, there were 2 miscarriages prior to the proband

      CasePreviousTesting:

      CaseGenotypingMethod: Individuals IV:1 and IV:3 had NGS of 464 neurogenetic disease genes, Sanger sequencing to confirm recessive inheritance (confirmed heterozygosity in parents)

      InheritancePattern: autosomal recessive

      DiseaseEntity: n/a

      Variant: NM_000257.4(MYH7):c.5134C>T (p.Arg1712Trp), homozygous

      ClinVar: 14118, https://www.ncbi.nlm.nih.gov/clinvar/variation/14118/

      gnomAD: n/a

    1. DiseaseAssertion: Hypertrophic Cardiomyopathy

      VariantPreviousTesting: ACTC1, ACTN2, CSRP3, LAMP2, MYBPC3, MYH7, NEXN, PLN, TNNC1, TNNI3, TNNT2, TPM1, CAV3, GLA, MYL2, MYL3, MYOZ2, PRKAG2, and TTR were all tested via NGS.

      VariantGenotypingMethod: Next-generation sequencing panels were used to sequence and read the genetic information of the 760 HCM probands for variants within exons and in +/- 10 nucleotides within the flanking introns of the genes provided above. These variants were then interpreted and filtered for pathogenicity.

      VariantAddInfo: Seen in one HCM proband

      Variant: NM_000257.4(MYH7):c.2609G>A (p.Arg870His)

      ClinVarID: 14120 https://www.ncbi.nlm.nih.gov/clinvar/variation/14120/

      gnomAD: 0.00001549, http://gnomad.broadinstitute.org/variant/14-23894048-C-T

    2. DiseaseAssertion: Hypertrophic Cardiomyopathy

      VariantPreviousTesting: ACTC1, ACTN2, CSRP3, LAMP2, MYBPC3, MYH7, NEXN, PLN, TNNC1, TNNI3, TNNT2, TPM1, CAV3, GLA, MYL2, MYL3, MYOZ2, PRKAG2, and TTR were all tested via NGS.

      VariantGenotypingMethod: Next-generation sequencing panels were used to sequence and read the genetic information of the 760 HCM probands for variants within exons and in +/- 10 nucleotides within the flanking introns of the genes provided above. These variants were then interpreted and filtered for pathogenicity.

      VariantAddInfo: Seen in one HCM proband

      Variant: NM_000257.4(MYH7):c.1816G>A (p.Val606Met)

      ClinVarID: 14091 https://www.ncbi.nlm.nih.gov/clinvar/variation/14091/

      gnomAD: 0.00001548, http://gnomad.broadinstitute.org/variant/14-23896866-C-T

    3. DiseaseAssertion: None

      VariantPreviousTesting: Some combination of ACTC1, ACTN2, CSRP3, LAMP2, MYBPC3, MYH7, NEXN, PLN, TNNC1, TNNI3, TNNT2, TPM1, ABCC9, CTF1, DES, EMD, LDB3, LMNA, MYH6, RBM20, SGCD, TAZ, TCAP, TTN, VCL, CAV3, GLA, MYL2, MYL3, MYOZ2, PRKAG2, TTR, DSC2, DSG2, DSP, JUP, PKP2, RYR2, TMEM43, CASQ2 and RYR2 were tested via NGS.

      VariantGenotypingMethod: Next-generation sequencing panels were used to sequence and read the genetic information of probands for variants within exons and in +/- 10 nucleotides within the flanking introns of the genes provided above. These variants were then interpreted and filtered for pathogenicity.

      Variant: NM_000257.4(MYH7):c.2945T>C (p.Met982Thr)

      ClinVar: 42941 https://www.ncbi.nlm.nih.gov/clinvar/variation/42941/

      gnomAD: 0.001416, http://gnomad.broadinstitute.org/variant/14-23892910-A-G

    4. DiseaseAssertion: Hypertrophic Cardiomyopathy

      VariantPreviousTesting: ACTC1, ACTN2, CSRP3, LAMP2, MYBPC3, MYH7, NEXN, PLN, TNNC1, TNNI3, TNNT2, TPM1, CAV3, GLA, MYL2, MYL3, MYOZ2, PRKAG2, and TTR were all tested via NGS.

      VariantGenotypingMethod: Next-generation sequencing panels were used to sequence and read the genetic information of the 760 HCM probands for variants within exons and in +/- 10 nucleotides within the flanking introns of the genes provided above. These variants were then interpreted and filtered for pathogenicity.

      VariantAddInfo: Seen in one HCM probands

      Variant: NM_000257.4(MYH7):c.958G>A (p.Val320Met)

      ClinVar: 161328 https://www.ncbi.nlm.nih.gov/clinvar/variation/161328/

      gnomAD: 0.00006154, http://gnomad.broadinstitute.org/variant/14-23899810-C-T

    5. DiseaseAssertion: Cardiomyopathy

      VariantPreviousTesting: ACTC1, ACTN2, CSRP3, LAMP2, MYBPC3, MYH7, NEXN, PLN, TNNC1, TNNI3, TNNT2, TPM1, ABCC9, CTF1, DES, EMD, LDB3, LMNA, MYH6, RBM20, SGCD, TAZ, TCAP, TTN, VCL, CAV3, GLA, MYL2, MYL3, MYOZ2, PRKAG2, TTR, DSC2, DSG2, DSP, JUP, PKP2, RYR2, TMEM43, CASQ2 and RYR2 were all tested in the PanCM panel.

      VariantGenotypingMethod: Next-generation sequencing panels were used to sequence and read the genetic information of the 305 PanCM probands for variants within exons and in +/- 10 nucleotides within the flanking introns of the genes provided above. These variants were then interpreted and filtered for pathogenicity.

      VariantAddInfo: Seen in two PanCM probands

      Variant: NM_000257.4(MYH7):c.4498C>T (p.Arg1500Trp)

      ClinVar: 164284 https://www.ncbi.nlm.nih.gov/clinvar/variation/164284/

      gnomAD: Not in gnomAD

    1. CaseMYH7-30: Australia

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)

      HPOsFreeText: N/A

      CaseNotHPOs: N/A

      NotHPOsFreeText: N/A

      CaseAddInfo: N/A

      CasePreviousTesting: See Table 1

      CaseGenotypingMethod: DNA was isolated from peripheral blood. Most participants underwent testing from the Illumina Cardiomyopathy Sequencing Panel, which includes 46 cardiomyopathy related genes. For others, whole exome sequencing or Sanger squencing was used. After the results were returned, variants were filtered for pathogenicity and rarity.

      Variant: NM_000257.3:c.1988G>A (p.Arg663His)

      ClinVar: 42875 https://www.ncbi.nlm.nih.gov/clinvar/variation/42875/

      gnomAD: European (Non-Finnish) 3.097e-5, Overall 1.414e-5 https://gnomad.broadinstitute.org/variant/14-23896042-C-T

    2. BJJ

      CaseBJJ: 16 years diagnosis, Australia

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      FamilyInfo: No family history of HCM or Sudden Cardiac Death

      CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)

      HPOsFreeText: Maximum left ventricular hypertrophy at 22 mm,

      CaseNotHPOs: N/A

      NotHPOsFreeText: Sudden cardiac death events

      CaseAddInfo: Cis/trans status is unknown

      CasePreviousTesting: See Table 1

      CaseGenotypingMethod: DNA was isolated from peripheral blood. Most participants underwent testing from the Illumina Cardiomyopathy Sequencing Panel, which includes 46 cardiomyopathy related genes. For others, whole exome sequencing or Sanger squencing was used. After the results were returned, variants were filtered for pathogenicity and rarity.

      Variant1: NM_000257.3:c.2389G>A (p.Ala797Thr)

      ClinVar: 42901 https://www.ncbi.nlm.nih.gov/clinvar/variation/42901/

      gnomAD: African 1.230e-4, Overall 2.386e-5 https://gnomad.broadinstitute.org/variant/14-23894525-C-T

      Variant2: NM_000257.3:c.2420G>A (p.Arg807His)

      ClinVar: 391904 https://www.ncbi.nlm.nih.gov/clinvar/variation/391904/

      gnomAD: Latino 5.644e-5, Overall 1.414e-5 https://gnomad.broadinstitute.org/variant/14-23894494-C-T

    3. CaseMYH7-26: Australia

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)

      HPOsFreeText: N/A

      CaseNotHPOs: N/A

      NotHPOsFreeText: N/A

      CaseAddInfo: N/A

      CasePreviousTesting: See Table 1

      CaseGenotypingMethod: DNA was isolated from peripheral blood. Most participants underwent testing from the Illumina Cardiomyopathy Sequencing Panel, which includes 46 cardiomyopathy related genes. For others, whole exome sequencing or Sanger squencing was used. After the results were returned, variants were filtered for pathogenicity and rarity.

      Variant: NM_000257.3:c.2167C>T (p.Arg723Cys)

      ClinVar: 14095 https://www.ncbi.nlm.nih.gov/clinvar/variation/14095/

      gnomAD: South Asian 3.266e-5, Overall 1.194e-5 https://gnomad.broadinstitute.org/variant/14-23895023-G-A

    4. CaseMYH7-1: Australia

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)

      HPOsFreeText: N/A

      CaseNotHPOs: N/A

      NotHPOsFreeText: N/A

      CaseAddInfo: N/A

      CasePreviousTesting: See Table 1

      CaseGenotypingMethod: DNA was isolated from peripheral blood. Most participants underwent testing from the Illumina Cardiomyopathy Sequencing Panel, which includes 46 cardiomyopathy related genes. For others, whole exome sequencing or Sanger squencing was used. After the results were returned, variants were filtered for pathogenicity and rarity.

      Variant: NM_000257.3:c.5452C>T (p.Arg1818Trp)

      ClinVar: 217826 https://www.ncbi.nlm.nih.gov/clinvar/variation/217826/

      gnomAD: Latino 5.782e-5, Overall 7.956e-6 https://gnomad.broadinstitute.org/variant/14-23884311-G-A

    1. MYH7 (n=1)

      Case - SCAS1: Korean, 66yo, Male

      CasePresentingHPOs: HP:0012622 (chronic kidney disease,

      CaseHPOFreeText: survived sudden cardiac arrest caused by idiopathic ventricular fibrillation, previous smoker, no evidence of cardiomyopathy in 2-D echocardiography, mild hypertrophic manifestation of cardiac septum

      CaseNotHPOs: HP:0001677 (coronary artery disease)

      CaseNotHPOFreeText: abnormal coronary angiography, positive spasm provocation test with ergonovine

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      FamilyInfo: Family history was recorded, daughter has congestive heart failure

      CasePreviousTesting: electrocardiogram, two-dimensional echocardiography, coronary angiography or cardiac MRI, full testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1), additional testing (supplementary data, table S3)

      CaseGenotypingMethod: Genomic DNA extracted from peripheral blood leukocytes, WES, gene-specific analysis with an in silico gene panel composed of 100 genes including 96 channelopathy and cardiomyopathy genes, variants found in WES confirmed via PCR and Sanger Sequencing

      Variant: NM_000257.3(MYH7):c.4130C>T (p.Thr1377Met)

      ClinVar: 42992, https://www.ncbi.nlm.nih.gov/clinvar/variation/42992/

      gnomAD: 0.000003977, https://gnomad.broadinstitute.org/variant/14-23887458-G-A

    1. HCM7.1

      CaseHCM7.1: Mixed ancestry

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)

      HPOsFreeText: N/A

      CaseNotHPOs: HP:0000819 (Diabetes mellitus)

      NotHPOsFreeText: N/A

      CaseAddInfo: N/A

      CasePreviousTesting: See Table 1

      CaseGenotypingMethod: DNA was extracted from the probands' blood, followed by sequencing of the coding regions and exon/intron boundaries of 15 genes associated with HCM. From there, they were amplified by PCR ampliication and variants were filtered by pathogenicity. Every unclassified variant was confirmed by Sanger sequencing afterwards.

      Variant: NM_000257.3:c.4258C>T (p.Arg1420Trp)

      ClinVar: 43003 https://www.ncbi.nlm.nih.gov/clinvar/variation/43003/

      gnomAD: European (Non-Finnish) 1.758e-5, Overall 7.953e-6 https://gnomad.broadinstitute.org/variant/14-23886807-G-A

    1. Case Report

      Case: proband, 9mo at presentation

      DiseaseAssertion: Idiopathic dilated cardiomyopathy

      CasePresentingHPOs: HP:0001635, HP:0001695, HP:0001263, HP:0007018, HP:0007018, HP:0002059, HP:0031332 (congestive heart failure, cardiac arrest, global developmental delay, attention deficit, autism, cerebral atrophy, myocyte degeneration)

      CaseHPOFreeText: had transvenous pacemaker for complete heart block and left ventricular assist device, ABO-incompatible heart transplant at 1yo, walked at 2.5yo, sensory and behavioral deficits, suspected mitochondrial disorder

      FamilyInfo: Parents underwent Sanger Sequencing to confirm variant was de novo in proband (Fig. 2)

      CasePreviousTesting: MRI, metabolic evaluation, Full testing (MYPBC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1), Additional testing (TruSight One Gene List)

      CaseGenotypingMethod: chromosomal microarray, trio analysis with fluorescent in situ hybridization, next-gen sequencing of 4813 genes (TruSight One Sequencing Panel), Sanger Sequencing

      Variant: NM_000257.3(MYH7):c.2513C>T (p.Pro838Leu) (previously reported as de novo, PMID: 18380764)

      ClinVar: 42910, https://www.ncbi.nlm.nih.gov/clinvar/variation/42910/

      gnomAD: n/a

      MultipleGeneVariants:

      (1) NRXN1 Variant:

      Variant: 181,000bp copy number loss within chr 2:6.3, build NCBI 37/hg19 (from position 51201593-51382885)

    1. CaseCM0934: Male, 6 years diagnosis, Japan, Asian

      CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)

      HPOsFreeText: N/A

      CaseNotHPOs: HP:0001939 (Abnormality of metabolism/homeostasis)

      NotHPOsFreeText: Neuromuscular disease, Malformation syndromes

      CaseAddInfo: Positive family history of cardiomyopathy or sudden death, Proband found in Supplementary Table 2, Mother tested negative for the variant


      CasePreviousTesting: 8 patients with HCM and one with RCM were analyzed by NGS for the eight sarcomere-encoding genes and MYP.

      CaseGenotypingMethod: Probands were subject to PCR amplification and direct sequencing of 64 cardiomyopathy-associated genes, including the eight sarcomere-encoding genes. The variants were then filtered for rarity and tested for pathogenicity.


      Variant: NM_000257.3:c.1357C>T (p.Arg453Cys)

      ClinVar: 14089 https://www.ncbi.nlm.nih.gov/clinvar/variation/14089/

      gnomAD: Not in gnomAD

    2. CaseCM1824: Female, 13 years diagnosis, Japan, Asian

      CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)

      HPOsFreeText: N/A

      CaseNotHPOs: HP:0001939 (Abnormality of metabolism/homeostasis)

      NotHPOsFreeText: Neuromuscular disease, Malformation syndromes

      CaseAddInfo: Positive family history of cardiomyopathy or sudden death, Proband found in Supplementary Table 2, Father afflicted with HCM and also positive for same variant


      CasePreviousTesting: 8 patients with HCM and one with RCM were analyzed by NGS for the eight sarcomere-encoding genes and MYP.

      CaseGenotypingMethod: Probands were subject to PCR amplification and direct sequencing of 64 cardiomyopathy-associated genes, including the eight sarcomere-encoding genes. The variants were then filtered for rarity and tested for pathogenicity.


      Variant: NM_000257.3:c.2146G>A (p.Gly716Arg)

      ClinVar: 14105 https://www.ncbi.nlm.nih.gov/clinvar/variation/14105/

      gnomAD: Not in gnomAD

    3. CaseCM1811: Female, 15 years diagnosis, Japan, Asian

      CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)

      HPOsFreeText: N/A

      CaseNotHPOs: HP:0001939 (Abnormality of metabolism/homeostasis)

      NotHPOsFreeText: Neuromuscular disease, Malformation syndromes

      CaseAddInfo: No family history of cardiomyopathy or sudden death, Proband found in Supplementary Table 2, Mother shows positive for this variant with no symptoms while Father shows negative for this variant with no symptoms


      CasePreviousTesting: 8 patients with HCM and one with RCM were analyzed by NGS for the eight sarcomere-encoding genes and MYP.

      CaseGenotypingMethod: Probands were subject to PCR amplification and direct sequencing of 64 cardiomyopathy-associated genes, including the eight sarcomere-encoding genes. The variants were then filtered for rarity and tested for pathogenicity.


      Variant: NM_000257.3:c.1988G>A (p.Arg663His)

      ClinVar: 42875 https://www.ncbi.nlm.nih.gov/clinvar/variation/42875/

      gnomAD: European (Non-Finnish) 3.097e-5, Overall 1.414e-5 https://gnomad.broadinstitute.org/variant/14-23896042-C-T

    1. Supplementary Data: Table S3

      Case 1:

      DiseaseAssertion: left ventricular noncompaction

      CasePresentingHPOs: HP:0030682 (left ventricular noncompaction)

      CaseHPOFreeText: >7yo, able to hold breath, non compacted segment = distinct 2-layered appearance of trabeculated and compacted myocardium, NC/C ratio > 2.3:1

      CasePreviousTesting: Cardiac MRI using 17-segment model of LV segmentation, ECG, transthoracic echocardiography, full testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1), additional testing listed in supplementary data tables S1 and S2.

      CaseGenotypingMethod: WES, variant enrichment analysis

      Variant: NM_000257.3(MYH7):c.3286G>T (p.Asp1096Tyr)

      ClinVar: 42963, https://www.ncbi.nlm.nih.gov/clinvar/variation/42953/

      gnomAD: 0.0001414, https://gnomad.broadinstitute.org/variant/14-23890217-C-A

      MultipleGeneVariants:

      (1) ACTN2 Variant:

      Variant: NM_001103.3(ACTN2):c.893G>A (p.Arg298His)

      ClinVar: 43951, https://www.ncbi.nlm.nih.gov/clinvar/variation/43951/

      gnomAD: 0.0004457, https://gnomad.broadinstitute.org/variant/1-236902618-G-A

    2. Supplementary Data: Table S3

      Case 7:

      DiseaseAssertion: left ventricular noncompaction

      CasePresentingHPOs: HP:0030682 (left ventricular noncompaction)

      CaseHPOFreeText: >7yo, able to hold breath, non compacted segment = distinct 2-layered appearance of trabeculated and compacted myocardium, NC/C ratio > 2.3:1

      CasePreviousTesting: Cardiac MRI using 17-segment model of LV segmentation, ECG, transthoracic echocardiography, full testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1), additional testing listed in supplementary data tables S1 and S2.

      CaseGenotypingMethod: WES, variant enrichment analysis

      Variant: NM_000257.3(MYH7):c.2890G>C (p.Val964Leu)

      ClinVar: 42938, https://www.ncbi.nlm.nih.gov/clinvar/variation/42938/

      gnomAD: 0.0004383, https://gnomad.broadinstitute.org/variant/14-23893148-C-G

      MultipleGeneVariants:

      (1) TTN Variant:

      Variant: p.Arg12731Ter no ClinVar or CAID

    1. 2

      Case2: Male, 46 yrs onset, China, Asian

      DiseaseAssertion: Arrhythmogenic Cardiomyopathy

      FamilyInfo: Brother has ACM with dyskinesia and enlargement in RVOT and frequent VES, PKP2 variant segregated with disease but MYH7 variant was detected in 9 unaffected relatives (See Fig 3)

      CasePresentingHPOs: HP:0001638, HP:0011675, HP:0010872, HP:0011712, HP:0004756, HP:0001962, HP:0002321, HP:0006682, HP:0001707 (Cardiomyopathy, Arrhythmia, T-wave inversion, Right bundle branch block, Ventricular tachycardia, Palpitations, Vertigo, Ventricular extrasystoles, Abnormality of the right ventricle)

      HPOsFreeText: Task force score of 5, Regional right ventricular dyskinesia, PLAX RVOT is 43 mm, 1897 VES / 24 h, LVEF of 64%, LVEDD at 51 mm, IVS at 8 mm

      CaseNotHPOs: HP:0001639, HP:0001711 (Hypertrophic cardiomyopathy, Abnormal morphology of the left ventricle)

      NotHPOsFreeText: Depolarization abnormalities

      CasePreviousTesting: Tested genes include MYH7, MYBPC3, TNNT2, TNNI3, TPM1, ACTC1, TTN, TCAP, ACTN2, LDB3, MYH6, TNNC1, MYPN and NEBL.

      CaseGenotypingMethod: The coding sequences of 15 genes were directly captured and sequenced. Candidate variants were then filtered by pathogenicity and confirmed via sanger sequencing. Family members were tested via Sanger sequencing afterwards.

      CaseAddInfo: Proband is heterozygous for both variants

      Variant: NM_000257.3:c.5116C>G (p.Leu1706Val)

      CAID: CA389036928 http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA389036928

      gnomAD: Not in gnomAD

      Multiple Gene Variants

      (1) PKP2 Variant

      Variant: NM_004572.3(PKP2):c.2489+1G>A

      ClinVar: 6757 https://www.ncbi.nlm.nih.gov/clinvar/variation/6757/

      gnomAD: 0.00008012, http://gnomad.broadinstitute.org/variant/12-32949042-C-T

    1. Supplementary Data: Online Table 2a

      Case:

      CasePreviousTesting: Full sarcomere testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1), Additional testing (ABCC9, ACTN2, ANKRD1, BAG3, CALR3, CRYAB, CSRP3, DES, DMD, DSC2, DSG2, DSP, EMD, GLA, JPH2, JUP, LAMA4, LAMP2, LMNA, MYH6, MYPN, MYOZ1, MYOZ2, PKP2, PLN, PRKAG2, RBM20, RYR2, SCN5A, SGCD, TAZ, TCAP, TMEM43, TNNC1, TTN, VCL and LDB3)

      CaseGenotypingMethod: DNA isolated from peripheral blood, targeted enrichment, next-gen sequencing with panel of 46 genes

      Variant: NM_000257.3(MYH7):c.732+1G>A

      ClinVar: 14127, https://www.ncbi.nlm.nih.gov/clinvar/variation/14127/

      gnomAD: 0.000003976, https://gnomad.broadinstitute.org/variant/14-23900793-C-T

    2. Supplementary Data: Online Table 1a

      Case:

      CasePreviousTesting: Full sarcomere testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1), Additional testing (ABCC9, ACTN2, ANKRD1, BAG3, CALR3, CRYAB, CSRP3, DES, DMD, DSC2, DSG2, DSP, EMD, GLA, JPH2, JUP, LAMA4, LAMP2, LMNA, MYH6, MYPN, MYOZ1, MYOZ2, PKP2, PLN, PRKAG2, RBM20, RYR2, SCN5A, SGCD, TAZ, TCAP, TMEM43, TNNC1, TTN, VCL and LDB3)

      CaseGenotypingMethod: DNA isolated from peripheral blood, targeted enrichment, next-gen sequencing with panel of 46 genes

      Variant: NM_000257.3(MYH7):c.728G>A (p.Arg243His)

      ClinVar: 14126, https://www.ncbi.nlm.nih.gov/clinvar/variation/14126/

      gnomAD: 0.000007953, https://gnomad.broadinstitute.org/variant/14-23900798-C-T

    3. Supplementary Data: Online Table 1a

      Case:

      CasePreviousTesting: Full sarcomere testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1), Additional testing (ABCC9, ACTN2, ANKRD1, BAG3, CALR3, CRYAB, CSRP3, DES, DMD, DSC2, DSG2, DSP, EMD, GLA, JPH2, JUP, LAMA4, LAMP2, LMNA, MYH6, MYPN, MYOZ1, MYOZ2, PKP2, PLN, PRKAG2, RBM20, RYR2, SCN5A, SGCD, TAZ, TCAP, TMEM43, TNNC1, TTN, VCL and LDB3)

      CaseGenotypingMethod: DNA isolated from peripheral blood, targeted enrichment, next-gen sequencing with panel of 46 genes

      Variant: NM_000257.3(MYH7):c.1106G>A (p.Arg369Gln)

      ClinVar: 42822, https://www.ncbi.nlm.nih.gov/clinvar/variation/42822/

      gnomAD: n/a

    1. Peripheral blood mononuclear cells (PBMCs) were obtained from a 43-year-old male with familial HCM

      Case: Male, 43yo

      DiseaseAssertion: HCM

      FamilyInfo: Variant (p.Val698Ala) segregates with HCM in 5 family members and 2 others are unaffected carriers

      CaseHPOFreeText: left ventricular wall thickness = 28 mm

      CasePreviousTesting: n/a

      CaseGenotypingMethod: n/a

      Variant: NM_000257.3(MYH7):c.2093T>C (p.Val698Ala) heterozygous

      ClinVar: 42878, https://www.ncbi.nlm.nih.gov/clinvar/variation/42878/

      gnomAD: n/a

    1. Case III-2 (Proband)

      Case#: Case III-2, 42 yr, female, early childhood onset

      DiseaseAssertion: DCM

      FamilyInfo: Family D, her father (II-5) had late-onset foot drop and hand weakness, died at age 51 from a myocardial infarction, her son (IV-3) had a severe generalized weakness since childhood, never walked and had prominent neck extensor contractures, died at age 19 years from a presumed cardiopulmonary event, 2 sisters (III-1 and III-3) had early-onset weakness and foot drop, her nephew (IV-1) had severe weakness and was wheelchair dependent, muscle biopsy, diagnosed with an unspecified muscular dystrophy, her niece (IV-2) had severe congenital weakness and died in her teens, all affected family members had contractures of neck extensors, heel cords, knee flexors, and elbow flexors

      CasePresentingHPOs: progressive muscle weakness, lower limb muscle weakness, gait disturbance, slender build, scapular winging, thoracic scoliosis, weakness of facial musculature, generalized limb muscle atrophy, sinus tachycardia (HP:0003323, HP:0007340, HP:0001288, HP:0001533, HP:0003691, HP:0002943, HP:0030319, HP:0009055, HP:0011703)

      CaseHPOFreeText: weakness and gait at age 5, nonambulatory by late-teens, wheelchair dependent, neck muscle atrophy, hypoactive myotatic reflexes

      CaseNotHPOs: respiratory distress, syncope, chest pain, palpitations (HP:0002098, HP:0001279, HP:0100749, HP:0001962)

      CaseNotHPOFreeText: normal sensory

      CasePreviousTesting: Analysis included most of the other congenital myopathy genes and was otherwise negative

      CaseGenotypingMethod: neurological examination, serum creatine kinase, nerve conduction studies, concentric needle electromyography, electrocardiogram, echocardiogram, forced vital capacity, muscle biopsy, immunohistochemical analyses, strength testing (MRC 3/2), arm flexors (MRC 4/4), arm extensors (MRC 3/3), wrist flexors (MRC 3/3), wrist extensors (MRC 1/3), finger flexors (MRC 2/2), finger extensors (MRC 2/2), finger adductors and abductors (MRC 4/4), hip flexors (MRC 2/2), hip abductors and adductors (MRC 3/3), knee flexors (MRC 2/2), knee extensors (MRC 2/2), foot dorsiflexors (MRC 0/0), plantar flexors (MRC 3/3) toe flexors (MRC 2/2), and toe extensors (MRC 1/1), normal 0.82 L (25%) FVC, 25% left ventricular ejection fraction, normal NCSs, increased small polyphasic MUAP, occasional fibrillation potentials, positive sharp waves, and brief myotonic discharges, facioscapulohumeral muscular dystrophy type 1, Emery–Dreifuss muscular dystrophy (EMD, LMNA, and FHL1 gene disorders), and limb-girdle muscular dystrophy type 1C were negative

      Variant: NM_000257.2

      ClinVar: absent

      CAID: absent

      gnomAD: absent

    2. Case III-2 (Proband)

      Case#: Case III-2, female, 64 yr, early childhood onset

      DiseaseAssertion: None

      FamilyInfo: Family C, her mother (II-1) and maternal grandmother (I-1) had late-onset leg weakness (Fig. 1C), her brother (III-4) had severe generalized weakness and was diagnosed with an unspecified muscular dystrophy

      CasePresentingHPOs: Gait disturbance, lower limb muscle weakness, hypertension, osteoarthritis, hyperlipidemia, glaucoma, neck flexor weakness, weakness of facial musculature, weakness of long finger extensor muscles, foot dorsiflexor weakness (HP:0001288, HP:0007340, HP:0000822, HP:0002758, HP:0003077, HP:0000501, HP:0003722, HP:0030319, HP:0009077, HP:0009027)

      CaseHPOFreeText: mild heel cord contractures, mild eye closure weakness, unable to stand on heels, limb weakness

      CaseNotHPOs: Scoliosis, scapular winging, generalized muscle hypertrophy (HP:0002650, HP:0003691, HP:0003720)

      CaseNotHPOFreeText: hand or foot deformities, normal knee bend and stand on tiptoes, normal reflexes and sensory

      CasePreviousTesting: N/A

      CaseGenotypingMethod: neurological examination, serum creatine kinase, nerve conduction studies, concentric needle electromyography, electrocardiogram, echocardiogram, forced vital capacity, muscle biopsy, immunohistochemical analyses, CK 156 unit/L (n < 143), FVC 2.13 L (68%), ECG and echo normal, left ventricular ejection fraction 65%, normal NCS except low-amplitude peroneal and tibial compound muscle action potential, abnormal increase of small polyphasic MUAP in tibialis anterior, no fibrillation potentials, no positive sharp waves, no myotonic discharges

      Variant: NM_182476.3(COQ6):c.115G>A (p.Val39Met) & NM_000257.4(MYH7):c.4844_4846AGA[2] (p.Lys1617del)

      ClinVar: 214236 https://www.ncbi.nlm.nih.gov/clinvar/variation/214236/ & 190401 https://www.ncbi.nlm.nih.gov/clinvar/variation/190401/

      CAID: N/A

      gnomAD: 0.00006720 African https://gnomad.broadinstitute.org/variant/14-74417150-G-A & absent

    1. Supplementary Data: S2 Table

      Case 236: Spanish, 37yo, Male

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      CasePreviousTesting: Full Testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1), additional testing listed in supplementary data table S1

      CaseGenotypingMethod: genomic DNA obtained from blood or saliva, Next-gen sequencing panels of 55 or 78 genes

      Variant1: NM_000257.3(MYH7):c.4954G>T (p.Asp1652Tyr)

      ClinVar: 43047, https://www.ncbi.nlm.nih.gov/clinvar/variation/43047/

      gnomAD: 0.00004774, https://gnomad.broadinstitute.org/variant/14-23885041-C-A

      Variant2: NM_000257.3(MYH7):c.4817G>A (p.Arg1606His)

      ClinVar: 43039, https://www.ncbi.nlm.nih.gov/clinvar/variation/43039/

      gnomAD: 0.00003889, https://gnomad.broadinstitute.org/variant/14-23885349-C-T

    2. Supplementary Data: S2 Table

      Case 1: Spanish, 42yo, Male

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      CasePreviousTesting: Full Testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1), additional testing listed in supplementary data table S1

      CaseGenotypingMethod: genomic DNA obtained from blood or saliva, PCR, Sanger Sequencing

      Variant: NM_000257.3(MYH7):c.427C>T (p.Arg143Trp)

      ClinVar: 164401, https://www.ncbi.nlm.nih.gov/clinvar/variation/164401/

      gnomAD: 0.00002784, https://gnomad.broadinstitute.org/variant/14-23901923-G-A

    3. Supplementary Data: S2 Table

      Case 195: Spanish, 53yo, Female

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      CasePreviousTesting: Full Testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1), additional testing listed in supplementary data table S1

      CaseGenotypingMethod: genomic DNA obtained from blood or saliva, Next-gen sequencing panels of 55 or 78 genes

      Variant: NM_000257.3(MYH7):c.958G>A (p.Val320Met)

      ClinVar: 161328, https://www.ncbi.nlm.nih.gov/clinvar/variation/161328/

      gnomAD: 0.00001591, https://gnomad.broadinstitute.org/variant/14-23899810-C-T

    4. Supplementary Data: S2 Table

      Case 47: Spanish, 40yo, Male

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      CasePreviousTesting: Full Testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1), additional testing listed in supplementary data table S1

      CaseGenotypingMethod: genomic DNA obtained from blood or saliva, Next-gen sequencing panels of 55 or 78 genes

      Variant: NM_000257.3(MYH7):c.4066G>A (p.Glu1356Lys)

      ClinVar: 164294, https://www.ncbi.nlm.nih.gov/clinvar/variation/164294/

      gnomAD: n/a

    1. Table 1 and 4

      Case 64: Male, 42yo

      DiseaseAssertion: HCM

      FamilyInfo: negative family history

      CaseHPOFreeText: interventricular septum thickness = 18.1mm, left ventricular end diastolic diameter = 51.7mm, left ventricular end systolic diameter = 34.4mm, left ventricular posterior wall thickness = 9.8mm, left atrium = 44mm, left ventricular ejection fraction = 61%

      CasePreviousTesting: 12-lead ECG, echocardiography, full testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1), additional testing (LMNA, PRKAG2, SCN5A, MYH6)

      CaseGenotypingMethod: genomic DNA collected from peripheral whole blood samples, PCR, high-throughput sequencing using PGM Sequencing 400 kit, variants verified via Sanger Sequencing

      Variant: NM_000257.3(MYH7):c.1987C>T (p.Arg663Cys)

      ClinVar: 42874, https://www.ncbi.nlm.nih.gov/clinvar/variation/42874/

      gnomAD: n/a

    1. Case12: Female, 60 years diagnosis, China, Asian

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      FamilyInfo: One sibling and one child died of SCD in their 30s, with child having confirmed HCM

      CasePresentingHPOs: HP:0001639, HP:0030148 (Hypertrophic cardiomyopathy, Heart murmur)

      HPOsFreeText: Mixed features of apical and classic HCM

      CaseNotHPOs: N/A

      NotHPOsFreeText: N/A

      CaseAddInfo: N/A

      CasePreviousTesting: Probands were only genotyped for MYH7 and MYBPC3 in that order, stopping once a positive finding was detected.

      CaseGenotypingMethod: Genomic DNA was extracted from peripheral blood. Each gene's coding exons and flanking introns were subject to PCR amplification and sequencing. From there, any variants found were filtered for pathogenicity and low frequencies.

      Variant: NM_000257.3:c.1273G>A (p.Gly425Arg)

      ClinVar: 42834 https://www.ncbi.nlm.nih.gov/clinvar/variation/42834/

      gnomAD: Not in gnomAD

    2. Case15: Female, 48 years diagnosis, China, Asian

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      FamilyInfo: One parent died of cardiomyopathy/sudden death, one offspring had a heart murmur and found to have HCM

      CasePresentingHPOs: HP:0001639, HP:0001279, HP:0005162, HP:0003546 (Hypertrophic cardiomyopathy, Syncope, Left ventricular failure, Poor exercise tolerance)

      HPOsFreeText: N/A

      CaseNotHPOs: N/A

      NotHPOsFreeText: N/A

      CaseAddInfo: Heart transplantation done

      CasePreviousTesting: Probands were only genotyped for MYH7 and MYBPC3 in that order, stopping once a positive finding was detected.

      CaseGenotypingMethod: Genomic DNA was extracted from peripheral blood. Each gene's coding exons and flanking introns were subject to PCR amplification and sequencing. From there, any variants found were filtered for pathogenicity and low frequencies.

      Variant: NM_000257.3:c.2155C>T (p.Arg719Trp)

      ClinVar: 14104 https://www.ncbi.nlm.nih.gov/clinvar/variation/14104/

      gnomAD: European (Non-Finnish) 6.481e-5, Overall 3.185e-5 https://gnomad.broadinstitute.org/variant/14-23895180-G-A

    1. Supplementary Material 4

      Case M-10: Japanese

      DiseaseAssertion: idiopathic cardiomyopathy (HCM and DCM)

      CasePreviousTesting: Clinical evaluation, chest radiography, electrocardiography, echocardiography, cardiac catheterization, full testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1)

      CaseGenotypingMethod: 8 sarcomeric genes amplified from genomic DNA via PCR then screened using bidirectional direct sequencing

      Variant: NM_000257.3(MYH7):c.1987C>T (p.Arg663Cys)

      ClinVar: 42874, https://www.ncbi.nlm.nih.gov/clinvar/variation/42874/

      gnomAD: n/a

    2. Supplementary Material 4

      Case M-6: Japanese

      DiseaseAssertion: idiopathic cardiomyopathy (HCM and DCM)

      CasePreviousTesting: Clinical evaluation, chest radiography, electrocardiography, echocardiography, cardiac catheterization, full testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1)

      CaseGenotypingMethod: 8 sarcomeric genes amplified from genomic DNA via PCR then screened using bidirectional direct sequencing

      Variant 2: NM_000257.3(MYH7):c.1357C>T (p.Arg453Cys)

      ClinVar: 14089, https://www.ncbi.nlm.nih.gov/clinvar/variation/14089/

      gnomAD: n/a

    3. Supplementary Material 4

      Case M-23: Japanese

      DiseaseAssertion: idiopathic cardiomyopathy (HCM and DCM)

      CasePreviousTesting: Clinical evaluation, chest radiography, electrocardiography, echocardiography, cardiac catheterization, full testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1)

      CaseGenotypingMethod: 8 sarcomeric genes amplified from genomic DNA via PCR then screened using bidirectional direct sequencing

      Variant: NM_000257.3(MYH7):c.2546T>C (p.Met849Thr)

      ClinVar: 42914, https://www.ncbi.nlm.nih.gov/clinvar/variation/42914/

      gnomAD: n/a

    4. Supplementary Material 4

      Case M-30: Japanese

      DiseaseAssertion: idiopathic cardiomyopathy (HCM and DCM)

      CasePreviousTesting: Clinical evaluation, chest radiography, electrocardiography, echocardiography, cardiac catheterization, full testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1)

      CaseGenotypingMethod: 8 sarcomeric genes amplified from genomic DNA via PCR then screened using bidirectional direct sequencing

      Variant: NM_000257.3(MYH7):c.2803G>A (p.Glu935Lys)

      ClinVar: 14106, https://www.ncbi.nlm.nih.gov/clinvar/variation/14106/

      gnomAD: n/a

    5. Supplementary Material 4

      Case M-9: Japanese

      DiseaseAssertion: idiopathic cardiomyopathy (HCM and DCM)

      CasePreviousTesting: Clinical evaluation, chest radiography, electrocardiography, echocardiography, cardiac catheterization, full testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1)

      CaseGenotypingMethod: 8 sarcomeric genes amplified from genomic DNA via PCR then screened using bidirectional direct sequencing

      Variant: NM_000257.3(MYH7):c.1987C>T (p.Arg663Cys)

      ClinVar: 42874, https://www.ncbi.nlm.nih.gov/clinvar/variation/42874/

      gnomAD: n/a

    6. Supplementary Material 4

      Case M-26: Japanese

      DiseaseAssertion: idiopathic cardiomyopathy (HCM and DCM)

      CasePreviousTesting: Clinical evaluation, chest radiography, electrocardiography, echocardiography, cardiac catheterization, full testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1)

      CaseGenotypingMethod: 8 sarcomeric genes amplified from genomic DNA via PCR then screened using bidirectional direct sequencing

      Variant: NM_000257.3(MYH7):c.2609G>A (p.Arg870His)

      ClinVar: 14120, https://www.ncbi.nlm.nih.gov/clinvar/variation/14120/

      gnomAD: 0.000007072, https://gnomad.broadinstitute.org/variant/14-23894048-C-T

    1. HCM443

      Case#: HCM443, female, 28 years, not a smoker

      DiseaseAssertion: HCM

      FamilyInfo: None

      CasePresentingHPOs: 46mm LAD, 17mm LVST, 44mm LVEDD, 69% LVEF, 18mm Maxi LVWT, 68mmHg Maxi LVOTG, 103385170 raw RNA-seq reads, 96969874 HQ reads (93.79%), 96.18% mapping rate, 707524 total variant, 33016 exonic variant

      CaseHPOFreeText: N/A

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      CaseGenotypingMethod: RNA-seq, read mapping, variant calling, identify functional variants, differential expression analysis, miRWalk miRNA target prediction, LncRNA annotation, Co-expression network analysis, PPI network analysis, gene over-representation analysis,

      Variant: NM_000257.4(MYH7):c.2221G>T (p.Gly741Trp)

      ClinVar: 177665 https://www.ncbi.nlm.nih.gov/clinvar/variation/177665/

      CAID: N/A

      gnomAD: absent

    2. HCM431

      Case#: HCM431, male, 24 years, not a smoker

      DiseaseAssertion: HCM

      FamilyInfo: None

      CasePresentingHPOs: 57mm LAD, 18mm LVST, 49mm LVEDD, 80% LVEF, 21mm Maxi LVWT, 80mmHg Maxi LVOTG, 95467544 raw RNA-seq reads, 91611504 HQ reads (95.96%), 96.60% mapping rate, 701266 total variant, 33263 exonic variant

      CaseHPOFreeText: N/A

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      CaseGenotypingMethod: RNA-seq, read mapping, variant calling, identify functional variants, differential expression analysis, miRWalk miRNA target prediction, LncRNA annotation, Co-expression network analysis, PPI network analysis, gene over-representation analysis,

      Variant: NM_000257.4(MYH7):c.4066G>A (p.Glu1356Lys)

      ClinVar: 164294 https://www.ncbi.nlm.nih.gov/clinvar/variation/164294/

      CAID: N/A

      gnomAD: absent

    3. HCM483

      Case#: HCM483, male, 37 years, smoker

      DiseaseAssertion: HCM

      FamilyInfo: None

      CasePresentingHPOs: 57mm LAD, 23mm LVST, 40mm LVEDD, 72% LVEF, 26mm Maxi LVWT, 70mmHg Maxi LVOTG, 132375212 raw RNA-seq reads, 125845538 HQ reads (95.07%), 96.52% mapping rate, 838862 total variant, 35806 exonic variant

      CaseHPOFreeText: N/A

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      CaseGenotypingMethod: RNA-seq, read mapping, variant calling, identify functional variants, differential expression analysis, miRWalk miRNA target prediction, LncRNA annotation, Co-expression network analysis, PPI network analysis, gene over-representation analysis,

      Variant: NM_000257.4(MYH7):c.1816G>A (p.Val606Met)

      ClinVar: 14091 https://www.ncbi.nlm.nih.gov/clinvar/variation/14091/

      CAID: N/A

      gnomAD: 0.00001548 European (non-finnish) https://gnomad.broadinstitute.org/variant/14-23896866-C-T

    1. CaseMYH7-5: Japan, Asian

      CasePresentingHPOs: HP:0001639, HP:0006685 (Hypertrophic cardiomyopathy, Endomyocardial fibrosis)

      HPOsFreeText: N/A

      CaseNotHPOs: N/A

      NotHPOsFreeText: N/A

      CaseAddInfo:


      CaseGenotypingMethod: Genomic DNA was extracted from whole blood from each proband. They each had 95 genes associated with DCM, HCM, and other inherited cardiovascular diseases sequenced with a panel, including both the exons and spicing regions. Variants were then filtered for rarity and pathogenicity.


      Variant: NM_000257.3:c.2155C>T (p.Arg719Trp)

      ClinVar: 14104 https://www.ncbi.nlm.nih.gov/clinvar/variation/14104/

      gnomAD: European (Non-Finnish) 6.481e-5, Overall 3.185e-5 https://gnomad.broadinstitute.org/variant/14-23895180-G-A

    2. CaseMYH7-1: Japan, Asian

      CasePresentingHPOs: HP:0001639, HP:0006685 (Hypertrophic cardiomyopathy, Endomyocardial fibrosis)

      HPOsFreeText: N/A

      CaseNotHPOs: N/A

      NotHPOsFreeText: N/A

      CaseAddInfo:


      CaseGenotypingMethod: Genomic DNA was extracted from whole blood from each proband. They each had 95 genes associated with DCM, HCM, and other inherited cardiovascular diseases sequenced with a panel, including both the exons and spicing regions. Variants were then filtered for rarity and pathogenicity.


      Variant: NM_000257.3:c.2803G>A (p.Glu935Lys)

      ClinVar: 14106 https://www.ncbi.nlm.nih.gov/clinvar/variation/14106/

      gnomAD: Not in gnomAD

    1. Table 5

      Case LO13: Italian

      DiseaseAssertion: HCM (late-onset)

      FamilyInfo: positive family history

      CasePreviousTesting: echocardiography, Full testing (MYBPC3, MYH7, TNNT2, TNNI3, TPM1, MYL2, MYL3, ACTC1), additional testing: (GLA, LAMP2, PRKAG2, TNNC1, MYH6, CSPR3, PLN, TCAP, CAV3), electrocardiography

      CaseGenotypingMethod: Genomic DNA extracted from periphera whole blood, emulsion PCR, 17 HCM genes sequenced using Personal Genome Machine (PGM) IonTorrent sequencer, variants confirmed via Sanger sequencing

      Variant: NM_000257.3(MYH7):c.1816G>A (p.Val606Met)

      ClinVar: 14091, https://www.ncbi.nlm.nih.gov/clinvar/variation/14091/

      gnomAD: 0.000007070, https://gnomad.broadinstitute.org/variant/14-23896866-C-T

    1. Supplemental data table e-1

      Case: MYH7 Case 1

      InheritancePattern: autosomal recessive

      DiseaseEntity: n/a

      PreviouslyPublished: PMID: 29300372

      PreviousTesting: Not specified

      CaseGenotypingMethod: paper notes single gene, NGS, and WES were used, but does not specify which method was used for each individual family

      Variant: NM_000257.4(MYH7):c.1358G>A (p.Arg453His)

      ClinVar: 42838, https://www.ncbi.nlm.nih.gov/clinvar/variation/42838/

      gnomAD: n/a

    2. Supplemental data table e-1

      Case: MYH7 Case 2

      InheritancePattern: autosomal recessive

      DiseaseEntity: n/a

      PreviouslyPublished: PMID: 27282841

      PreviousTesting: Not specified

      CaseGenotypingMethod: paper notes single gene, NGS, and WES were used, but does not specify which method was used for each individual family

      Variant: NM_000257.4(MYH7):c.5459G>A (p.Arg1820Gln)

      ClinVar: 419278, https://www.ncbi.nlm.nih.gov/clinvar/variation/419278/

      gnomAD: 0.00001989, https://gnomad.broadinstitute.org/variant/14-23884304-C-T

    1. Country: Portugal

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      GenotypingMethod: Genetic testing was performed at the discretion of participating centers and laboratories. All variants were classified by pathogenicity based on ClinVar interpretations and populations frequency.

      PreviousTesting: All nine sarcomeric genes (MYH7, MYBPC3, TNNT2, TNNI3, MYL2, MYL3, ACTC1, TPM1, CSRP3) were compared with others likely being done depending on the submitting center/lab.

      VariantAddInfo: 7 individuals inc. carriers reported

      Variant: NM_000257.4(MYH7):c.2539_2541del (p.Lys847del)

      ClinVar: 42913 https://www.ncbi.nlm.nih.gov/clinvar/variation/42913/

      gnomAD: Not in gnomAD

    1. 4

      Case4: Male, 26 years report, Netherlands

      CasePresentingHPOs: HP:0011663, HP:0011675, HP:0001279, HP:0005135, HP:0001707, HP:0004308, HP:0001711 (Right ventricular cardiomyopathy, Arrhythmia, Syncope, Abnormal T-wave, Abnormality of the right ventricle, Ventricular arrhythmia, Abnormality of the left ventricle)

      HPOsFreeText: Positive EPS inducibility

      CaseNotHPOs: HP:0001639, HP:0001635 (Hypertrophic cardiomyopathy, Congestive heart failure)

      NotHPOsFreeText: ECG Depolarization abnormality, Cardiac transplant

      CaseAddInfo:


      CasePreviousTesting: No variants were in any of DSP, PKP2, DSG2, DSC2, and JUP. Patients were tested for variants in ACTC1, MYBPC3, MYH7, MYL2, MYL3, TNNC1, TNNI3, TNNT2, and TPM1.

      CaseGenotypingMethod: 92 patients underwent panel sequencing of the specific genes listed above, and 45 were subject to Whole Exome Sequencing to locate variants. Afterwards, all variants were verified by PCR amplification and Sanger sequencing and filtered for pathogenicity.


      Variant: NM_000257.3:c.2167C>T (p.Arg723Cys)

      ClinVar: 14095 https://www.ncbi.nlm.nih.gov/clinvar/variation/14095/

      gnomAD: South Asian 3.266e-5, Overall 1.194e-5 https://gnomad.broadinstitute.org/variant/14-23895023-G-A

    1. CaseA: Female, 49 yrs report

      DiseaseEntity: Hypertrophic Cardiomyopathy (AD)

      FamilyInfo: Has a monozygotic twin sister w/ same genotype and similar phenotype who lived far apart and had different living environments / life habits, Other family members were diagnosed with HCM afterwards and were genotype positive, See Figure 3 for pedigree

      CasePresentingHPOs: HP:0001962, HP:0002875, HP:0001639, HP:0005110, HP:0031185, HP:0011713, HP:0001670, HP:0031295, HP:0030718, HP:0006683, HP:0001712 (Palpitations, Exertional dyspnea, Hypertrophic cardiomyopathy, Atrial fibrillation, Increased NT-proBNP level, Left bundle branch block, Asymmetric septal hypertrophy, Left atrial enlargement, Right atrial enlargement, Abnormal ventricular filling, Left ventricular hypertrophy)

      HPOsFreeText: N/A

      CaseNotHPOs: HP:0031480 (Abnormal mitral valve leaflet morphology)

      NotHPOsFreeText: N/A

      CaseAddInfo: N/A

      CasePreviousTesting: Elevated cardiac troponin T (cTnT) (19 ng/L; reference 0-14), Elevated N-terminal pro-brain natriuretic peptide (NT-proBNP) (10,214 pg/mL; reference 0-88 pg/mL), Electrocardiogram (ECG) and multi-modality imaging

      CaseGenotypingMethod: Whole exome sequencing was performed in the twins using Illumina Hiseq 2500. Low quality variations were filtered and analysed to find potentially pathogenic mutations. The findings were then confirmed using Sanger sequencing.

      Variant: NM_000257.4(MYH7):c.2302G>A (p.Gly768Arg)

      ClinVar: 164337 https://www.ncbi.nlm.nih.gov/clinvar/variation/164337/

      gnomAD: Not in gnomAD

    1. The proband (III1)

      CaseIII-1: Male, China, Asian, 51 years report

      CasePresentingHPOs: HP:0001962, HP:0100749, HP:0002094, HP:0500020, HP:0031185, HP:0004755, HP:0031295, HP:0011103 (Heart palpitations, Chest pain, Dyspnea, Abnormal cardiac biomarker test, Increased NT-proBNP level, Supraventricular tachycardia, Left atrial enlargement, Abnormality of the left ventricular outflow tract)

      HPOsFreeText: Experienced palpitations for 9 years, Chest pain and mild dyspnea for 2 years, Slightly elevated cardiac troponin T level of 21.8 ng/L (normal 0 to 14 ng/L), Significantly elevated N-terminal pro-brain natriuretic peptide level of 537 pg./mL (normal 0 to 125 pg/mL), ECG showed non-specific ST_T change, Preserved biventricular systolic function, Severe LV outflow tract obstruction (peak aortic outflow velocity = 4.8 m/s, peak gradient = 92 mmHg), Proband had a sigmoid septum with LV outflow tract obstruction and LV mass index to body surface area (BSA) of 87.2 g/m2

      CaseNotHPOs: HP:0001677 (Coronary artery disease)

      NotHPOsFreeText: N/A

      CaseAddInfo:


      CaseGenotypingMethod: Genomic DNA was acquired from the proband and all surviving members of his extended family. These were all tested by a 117 gene screening panel that were connected to Cardiomyopathy. The results were confirmed by Sanger sequencing and the variants found were filtered for pathogenicity.


      Variant: NM_000257.3:c.4130C>T (p.Thr1377Met)

      ClinVar: 42992 https://www.ncbi.nlm.nih.gov/clinvar/variation/42992/

      gnomAD: European (Non-Finnish) 8.791e-6, Overall 3.977e-6 https://gnomad.broadinstitute.org/variant/14-23887458-G-A


      Segregation

      Affected: 9

      Unaffected: 17

      Segregations: 23

      PublishedLOD: N/A

      eLOD: 6.92

      AddSegInfo: 6 individuals died before this investigation so clinical data and phenotypes could not be collected, 10 individuals were genotype positive but phenotype negative

    1. CaseIII-6: Female, 32 years report, 17 years diagnosis, China, Asian

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      FamilyInfo: Proband's son had the same variant; the father had echocardiograph results but was asymptomatic

      CasePresentingHPOs: HP:0001639, HP:0002094, HP:0100749, HP:0001962, HP:0001279, HP:0030879 (Hypertrophic cardiomyopathy, Dyspnea, Chest pain, Palpitations, Syncope, Interlobular septal thickening on pulmonary HRCT)

      HPOsFreeText: Septum thickness 25 mm, Left ventricle at 44 mm, Left atrium at 40 mm, Ejection fraction at 54%

      CaseNotHPOs: N/A

      NotHPOsFreeText: N/A

      CaseAddInfo: Mutation is classified as de novo

      CasePreviousTesting: See list of 26 genes under Target sequence capture sequencing

      CaseGenotypingMethod: Genomic DNA was extracted from the proband and other family members. Afterwards, it was subject to PCR amplification and sequencing. Any variants found were confirmed with Sanger sequencing before being filtered for pathogenicity.

      Variant: NM_000257.3:c.2146G>A (p.Gly716Arg)

      ClinVar: 14105 https://www.ncbi.nlm.nih.gov/clinvar/variation/14105/

      gnomAD: Not in gnomAD

    1. Here, we report detailed biochemical characterization and mechanochemical cycle modeling of recombinant human β-cardiac myosin motor domains carrying five DCM mutations

      DiseaseAssertion: DCM

      Variant1: NM_000257.3(MYH7):c.602T>C (p.Ile201Thr)

      ClinVar: 43093, https://www.ncbi.nlm.nih.gov/clinvar/variation/43093/

      gnomAD: n/a

      Variant2: NM_000257.3(MYH7):c.667G>A (p.Ala223Thr)

      ClinVar: 14112, https://www.ncbi.nlm.nih.gov/clinvar/variation/14112/

      gnomAD: 0.000003976, https://gnomad.broadinstitute.org/variant/14-23900859-C-T

      Variant3: NM_000257.3(MYH7):c.709C>T (p.Arg237Trp)

      ClinVar: 43098, https://www.ncbi.nlm.nih.gov/clinvar/variation/43098/

      gnomAD: 0.00001193, https://gnomad.broadinstitute.org/variant/14-23900817-G-A

      Variant4: NM_000257.3(MYH7):c.1594T>C (p.Ser532Pro)

      ClinVar: 14108, https://www.ncbi.nlm.nih.gov/clinvar/variation/14108/

      gnomAD: n/a

      Variant5: NM_000257.3(MYH7):c.2292C>G (p.Phe764Leu)

      ClinVar: 14109, https://www.ncbi.nlm.nih.gov/clinvar/variation/14109/

      gnomAD: n/a

    1. HCM085

      CaseHCM085: 49 yrs report, Vietnam, Asian

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0001712, HP:0002875, HP:0011103, HP:0031295, HP:0001653, HP:0001279 (Left ventricular hypertrophy, Exertional dyspnea, Abnormality of the left ventricular outflow tract, Left atrial enlargement, Mitral regurgitation, Syncope)

      HPOsFreeText: Maximal LV thickness 19 mm

      CaseNotHPOs: HP:0005110, HP:0001297, HP:0004756 (Atrial fibrillation, Stroke, Ventricular tachycardia)

      NotHPOsFreeText: N/A

      CaseAddInfo: N/A

      CasePreviousTesting: The gene panel included 10 sarcomeric genes (MYH7, MYBPC3, TNNT2, TNNI3, TPM1, MYL2, MYL3, ACTC1, TNNC1, MYH6), 9 genes encoding Z-disk components and Ca2+ homeostasis factors (LDB3, CSRP3, TCAP, VCL, ACTN2, MYOZ2, NEXN, JPH2, PLN), and 4 genes involved in HCM phenocopies (GLA, LAMP2, PRKAG2, TTR), All probands had left ventricular wall thickness >= 15 mm and no other diseases that can cause secondary hypertrophy

      CaseGenotypingMethod: The coding region, flanking sequences, and untranslated regions of each gene were enriched by LC-PCR, amplified, and sequenced on the Illumina MiSeq or MiniSeq platform. Identified variants were then filtered for pathogenicity and confirmed by Sanger sequencing.

      Variant: NM_000257.4(MYH7):c.1750G>A (p.Gly584Ser)

      ClinVar: 42862 https://www.ncbi.nlm.nih.gov/clinvar/variation/42862/

      gnomAD: Not in gnomAD

    1. Pedigree 3

      Case: Pedigree 3 proband, female, 3mo at diagnosis, North African and Jewish

      CasePresentingHPOs: HP:0001644 (dilated cardiomyopathy)

      HPOsFreeText: clinical severity: severe (fatal)

      CaseNotHPOs:

      NotHPOsFreeText: skeletal involvement

      CasePreviousTesting: exact genes sequenced not specified

      CaseGenotypingMethod: DCM CardioChip, included 19 genes known to cause DCM

      Variant 1: NM_000257.3(MYH7):c.427C>T (p.Arg143Trp)

      ClinVar: 164401, https://www.ncbi.nlm.nih.gov/clinvar/variation/164401/

      gnomAD: 0.00002784, https://gnomad.broadinstitute.org/variant/14-23901923-G-A

      Variant 2: NM_000257.4(MYH7):c.4588C>T (p.Arg1530Ter)

      ClinVar: 43029, https://www.ncbi.nlm.nih.gov/clinvar/variation/43029/

      gnomAD: 0.00001591, https://gnomad.broadinstitute.org/variant/14-23886133-G-A

      FamilyInfo: mother is of North African and Iraqi‐Jewish descent, while the father is of North African and Balkan Jewish descent, probands brother died at 3.5mo and also carried both variants, maternal cousin died of RCM in early childhood, maternal aunt carried p.R143W

    1. 8

      Case8: Female, 12 yrs onset, Slovakia

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      FamilyInfo: Affected family members

      CasePresentingHPOs: HP:0001639 (Hypertrophic Cardiomyopathy)

      HPOsFreeText: N/A

      CaseNotHPOs: N/A

      NotHPOsFreeText: Normal LV ejection fraction

      CasePreviousTesting: ABCC9, ACTC1, ACTN2, ANKRD1, CASQ2, CAV3, CRYAB, CSRP3, CTF1, DES, DSC2, DSG2, DSP, DTNA, EMD, FHL2, GLA, JUP, LAMA4, LAMP2, LDB3, LMNA, MYBPC3, MYH6, MYH7, MYL2, MYL3, MYLK2, MYOZ2, NEXN, PKP2, PLN, PRKAG2, RBM20, RYR2, SGCD, TAZ, TCAP, TMEM43, TNNC1, TNNI3, TNNT2, TPM1, TTN, TTR, VCL were all tested on NGS panel

      CaseGenotypingMethod: Genomic DNA was extracted from whole blood and samples were purified and amplified. The coding exons for the above genes were enriched and sequenced. The resulting variants were analyzed and filtered for predicted pathogenicity.

      CaseAddInfo: N/A

      Variant: NM_000257.4(MYH7):c.746G>A (p.Arg249Gln)

      ClinVar: 14088 https://www.ncbi.nlm.nih.gov/clinvar/variation/14088/

      gnomAD: Not in gnomAD

      MultipleGeneVariants

      (1) DSP Variant

      Variant: NM_004415.4(DSP):c.484C>G (p.Arg162Gly)

      ClinVar: 546994 https://www.ncbi.nlm.nih.gov/clinvar/variation/546994/

      gnomAD: 0.00006152, http://gnomad.broadinstitute.org/variant/6-7559520-C-G

    1. all 74 patients with finally confirmed Pompe

      GroupPresentingHPOs: HP:0003701, HP:0003327, HP:0003325, HP:0003236

      HPOsFreeText: average GAA activity with inhibitor of 0.18 nmol/punch × 21 hours

      GroupNotHPOs: n/a

      NotHPOsFreeText: n/a

      NumberMales: 32 (44%)

      NumberFemales: 42 (56%)

      CountryOrigin: n/a

      Ethnicity: n/a

      Race: n/a

      AgeRange: 18-81 years, median = 48 years

      TotalNumber: 74

      FamilyInfo: n/a

      NoFamily: n/a

      GroupPreviousTesting: DBS collected from peripheral vein analyzed with fluorometric assay

      GroupGenotypingMethod: Sanger sequencing of coding and exon flanking region of GAA gene

      Variant Count: 74

      Variant: NM_000152.4(GAA):c.-32-13T>G

      ClinVar: 4027, https://www.ncbi.nlm.nih.gov/clinvar/variation/4027/

      gnomAD: 0.003582, http://exac.broadinstitute.org/variant/17-78078341-T-G

    1. c.1827delC(p.Tyr609*)

      Case66

      HPOsFreeText: See Group Phenotypes


      CasePreviousTesting: Sanger sequencing

      CaseMethod1: Sanger sequencing and PCR Amplification

      CaseMethod2: Whole Exome Sequencing (WES)

      CaseGenotypingMethod: Patients were previously confirmed with Pompe disease by Sanger sequencing to capture the pathogenic variants. The process was repeated as part of the study taking care to amplify the coding regions and exon/intron boundaries to compare with the WES results afterwards.


      Variant1: NM_000152.4:c.1827delC (p.Tyr609*)

      ClinVar: 188936 https://www.ncbi.nlm.nih.gov/clinvar/variation/188936/

      gnomAD: European (Non-Finnish) 7.181e-5, Overall 3.260e-5 http://gnomad.broadinstitute.org/variant/17-78086448-AC-A


      Variant2: NM_000152.4:c.-32-13T>G

      ClinVar: 4027 https://www.ncbi.nlm.nih.gov/clinvar/variation/4027/

      gnomAD: Ashkenazi Jewish 5.541e-3, Overall 3.401e-3 http://gnomad.broadinstitute.org/variant/17-78078341-T-G


      CaseAddInfo: Adult Late Onset Pompe Disease

    1. 20 mg/kg (N = 16)

      Case19HPOsFreeText: 20 mg/kg GAA treatment, GAA activity at 8 pmol/spot/hr, GAA activity at 33% lower limit of normal

      CaseAddInfo: Late Onset Pompe Disease


      CaseGenotypingMethod: Method not described, only that the diagnosis was "confirmed … based on 2 GAA gene mutations"


      Variant1: NM_000152.4:c.-32-13T>G

      ClinVar: 4027 https://www.ncbi.nlm.nih.gov/clinvar/variation/4027/

      gnomAD: Ashkenazi Jewish 5.541e-3, Overall 3.401e-3 https://gnomad.broadinstitute.org/variant/17-78078341-T-G


      Variant2: NM_000152.4:c.525delT (p.Glu176Argfs)

      ClinVar: 4033 https://www.ncbi.nlm.nih.gov/clinvar/variation/4033/

      gnomAD: European (Non-Finnish) 1.880e-4, Overall 9.959e-5 https://gnomad.broadinstitute.org/variant/17-78078909-CT-C


      CaseAddInfo: